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Fluorescent hybridisation methodologies have not changed in principles over the past 
30 years, with the increase of computational sequencing technologies causing the 
replacement of in situ hybridisations. Fluorescence in situ hybridisation (FISH) is in need of 
a refresh to be a worthwhile tool in a modern day cytogenetic laboratory to overcome 
short comings of these new methods. The creation of the novel multilayer FISH protocol 
has effectively eliminated many negative aspects of classic FISH based experiments, such as 
a large reduction in cost and is no longer as limited by fluorophore availability. Here 
presented within this thesis is the creation of this methodology and application to a wide 
variety of cytogenetic hypothesises.  
Key species from the Galliform order were investigated in order to detect previously 
missed intrachromosomal rearrangements within their macrochromosomes, a premise 
formerly overlooked. Rearrangements were found within chromosomes of the galliforme 
species used such as E.chinensis which displays a intrachromosomal inversion on the p-arm 
of chromosome 2. Furthermore, the creation of an interphase state folding prediction tool 
has been used to assess the arrangement of macrochromosomes during cellular growth 
stages within G.gallus. Here it is noted that there are particular arrangements identified 
which are similar across chromosomes studied.  
The chicken lymphoma cell line DT40 is of great importance in B-cell receptor studies along 
with gene disruption experiments. Presented here is an updated karyotype for the cell line. 
Here shows contrasting and more in-depth evidence of aberrations to further develops our 
understanding of the genomic arrangement of this useful cell line.  
The level of tumour heterogeneity in a cancer is a diagnostic tool allowing clinicians to 
comment on therapeutic choices and prognosis of the disease. Found to be dominant in 
recurrent cancers, cytotoxic resistant tumour cell populations may indeed exist within 
initial primary tumours at low frequency to be positively selected during chemotherapy. 
Within a neuroblastoma cell line, and cyto-toxic resistant derivatives lines, there has been 
identified a level of genomic heterogeneity which may give clues towards the generation of 




1. Introduction - An overview of cytogenetics 
1.1 The Chromosome 
1.1.1 A brief history of the chromosome 
 Thought to be first observed by von Nägeli in 1848 (Nägeli ,1884) the naming of the 
chromosome, and more precisely chromatin, was coined by von Waldeyer-Hartz 
(Waldeyer, 1888) alongside W. Flemming who proposed the idea of a heritable element 
within the nucleus came from a parental nucleus (Flemming, 1878). It was not until the 
early 1900’s until the karyotype was defined as the phenotypic representation of the 
genetic content found within cells in the form of somatic chromosomes. (Levitsky, 1924; 
Levitsky, 1931) and identifying that it was the chromosome which was the means of 
inheritance via the Boveri-Sutton theory (Sutton, 1902; Sutton, 1903; Wilson 1925). This 
work made the Mendelian theory popular and led to the famous Drosophila mutations 
experiments by Thomas Hunt Morgan showing patterns of inheritance of phenotypic 
changes from one generation to the next, alongside the proposal of genetic linkage and 
crossing over (Morgan, 1910). The number of chromosomes present within humans was 
debated initially, from a XX/XO sex determination system resulting in 48 chromosomes 
(Winiwarter, 1912), down to 46 (Painter, 1922) but later re-established as 48 with the 
discovery of the correct XX/XY sex determination mechanism (Painter, 1923). It was not 
until 1956 when a new methodology of isolating chromosomes was created where the 
count of 46 was confirmed (Tjio & Levan, 1956). Improvements in cytogenetic methods 
rapidly improved the study of chromosomes till the end of the century where a predictive 
computational approach rose in popularity as with most research in the modernising digital 
age.  
1.1.2 Eukaryote chromosome structure  
Eukaryotic cells localise their DNA within the nucleus of the cell; with the interaction of 
scaffold proteins, the DNA-protein structures (chromatin) can be manipulated further as a 
means of gene switching and packing efficiency. The association of DNA to histone 
octamers makes up the nucleosome, which in-turn best represents the 10nm ‘beads on a 
string’ model that allows genes to be actively transcribed from (Olins & Olins, 2003). With 
regards to the structure conformed by the nucleosome-DNA interactions, there are 
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additional associations to linker histones causes further condensing of the structure, found 
commonly in regions of less active genes  (Hammond et al., 2017; Wanner & Formanek, 
2000). During cellular replicative periods, scaffold proteins associate with the DNA-histone 
complex to again condense these vast structures (completely inhibiting transcription) into 
the commonly recognised chromosome shape that is essential for correct cellular division 
(Fukui, 2009). Following DNA replication, each length of DNA – a single chromatid – now 
exists as two identical copies (in regards to somatic cells), in which these two identical 
‘sister chromatids’ are connected by the centromere complex and cohesin protein rings 
(Gligoris & Löwe, 2016; Naumova et al., 2013).  
Each chromosome has two ‘arms’, which resemble the length of chromatin either side 
of the chromosome; the ‘p’ (petit) arm being the shorter and the ‘q’ arm the longer. 
Chromosomes are further categorised by the relative ratio of p to q arm size; a 
chromosome of equal arm size are termed metacentric, slight offsets of arm size from 
centromere are referred to as submetacentric chromosomes, when q arms are much 
longer than p arms places them into the acrocentric description and chromosomes with 
near non-visible p arms i.e. centromere is at the ‘top’ are termed telocentric (Levan, Fredga 
& Sandberg, 1964). Throughout each chromosome are lengths of relatively de-condensed 
(euchromatin) and more condensed (heterochromatin) regions. Within protein 
coding/associated regions of the chromosome, there are multiple elements that may be 
found such as enhancer regions, promoter regions, the transcribed and eventually 
translated exons and introns which are spaced between exons not to be translated. Typical 
of higher eukaryotes, repeat sequences are abundant throughout the genome, such as 
satellites and retrotransposons. Satellites are repeat sequences found at specific locations 
across the chromosomes and classified by the length of repeat, minisatellites for short 
nucleotide repeats and microsatellites for very small nucleotide repeats, such as di- and 
trinucleotide repeats. Centromeres can be an example of satellite regions – sequences that 
are commonly repeated. In humans this can be identified as α-satellites and can be used as 
targeted markers for chromosomal analysis (Mehta et al., 2010). Retrotransposons, or 
interspersed sequences are repetitive sequences that are found all over the genome as 
opposed to one location. Similar to satellites, they are further classified by size, short 
interspersed sequences (SINE), such as Alu elements which make up approximately 10% of 
the human genome (international Human Genome Sequencing Consortium, 2001; 2004), 
and long interspersed regions (LINE) of several thousand base pairs in length to make up 
approximately 21% of the human genome (Pierce, 2012). 
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As described, the chromosome is essential for cellular health and correct functionality; 
it is a highly specialised structure that has been the basis of evolutionary drive of eukaryotic 
organisms over time. However, chromosomal aberrations that cause a disruption in this 
specialised structure could be lethal or result in abnormal cellular activity, such as cancers 
or systemic genetic disorders. 
1.1.3 The cell cycle and cell division 
 The cell must be able to replicate a copy of itself for the purpose of the organism’s 
growth, repair, and reproduction. Within eukaryotic cells, this is classified as the cell 
division cycle which defines clear phases of cellular activity relating to this division process. 
(Bell & Dutta, 2002; Bertoli et al., 2013). 
1.1.3.1 Interphase 
Before the process of mitosis or meiosis, the cell must progress through interphase 
(Figure 1.1), this phase can be split into three distinct stages, two growth stages G1 and G2 
(Pardee, 1989) which flank S –phase, dedicated for chromosome replication (Takeda & 
Dutta, 2005). Each stage is shown to have highly conserved regulatory mechanisms crucial 
for the transition between stages (Nurse & Bissett, 1981; Foster et al., 2010). A newly 
constructed cell from a previous cycle shall enter at the G1 phase, to undergo high energy 
dependant metabolic activities such as protein synthesis (Pardee, 1989) to either progress 
further onto the cell cycle, s-phase (Figure 1.1) or leave the cycle to be in a state of rest, 
known as G0 where no cellular division happens. The cell will enter G0 any time before the 
restriction point, but once past this checkpoint stage it is committed towards division 
(Pardee, 1974). S-phase is the dedicated genetic content replication step, where cellular 
functions focus on the duplication of material adequate for two identical daughter cells 
(Nurse & Bissett, 1981; Aparicio et al., 1997). The phase after is G2, the second gap phase 
(Figure 1.1) where cellular machinery for division is developed and recruited (Zhai et al. 
1996; Meraldi et al., 1999) and can be a means of controlling cellular size via Cdr2 
regulation, as shown in yeast (Moseley et al., 2009). Before entry into division, G2 acts as a 
checkpoint to detect any errors in the DNA (O'Connor, 1997) to be repaired via 
homologous recombination (Burgoyne et al., 2007). Failure to so could lead onto 
malformed daughter cells but typically end up in cell apoptosis (Li et al., 1998); the 
mechanisms to achieve this are also highly regulated, such as the ability to detect mutative 
stress factors via p53 (Taylor & Stark, 2001) and the specific signal pathway to arrest the 
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cell cycle at this stage in order to correctly repair the genetic content of the cell (Xiao et al., 
2003; Charrier-Savournin et al., 2004).  
1.1.3.2 Mitosis 
The majority of human cells are produced as a result of mitotic cellular division, with 
the exception of sex gametes which are instead produced by meiosis. Mitosis can be 
subdivided further into separate stages, each with distinctive identifiers as represented in 
figure 1.1 and seen in live cells in figure 1.2. The first stage of mitosis is prophase, classified 
by the phosphorylation and therefore breaking down of the nuclear membrane releasing 
the now condensing chromatin strands (chromosomes) into the cellular interior 
(Schermelleh et al., 2008). Microtubules from the centrosome shall start to attach to each 
chromosome at the kinetochore (Chan et al., 2005a); the kinetochore being a 
protein/microtubule structure that has been synthesised on each centromere during this 
stage (Chan et al., 2005). When all microtubules are attached to every kinetochore, the cell 
now enters metaphase. Here the spindles pull the chromosomes towards the approximate 
midline of the cell, the metaphase plate (Winey et al., 1995). At the metaphase plate, the 
spindle/metaphase checkpoint ensures correct attachment of kinetochores and proper 
alignment of chromosomes (Chan & Yen, 2003); mistakes at this stage would cause the 
daughter cells to have incorrect chromosomal counts (aneuploidy) to arise in diverse 
phenotypic results (cancer) or cellular death (Santaguida & Amon, 2015). After the 
metaphase checkpoint, the cell progresses into anaphase, being signalled by the cleaving of 
cohesisns which bind the sister chromatids together (Rao et al., 2001). The mechanics of 
kinetochore microtubules cause the pulling of the separated sister chromatids to the 
opposite poles of the cell, paired with alternate microtubules which push against one 
another and the cell membrane to elongate the cell in parallel to chromatid separation 
(Civelekoglu-Scholey & Cimini 2014; Asbury, 2017). With separation finished the cell enters 
telophase, in which the chromosomes start to de-condense as the nuclear envelope 
reforms around them (Sansregret & Petronczki 2013), leading directly onto cytokinesis and 
the development of the cleavage furrow (which acts as a contractile ring) at the metaphase 


























Figure 1.1. The cell cycle for eukaryotic cells 
The cyclic nature of the cell cycle is shown, split up into interphase (thick black 
arrow), metaphase (green) and cytokinesis (purple). A representative 2n cell is shown at 
key points to visually describe the replication and separation of chromatids.  
Figure 1.2. Examples of human cells in stages of mitosis 
Live human induce pluripotent cells (hiPS) captured in increments along the cell 
cycle. DNA is labelled with NucBlue (Cyan) and cell membranes with CellMask Deep Red 
(magenta) 




1.1.4 Chromosomal abnormities and aberrations 
1.1.4.1 Aneuploidy 
Aneuploidy is generally defined as the ‘state’ of the cell’s genome/karyotype as 
abnormal due to numerical number variations of whole chromosomes, which is not a result 
of a multiplication of the haploid number; the term was first named by G. Täckholm in 1922 
(Täckholm, 1922). Aneuploidy tends to be as result of chromosome mis-segregation during 
cellular division, which is a tightly regulated system as the spindle assembly checkpoint 
identifies most errors (Musacchio & Salmon, 2007; Pfau & Amon, 2012). Incorrect spindle 
fibre attachment and subsequent incorrect separation causes lagging chromosomes 
(Janssen et al., 2011), or in the event of a weakened mitotic checkpoint, incorrect pairing or 
lining up on the metaphase plate could cause whole copy number variations in the two 
daughter cells, known as non-disjunction. Lagging chromosomes can cause abnormalities in 
a multitude of ways; one example is be caught in the cleavage furrow formed in telophase, 
causing damage to elicit the DNA repair action of p53, which may cause aberrations such as 
translocations or deletions (Janssen et al., 2011; Crasta et al., 2012). Micronuclei can also 
form around lagging chromosomes, which facilitate a harsh environment for typical nuclear 
reactions causing a non-functional chromosome, and seen as an indicator for chromosomal 
instability (Crasta et al., 2012; Luzhna et al., 2013); a micronucleus can also stall DNA 
replication and induce stresses on the replication machinery to cause extensive DNA 
damage (Xu et al., 2011). Aneuploidy within cells tends to cause a change of gene 
expression of up to 50% (Stingele et al., 2012; Kahlem et al., 2004), and to detect the 
significance of the incorrect dosage at this scale requires complex live-cell imaging methods 
or extensive quantitative single cell genome analysis tools (Santaguida & Amon 2015). 
Aneuploidy is also noted to be the leading cause of miscarriages in humans, as frequencies 
of aneuploidy are, spontaneous abortions 35%, still births 4% and newborns 0.3% (Hassold 
& Hunt, 2001; Hassold et al., 1996; Hartl & Jones, 2005), and of high frequency in cancers 
>85% (Gordon et al., 2012; Weaver & Cleveland, 2006).  
1.1.4.2 Deletions 
Chromosome deletions are classified by segments of DNA being lost from the cell’s 
genome, typically during cellular division/DNA replication.  Small deletions, such as single 
base deletions, could lead to frameshift mutations which would interfere with the reading 
frames of codons in eukaryotic organisms, yielding incorrect transcription products (which 
may ultimately formulate as malformed proteins). 
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The magnitude of disruption deletions cause are somewhat reliant to a disruption to 
normal cellular processes, for example, single base deletions occur mainly due to single 
base flipping events or DNA slippage within DNA polymerase in that stage of DNA 
replication (Banavali, 2013; Manjari et al. 2014) . Other large-scale losses can be explained 
by losses during translocation events during chromosomal inversion events (Figure 1.3), 
unequal crossing over during meiosis (Comings, 1966; Jelesko, et al. 2004) and DNA 
breakage without rejoining.  
Deletions can cause systemic wide issues for the organism with large loss of gene 
products, for instance deletions of the 15q11-13 are indicative of Prader-Willi syndrome 
with loss of small nuclear RNAs, essential for regulation (Cavaillé et al., 2000; de Smith et 
al., 2009). Deletions, such as multiple micro-deletions along the Q arm of chromosome Y in 
males are associated with spematogenic failures (Krausz et al., 1999; Foresta et al., 2001); 
these deletions show that the Y chromosome has more function than just sex 
determination (Tiepolo & Zuffardi 1976; Burgoyne, 1998).  One of the more heavily studied 
in respect to deletions arising to tumorigenesis is the deletion of chromosome 17p, home 
to the p53 gene, TP53 (Isobe et al., 1986; Baker et al., 1989) and somewhat disrupted in at 
least 50% of all human tumours (Hollstein et al., 1991) indicating that this gene plays a vital 
role in cancer suppression (Surget et al., 2014). 
1.1.4.3 Duplications 
The term ‘duplication’ can compromise events such as as gene replication, whole 
chromosome duplication or gene amplification. These events act as a mechanism to 
increase the genetic content of the organism thus expanding the coding and conding 
elements within the genome.  Likewise with deletions, there are many cellular events that 
can cause duplications, such as unequal crossing over which can also duplicate a segment 
due to a possible large homologous region between chromatid pairs, (Comings, 1966; 
Jelesko, et al. 2004) and replication slippage. Whole chromosome number increases can be 
classified as duplication events. In the case of aneuploidy via non-disjunction during 
meiosis can give rise to whole chromosome increases such as in Down syndrome (Oliver et 
al., 2008) however aneuploidy events occur in approximately 15-20% of clinical pregnancies 
that result in a spontaneous abortion (Jia et al., 2015). The whole genome can be 
duplicated in polyploidy events, typically seen in plants as a means of speciation and 
adaptation (Rieseberg & Willis, 2007), with many examples of lineages expanding in ancient 
polyploidy events (Meyers & Levin, 2006). These can arise via autopolyploidy, such as the 
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potato (3n) (Potato Genome Sequencing Consortium, 2011; Visser et al., 2009) or by fusion 
between taxa -allopolyploidy- such as forms of wheat (6n) (Hancock, 2004).  Polyploidy is 
also present in animals where it is typically tied to evolutionary events (Dehal & Boore, 
2005) such as hox gene cluster duplications (Soshnikova et al., 2013) but also used for 
cellular, tissue and organ differentiation (Velicky, 2018). 
Diseases that may arise from duplication events are commonly caused by the over 
expression of specific gene products, typical of cancers such as MYC and cell cycle 
regulators CCND1 and CDK4 (Vogelstein & Kinzler, 2002). Examples of congenital conditions 
such as ‘Cat eye syndrome’, where 22p-q11 is in triplicate or quadruplicate (Rosias et 
al,2001), or Charcot-Marie-tooth disease which is caused by the duplication of 17p12 
containing PMP22 or 1p36.22 containing MFN2 (Krajewski et al.,2000; Baloh et al., 2007) 
both associated with nerve cell damage (Watila & Balarabe 2015).  
1.1.4.4 Translocations 
The rearrangement of chromosomes, the sharing of chromosome segments can be 
classified as translocations. Translocations come under different descriptive varieties, the 
quantity of DNA transferred between chromosomes (balanced or unbalanced) and by the 
method of translocation (reciprocal or Robertsonian, figure 1.3). 
The distinction between balanced and unbalanced is given as either: balanced, where a 
swap of equal genetic material occurs between chromosomes, typically non-homologous, 
which generally cause no loss or gain of function, or unbalanced translocations, which 
results in the exchanging of unequal volumes of DNA between chromosomes which can 
give rise to imbalances across the chromosomes affected.  Reciprocal translocations are 
characterised by the exchange of material between non-homologous chromosomes 
somewhat seen as a high occurrence estimated between 1-500 people (Ogilvie, 2002) to 1-
600 people (Estop, 1997). The majority of these are typically balanced, asymptomatic, and 
harmless to the organism yet may lead to fertility issues as gametogenesis can be impaired 
(Stern et al., 1999; Baccetti et al., 2003). XX male syndrome, or De la Chapelle syndrome, 
(De la Chapelle, 1972) demonstrates that approximately 90% of the cases are caused by a 
translocation aberration of the SRY gene to the X chromosome. This effectively causes 
individuals to either have a female karyotype (46,XX) but present phenotypically as males 
or alternatively a phenotypic female with a male karyotype (46,XY), without the SRY gene 
present on the Y (Margarit et al., 2000; Anık et al., 2013).  
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Robertsonian translocations, like to reciprocal translocations, can also be symptomless. 
However these abnormalities also carry the risk of unbalanced gametes to cause fertility 
issues (Keymolen et al., 2011). These translocations typically occur with the acrocentric 
chromosomes (Figure 1.3) as they contain highly similar DNA sequences within the short 
arms, thought to increase a possibility towards these types of translocations (Kim & 
Shaffer, 2002). These events yield a large metacentric appearing chromosome and a 
smaller gene poor chromosome which is typically lost during cellular division (Kim & 
Shaffer, 2002). Down syndrome is typically due to the trisomy of chromosome 21, however 
it can occur due to translocation events involving chromosome 21q, such as in the event of 
a Robertsonian translocations, between t(14;21) and t(21;21) (Polani et al., 1960; Penrose 
et al., 1960; Jyothy, 2002). This translocation event is somewhat comparable to trisomy 21 
as increase dosage of genetic material on the q arm is still present and expressed. 
However, findings indicate that the translocation causing sufferers express less severe 
learning difficulties and less severe obesity as compared to trisomy 21 sufferers (Prasher, 
1995).  
Translocations require two separate double strand breakages to occur. Double strand 
breakage can occur via pathological means such as during cellular processes like replication 
errors, destructive action at fragile sites and toposiomerase failures or via external 
influences such ionising radiation. Opposed to this, regulated non-random physiologic 
double strand DNA breaks can occur during V(D)J recombination and during class switching 
(Lieber, 2010). The breakages can either be repaired by homology directed repair during 
late S and G2 phase as the sister chromatid present act as a reference or donor, however 
outside of these stages non-homologous end joining (NHEJ) must occur to fix the breakages 
(Tsai & Lieber 2010).  NHEJ usually induces some nucleotide loss and no use of a template 
to guide any new nucleotide insertion by polymerases (Lieber, 2010). This can induce a 
translocation by joining arms from breakages from differing chromosomes during the 
repair step. It has been suggested that proximity of chromosomes involved in translocation 
events within the nuclei space are important for the aberration to occur (Roukos et al., 
2013). As a possible result from poorly mediated NHEJ, unbalanced translocations are 
typically iconic in formation of a wide variety of genetic diseases. Frequently acrocentric 
chromosomes are found to be malformed via unbalanced translocations in many cancers, 
more-so in blood cancers (Lin et al., 2018), thought to be as result of closer special 




Chromosome inversions occurs when a segment of a chromosome ‘flips’ and the gene 
order is reversed, either being paracentric when the reversed segment does not involve the 
centromere or pericentric when the centromere is located within the reversed segment. 
Many inversions do not cause any abnormalities, and are just evolutionary events that 
cause genetic dissimilarity and isolation between populations/species, creating post-zygotic 
barriers that prevent fertile heterozygotes (King, 1995) due to the inability to correctly 
balance chromosomes during crossing over events in gametogenesis due to mismatched 
homology. In addition to this, suppression of recombination would prevent the creation of 
an inversion containing heterozygote chromosomes from being dispersed into the 
population, causing offspring to either have a ‘normal’ or ‘inverted’ chromosome further 
fuelling speciation and genetic divergence (Dobzhansky,  1970; Trickett & Butlin, 1994).  
Evidence of that the presence of inversions and their impact on evolutionary events 
throughout time has been long predicted (Sturtevant, 1921; Dobzhansky, 1970). Classic 
cytogenetic techniques predicted 9 inversions between humans and chimps yet with the 
introduction of genomic sequencing there has been found to be an excess of over 1,500 
(Feuk et al., 2005). The process of inversions rely on several molecular mechanisms, such as 
reliance on key breakpoint regions which are staged along the genome (Ranz et al., 2007), 
where these inversions can span several megabases in the case of D.melanongaster 
(Hoffman & Rieseberg, 2008) or small as can be found to be less than 1KB (Feuk et al., 
2005). 
However, it is unlikely that an inversion would cause harm to the carrier as there is 
typically no gain or deletion of genetic material, similar to previously described 
chromosome aberrations. Nevertheless it is still possible if disruption occurs in gene 
reading frames/coding regions or expression controlling elements. An example of a 
possible link to autism is a balanced inverted paracentric inversion involving chromosome 
10(q11.1;q21.3), where breakpoints disrupt TRIP8 and REEP3 highlighting possible 







Ring chromosome aberrations arise due to the loss of both ‘ends’ of a chromosome 
with repair and recombination events connecting them improperly, first seen in 1926 
(Morgan, 1926) and has been reported for every human chromosome (Schinzel, 2001).  It is 
possible for rings to form with just lost of subtelomeric or telomeric sequences, and no loss 
of genetic content to typically yield a normal phenotype (Vermeesch, 2002; Sigurdardottir 
et al., 1999) but can show a delay in growth of an individual (Yip, 2015). 
Severity of conditions arising from ring chromosomes depend on the location of the ring 
fusion, a shorter ring will resemble a larger loss of genetic material whereas a ‘larger’ ring 
of same chromosome origin has a lower level of genetic material loss. Rings can be 
inherited or rarely spontaneously formed, rings are associated with mosaicism usually due 
to derivative cell lines/populations attempting to stabilise their genetic content after a 
previous aberration (Shchelochkov et al., 2008). Alongside other chromosomal aberrations, 
such as tetrasomy and deletions, the presence of ring chromosome 20 has been seen in 
cases of epilepsy, indicating that epilepsy is polygenic in nature and can be caused by 
multiple chromosomal malformations (Schinzel & Niedrist, 2001). 
Ring chromosomes have been identified within many plant species (Singh, 2016) and have 
been seen to be somewhat benifical as they can confer resistance to commonly used 
glyphosate based herbicides due to the presence of extra EPSPS (Koo et al., 2018).  
1.1.4.7 Isochromosomes 
‘Equal’-chromosome or isochromosome is an unbalanced chromosomal aberration 
where chromosome arms are replicas of one another. In other words, it is in appearance 
that one arm of a chromosome is deleted and replaced with a duplicated version of its 
remaining arm. These isochromosomes can arise from two different means during cellular 
division of an individual, or inherited from either parent’s gamete. 
One such mechanism is centromere misdivision; this is the process of incorrect 
disjuncture during metaphase/anaphase causing the chromatids to divide transversely and 
not longitudinally along the forming daughter cells. This is due to the action around the 
pericentromere, where homologous sequences are shared between sister chromatids to 
cause mismatching of separation complexes to form and incorrect separation around the 
centromere. This would typically form a di-centric chromosome albeit close in distance 
with possible gains of genetic material (Wolff et al., 1996). Another such mechanism is via 
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U type strand exchange, instead of incorrect separation, there is a double strand breakage 
in the pericentromeric regions of the sister chromatids to be repaired incorrectly. Likewise, 
two centromeres are present on one new ‘chromosome’ and lack of centromere for the 
other results in chromosomal loss (Rowe et al., 2009). U type strand exchange can also 
affect homologous chromosomes (similar and sometimes misinterpreted as Robertsonian 
translocations (Shaffer et al., 1991), if there are similar enough low copy repeats to allow 
partial folding onto itself to recombine incorrectly between these repeats, such as in the 
previous example of acrocentric short arms. 
The presence of isochromosomes affects the organism’s phenotypes differently, for 
example Candia albicans can gain a resistance to antifungals with the presence of a specific 
isochromosome (Selmecki, 2006). The 5L chromosome in isochromosome form, incurs a 
positive growth advantage when exposed to conditions containing the antifungal 
fluconazole. Unsurprisingly 5L is the location for ERG11, the target of fluconazole (White 
1997), and Tac1 which up regulates ATP binding cassette multidrug transporters CDR1 and 
CDR2 (Coste et al., 2004; Prasad, 2015). With increased genetic copies, it is predictable that 
with increased copy number due to the isochromosome increases resistance to the effects 
of the antifungal. 
In humans however, isochromosomes are associated with multiple diseases and 
syndromes. Turner syndrome is classically categorised by an X0 genotype, yet 
isochromosome Xq is reported in cases of live Turner syndrome births to exhibit milder 
symptoms than typical Turner syndrome (Akbas, 2012). In retrospect of current Turner 
syndrome sufferers, between 7-17% tested were found to be the 46,X,i(Xq) karyotype 
(Sybert & McCauley, 2004; Ćatović & Kendić, 2005) and can be maternally inherited (Cetin 
et al., 2011).  Both isochromosome variants exist with different symptoms of Turner 
syndrome expressed, i(Xq) (and therefore deleted Xp) have the short stature and 
congenital malformations whereas i(Xp) (and therefore deleted Xq) typically display 
gonadal dysfunction (Sönmez, 1997). 
As demonstrated, isochromosomes bring about the phenotypical changes due to dose 
variation, as effectively there is a trisomy dosage in the gained arm and a monosomy in the 
lost arm (Sidwell et al., 2000). Isochromosomes unsurprisingly relate to cancerous cell 
development and survivability, where the presence of isochromosome 17q correlates to 
high levels of neoplasia and poor survival rates in patients (Mendrzyk et al., 2006). The p 
arm has many low copy repeats localized to the pericentric region, allowing a higher rate of 
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recombination and U type strand exchange to occur creating the isochromosome 17q 
(Barbouti et al., 2004), multiple tumour suppressor genes are located on the p arm of 
chromosome 17 such as p53 so a worse prognosis is understandable in presence of this 







1.1.5 Cytogenetic methods of past and present 
1.1.5.1 Karyotyping  
The karyotype of an organism is the visual representation of its ordered chromosomes; 
this definition can also be expanded to be in reference to the ordered chromosomes of a 
whole species. The use of karyotyping extends from the detection of abnormalities that 
may cause pathological symptoms, to evolutionary biology where comparisons can be 
made to comment on chromosomal similarity or shifts between species.  
Using a karyotype, observations can be made about characteristics to further 
distinguish information about an organism (Fisher, 1919), seen in figure 1.4 as a 
representation of a normal human male karyotype. Features and characteristics can be; 
sizes of chromosomes, centromere positioning, chromosome count and ploidy number, 
featuring of satellites and banding pattern. Together this information can be used to 
characterise the organism in terms of species level, differ between the sexes (if sex is 
determined by chromosomes (Bull, 1980; Janzen & Phillips, 2006), differences between life 
stages of an organism (Goday & Esteban, 2001), differences between the gametes 
compared to normal body cells, and to identify abnormalities in the event of disease 
(Santaguida & Amon 2015). 
Figure 1.3. Schematic representations of chromosomal aberrations. 
Multiple chromosomal aberrations shown by simplistic colour coded figures. Each 
aberration has a normal chromosome(s), left and a representative of a possible 















The isolation of lymphocyte cultures in the 1960s allowed easier collection of genetic 
material that could be stimulated to a growing state ushered in an age of clinical 
cytogenetics (Morrhead et al., 1960; Ferguson-Smith, 2008). This allowed the discovery of 
whole chromosomal aberrations to link to medical diagnoses, such as translocation Down 
syndrome (Polani, 1960) and the Philadelphia chromosome (Rowley, 1973). The 
Philadelphia chromosome was the first discovered cancer chromosomal aberration 
(predominantly found in chronic myeloid leukaemia (CML)) with a direct link to 
tumorigenesis, consisting of a translocation to give a short chromosome 22. Furthermore, 
prenatal diagnosis was an area of interest; especially genetic analysis (Steele & Breg, 1966) 
yet the methodologies used yielded poor and low relevant information (Schmid, 1963; 
Ferguson-Smith et al., 1962).  
 
 
Figure 1.4. Normal Human male karyotype with ideogram 
A karyotype of a normal healthy human male, 46<2n>,XY. Chromosomes stained 
and banding highlighted by DAPI, image and assignment produced using SmartType 
(Digital scientific UK). 
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1.1.5.2 Whole chromosome banding 
The introduction of chromosome banding revolutionised the field of cytogenetics by 
quinacrine intercalating into DNA to produce varying dark and light bands visible by UV 
based microscopy (Caspersson et al., 1969). This technique known as Q-banding was used 
on the principle that the quinacrine binds to rich AT and CG dense regions, yet only the AT-
quinacrine complex produces detectable fluorescence when excited by UV light. AT 
regions, being common in heterochromatin segments of the chromosomes gave a reliable 
and repeatable means to classify chromosomes and lead to the ability to classify all human 
chromosomes by this one technique (Caspersson et al., 1970). Previous identified 
aberrations were able to be explored more, such as the Philadelphia chromosome (Rowley, 
1973) highlighting the significance of chromosome banding. More common stains used to 
give the same banding effect are DAPI (4’,6-diamidino-2-phenylindole) and Hoechst 33258 
(Kapuscinski, 1995; Latt et al., 1975). 
Alternative banding techniques arose for general banding pattern, such as G banding. 
G-banding instead uses Giemsa stain after trypsin digestion which binds to phosphate 
groups rather than insertion into the DNA structure, initially used to detect the malaria 
causing Plasmodium (Giemsa, 1904).  Similar to Q-banding, G-banding gives light and dark 
bands, however it is the CG light euchromatin that resolves as light bands and the AT right 
heterochromatic that displays as dark bands (Seabright, 1971). An offspring of G-banding is 
Reverse banding (R-banding), to give a similar banding pattern but in reverse colouration. 
This is achieved by heat denaturation in a high temperature phosphate buffer followed by 
Giemsa stain and in conjunction with G-banding it allows comparison to define any possible 
irregularities with precision (Richer et al., 1983). 
The use of stains can be used to also highlight specific features of chromosomes 
opposed to staining heterochromatin/euchromatin such as the centromere or telomeres. 
The use of C-banding highlights constitutive heterochromatin which stains darker (Angell & 
Jacobs, 1975), and is highly concentrated around the pericentromeric region of 
chromosomes which consists of high copy count tandem repeats classified into 
microsatellites, minisatellites, and transposons (Saksouk et al., 2015). C-banding is achieved 
by the use of Giemsa stain, yet has an alkaline denaturation step before staining which only 
constitutive heterochromatin binds, used typically to clearly visualise centromeres (Sumner 
et al., 1971). Lastly T banding is again very similar, where Giemsa stain is used with pre-
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staining parameters changed, such as high temperature denaturation, to stain the subset of 
R-bands found at the telomeres of chromosomes (Jack et al., 1986).  
1.1.5.3 In situ hybridisation 
Pardue and Gall first displayed a technique using previously isolated DNA 
(ultracentrifugation obtained mouse satellite DNA) to generate centromere specific probes 
by conjugation with radioactive isotopes (Pardue & Gall, 1970). This was the first time an in 
situ hybridisation (ISH) had been used in this way to detect features on chromosomes, with 
this methodology applied later to shown that ribosomal genes are located on the short 
arms of human acrocentric chromosomes (Henderson et al., 1972). Up to this point, only 
large, easy to isolate DNA material was able to be used to form useable probes. With the 
introduction of recombinant DNA techniques, the cloning of DNA fragments of interest was 
enabled to be high enough in yield to be labelled and provide sufficient signal radioactively. 
This allowed smaller features to be identified, such as the location of beta globin genes to 
be confirmed to the short arm of chromosome 11 (Malcolm et al., 1981). Obviously, use of 
radioactively labelled probes had plenty of safety issues regarding probe generation and 
imaging. The imaging process would take a multitude of days to accomplish a sufficient 
signal. With the drawbacks of isotope labelled probes, the replacement using fluorophore-
labelling and UV microscopy became the standard methodology for gene location studies 
and chromosome analysis, known as fluorescence in situ hybridisation (FISH) (Pinkel et al., 
1986; Lichter et al., 1990). Initially, biotin was the primary label used in conjugation with 
probe DNA (Hofmann & Kiso, 1976; Bayer et al., 1985). After hybridisation, adivin (which 
has high affinity towards biotin) labelled with fluorescein was used to produce an 
observable signal. An example of usage was interspecies translocations between human 
and hamster in human-hamster hybrid cell lines. This method also allowed the creation of a 
Y specific chromosome probe (Figure 1.5) and human 28S ribosomal RNA gene probes 






























Figure 1.5. Fluorescence hybridisation of human chromosomes 
Images from the first use of fluorescence in situ in gene location studies, using 
probes labeled with biotin with advin-fluorescein (green, but with counterstain appears 
yellow). Counterstained with propidium iodide (red) A/Top. Un-stimulated male human 
peripheral blood lymphocytes with Y-specific probe pY431A. B/Bottom. Specific 
ribosomal RNA-specific probe pAbb to human lymphocyte chromosomes. Images taken 
















The introduction of more colours from differing fluorophores further allowed specific 
gene mapping questions to be answered. More fluorophores allow for direction or gene 
order to be questioned and the establishment of gene loci along the chromosome (Trask et 
al., 1989). 
Flow cytometry allows the isolation of fluorescently labelled chromosomes based upon 
their size (Gray et al., 1975) with enough genetic material collection, each chromosome (or 
pool of chromosomes- see section 1.3 and section 4.1) can be amplified and labelled with a 
fluorophore. This effectively creates a whole chromosome probe, known as a chromosome 
‘paint’ which will fluoresces with successful hybridisation to its complimentary sequence 
(Young et al., 1981). Chromosomes previously had been used to make chromosome specific 
libraries, but now paints could be used to answer biological questions from clinical uses to 
ecological assignments (Reid et al., 1998). Now previous phylogenetic assignment could be 
questioned by direct chromosome comparison, looking for common homologous regions 
Figure 1.6. FISH principle and procedure 
A schematic representation of the FISH technique.  The probe DNA is isolated and 
labeled either directly with a fluorescent tag (as seen here) or indirectly (e.g. Biotin).  
The sample of target DNA is denatured alongside the probe DNA and allowed to 
hybridize with its specific target area. Upon analysis with a fluorescent microscope, a 




across species and taxa to redefine our understanding of evolutionary lineages, or direct 
karyotype evolution by cross species painting. Complex chromosome aberrations could 
now be classified and understood at a deeper level as human and mouse paints had be 
created enabling cancer researchers to draw conclusions easier as compared to previous 
banding pattern analysis which was technically challenging and gave questionable results 
(Ferguson-Smith, 1997). 
There was also a large relevance for the use of paints diagnostically in IVF, such as the 
detection of chromosome 21 copy number variants in uncultured amminocytes using a 
highly specific contig, unique to human chromosome 21 (Zheng et al., 1992). Sex 
chromosome paints and probes were used to correctly sex embryos before implantation 
(Griffin et al., 1992) and link dysmorphism events to specific chromosomal abnormalities 
with links to prevalence of these abnormalities to maternal age (Munné & Cohen, 1998). 
This was important for the identification of X linked diseases (Griffin et al., 1993), or 
associated aneuploidy/mosaicism sex chromosome linked diseases where clinical use of 
paints resulted in confirmed healthy pregnancy of a selected embryo after screening out 
affected embryos (Delhanty et al., 1993).  
The use of bacterial artificial chromosomes (BACs) in FISH has allowed the creation of 
whole genomic libraries by fragmenting genomic DNA into short 150-350 kbp lengths 
(O’Connor, 1989). By using specific BAC clones of model species it is possible to use these 
with fluorescent molecules to act as positional markers along a chromosome. In the 
example of a specific gene of interest, the locus of said gene can be identified from 
positional hybridisation of the BAC now probe sequence (Figure 1.6). Furthermore, 
hybridisation across different species allows indications towards possible regions of 
homology and gives information towards possible ancestral lineages between the samples.  
The use of comparative BAC mapping has shown that the platypus sex chromosomes are 
more avian like than classic mammalian like in their five X chromosomes (Grützner & 
Graves, 2004; Veyrunes et al., 2008). 
Multiplex in situ hybridisation (M-FISH, also known as Multi-Fluor and similar to 
multicolour, mFISH) uses many differing fluorophores attached to DNA paints hybridised 
simultaneously to show different successful hybridisations on the same preparation (Liehr 
et al., 2004). With this method it is possible to detect at a higher level of accuracy, as has 
been demonstrated that it is possible to detect new novel chromosomal rearrangements 
not previously detected by established banding techniques (Speicher et al., 1996). As this 
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technique is limited by fluorophore wavelength emission overlap, ratios of fluorophores 
can instead be used and computationally analysed to assign correct pseudo colouration, 
these can be detected by a typical set of varied fluorescence filters or by the use of an 
interferometer in the case of spectral karyotyping (SKY).  
As of 1996, using the differentiation of different spectra (SKY technique, figure 1.7) 
allowed the simultaneous identification of all human chromosomes and colourisation in 
pseudo colours (Schröck et al., 1996) SKY has great practicality when used to detect 
chromosomal malformations in context of unpredictable karyotype (Guo et al., 2014).  One 
of the first studies on haematological malignancies, acute myeloid leukaemia (AML) and 
myelodysplastic syndrome (MDS), used SKY to confirm results seen from G-banding yet also 
indicated that SKY detected more cryptic aberrations that were impossible to detect via G-
banding (Veldman et al., 1997). Even more recently, SKY still has applications to improve 
banding based assignments with more accurate results and to highlight unseen 
malformations. For example, in acute lymphoblastic leukaemia (ALL) to improve R-banding 
karyotype (Guo et al., 2014) and a discovery of a novel 5 way translocation event within 
chronic myeloid leukaemia (CML) via SKY, G-Banding and FISH (Vaidya, 2013). SKY can be 
also used to further classify and categorise patients of AML into specific aberration 
groupings when G-banding had failed to identify precise mutations (Mrózek et al., 2002). 
SKY’s advantages are clear in that it allows the detection of large aberrations which would 
simply appear as a multitude of differing colours on a derivative chromosome yet it does 
not come without its drawbacks. There are aberrations that would not directly cause a 
colour change, such as small deletions, duplications, reciprocal translocations and in 
particular intrachromosomeal events such as inversions (Fan et al., 2000; Imataka & 
Arisaka, 2012). The financial costs to set up and maintain reagents and equipment for SKY 
are high as well as skill of the user able to interpret and use the information (Padilla-Nash 
et al., 2006). SKY loses its usefulness without being paired with another analysis 
methodology, typically G-banding or Q-banding is usually performed alongside SKY (again 
requiring a skilled cytogeneticist) and usually requires FISH experimentation to some 
degree to verify claims such as small reciprocal translocations (Fan et al., 2000) and 
detection of clone variants (Saito, 2010). SKY can only detect down to an alteration of 
1000-2000bp, and fails to detect aberrations well close to telomeres (Fan et al., 2000), this 
causes what is known as the ‘sandwich effect’. The sandwich effect comes to fruition when 
the fluorophores from multiple contributing chromosomes (in context of an unknown 
derivative chromosome) slightly overlap and cannot be distinguished from one another 
  
21 
often leaving a small region from a third chromosome unseen (Padilla-Nash et al., 2006). In 
the event of mass malformation or a chromothripsis event (see section 1.3.4.2), SKY cannot 














1.1.5.4 Digital/Virtual Karyotyping 
Digital/virtual karyotyping is a methodology used to identify DNA via copy number on a 
whole genome scale. To explain further, short sequences from samples of DNA are tagged 
from previously specified loci across the genome that consistently overlap. These 
sequences are then processed and compared to a previously established reference genome 
to identify deletions, amplifications, foreign DNA and copy number variants (Wang, et al., 
2002). Contemporary methods to achieve a computational derived karyotype are 
comparative genomic hybridisations (CGH), more specifically arrayCGH (Figure 1.8) and via 
single nucleotide polymorphism arrays (SNP).  
Figure 1.7. SKY (spectral karyotyping) karyotype of a healthy normal human 
female, 46<2n>,XX 
A, DAPi labelled metaphase of human female XX. B, SKY assigned pseudo 
colouration according to different spectra recorded. C, Karyotype analysis of images A 
















These methodologies have changed the field of cytogenetics as it is able to merge the 
field of traditional chromosome analysis and specific molecular diagnostics. Constitutional 
disorders can be easily detected and resolved using these methodologies, such as copy 
number variant issues (Lee et al., 2007), or abnormalities that can be identified to link 
towards developmental delays in humans (Shaffer & Bejjani, 2006; Edelmann & Hirschhorn, 
2009). These methodologies require the use of disrupted DNA (DNA in which is different 
from the reference) to detect aberrations, which is also limited by the probes used within 
the array itself such as the ‘density’ of the probe (size) and the depth used in each sample. 
The most basic of disadvantages is a lack of the ability to detect balanced translocations or 
inversions (Gebhart, 2004), and there are issues regarding the computational analysis of 
sequenced samples (Roy & Motsinger-Reif, 2012). Studies show that there are variations 
when comparing results from replicates using various platforms (Baumbusch et al., 2008; 
Curtis et al., 2009) and even showing that variation of algorithms will provide different 
results on the same sample provided (Lai et al., 2005; Pinto et al., 2011).  
Figure 1.8. Overview of Array CGH methodology and principles  
Simplistic representative of the methodology used for array-comparative hybridization. 
Test DNA (green) and reference DNA (red) are mixed and be simultaneously hybridized 
on ‘pits’ containing complementary DNA to the reference genome. Competition 
between the differently labeled strands will yield yellow fluorescent results, yet a bias 
towards red or green signifies a lack of test DNA (red) or an abundance of test DNA 
(green) signifying a gain or loss of DNA in the test organism. 
Image based on http://compbio.cs.brown.edu/projects/nbc/ , accessed June 2019. 
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As previously described, virtual karyotype systems will compare any disrupted DNA 
found to a known reference, typically a normal diploid genome. In the case that there has 
been an elevation of genomic material due to an increase of ploidy, this will incur incorrect 
results as a ‘multi-ploidy’ sample will be condensed into reference of a diploid reference, 
within context of this example. This can only be rectified by conventional techniques, such 
as traditional karyotyping or FISH to reassess the sample if this issue is detected. Sub clones 
will be missed within the circumstance of a clonally diverse tumour and would be seen as 
low level background interference when averaged against the dominate clone present, 
which will impact the outcome of the treatment (Landau et al., 2013). There are 
associations between greater number of detectable subclonal populations and poorer 
clinical results (Pereira et al., 2016; Morris et al., 2016), and increased diversity can indicate 
increased resistance to selective pressures such as drug resistance (Zhao et al., 2016). In 
the context of these points, only detectable subpopulations are taken into account of 
current treatment and clinical diagnostics which is typically deduced by an ‘average’ 
population analysis (Figure 1.9). Currently undetectable subpopulations may give rise to 












Figure 1.9.  A global analysis technique vs. a single cell approach 
 A single cell analysis approach can identify individual cells as part of sub-
populations. A) Clear offshoots can be identified over time which may possess different 
intrinsic characteristics. B) a possible result of an averaged ‘global’ analysis not taking 






 1.1.5.5 Fluorescence microscopy  
 The dogma of fluorescence microscopy is that a molecule of fluorescent properties 
will chemically bind or somewhat help in the detection of a known biomolecule of interest 
(Sahoo, 2012). Fluorescence can be described as the emission of light at a lower 
wavelength/energy by a substance after absorption of a higher wavelength/energy light or 
other electromagnetic radiation In comparison to radioactive labelling, fluorescence is 
much safer to use and multiple fluorescent molecules can be used simultaneously.  
As described, fluorescent molecules require high energy wavelengths of light to be 
absorbed and then emit a lower energy higher wavelength of light, with the use of different 
spectral emission filters (for different wavelengths of light to be emitted to the sample) and 
a dichroic mirror/beamsplitter paired with a emission filter (to match the excitation 
wavelength from the fluorescent molecule) multiple fluorophores can be used of differing 
absorption and emission to separately identify different targets (Spring & 













Figure 1.10. A simplistic representation of a fluorescent microscope and parallel 
atomic events 
Shown, a basic overview of the rudimentary principles on which fluorescent 
microscopy requires. Left, a ‘slice-through’ representation of a fluorescent microscope 
and the path light travels to and from the specimen as different wavelengths of light. 
Right: a nuclear model showing a) a high wavelength of light exciting an electron to b) 
jump to a higher energy state to eventually, c) lose the energy and return to its ground 
state by, d) emission of light at a lower wavelength/energy. 
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Fluorescent labels such as ethidium bromide and GFP (green fluorescent protein) are 
used commonly, but there are multiple ways to generate unique targeted labelling options. 
To create a specific tag, typically a fluorophore will be attached to a unique molecule with 
affinity towards the target, examples of which include enzymatic labelling (Richter et al., 
2002), chemical labelling as an alternative to GFP (Wombacher & Cornish, 2011; Jung, 
2013), protein labelling such as histidine tags, and finally genetic labelling such as FISH 
allowing specific loci or sites along a chromosome to be identified.  
1.2 Comparative Genomics 
Within the field of genomics, comparisons of genomic features between many numbers 
of organisms can be studied to determine comparable biological features and evolutionary 
relationships. Since the work of Fisher in 1918 (Fisher, 1918), by formulating the idea that 
Mendelian inheritance was to account for the phenotypic variation in nature, gave birth to 
the research environment of genomics. It was not until 1986 with gene specific DNA 
sequences for the herpes simplex virus was studied to better understand its gene coding 
glycoproteins, that the Epstein Barr virus and Varicella zoster virus was also compared 
alongside to surprisingly discover over 100 shared gene homologs between these 
pathogenic viral agents (McGeoch & Davidson, 1986). This direct comparison between 
these viral groups and the identification of a multitude of genetic similarities that would 
relate to possible shared biological features, the field of comparative genomics was born. 
The genomic features of interest that can be used to compare species is not just limited to 
gene sequences. Genomic features analysed can encompass DNA base sequence, gene 
order, features of regulatory regions, homologous synteny blocks (HSBs), evolutionary 
breakpoint regions (ERBs), proteins/protein function, and all variants of RNA (Larkin et al., 
2009). All of these described genomic features can be used to detect evolutionary 
relationships between organisms, a closer relationship determined by; more commonality 
in sequences, alignment of regions, orthologs in sequences, and homologs in genes. The 
observation of evolutionary relationships will allow insight into possible positive or 
negative evolutionary changes that may have occurred, and allow a differing perspective of 
the phenotype observed of said species, such as the viral example above in relation to the 
pathogenic nature of viral components.  
The first genome of a cellular organism fully sequenced was detailed in 1995, 
Haemophilus influenzae, a bacterium thought to be the causative agent of influenza in 1892 
(Fleischmann et al., 1995). This was shortly followed by a parasitic bacterium, Mycoplasm 
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genitalium, in the same year (Fraser et al., 1995). A year later, the first eukaryotic organism 
was fully sequenced Saccharomyces cerevisiae (Goffeau et al., 1996), followed two years 
later by multicellular organism Caenorhabditis elegans (C. elegans Sequencing Consortium, 
1998). The release of the iconic model species Drosophila melanogaster genome in 2000 
(Adams et al., 2000) allowed the first major study of all genomes released thus far. This 
study showed that approximately 60% of genes from D. melanogaster to Human were 
conserved, and two thirds of genes that were then implicated in human cancer have 
counterparts in these fruit flies (Rubin et al., 2000). The first human genome draft was 
released in 2001 (International Human Genome Sequencing Consortium, 2001; McPherson, 
2001; Venter et al., 2001), to be completed in the following years (Collins, 2003; 
International Human Genome Sequencing Consortium, 2004). Interestingly this found 
around 22,000 protein coding genes in humans, similar to other mammals (Pertea & 
Salzberg, 2010) and contained large volumes of repetitive identical segments throughout 
which was a surprising find (International Human Genome Sequencing Consortium, 2004).  
Following human, a multitude of higher multicellular organisms were fully sequenced, such 
as the chicken, Gallus gallus (International Chicken Genome sequencing Consortium, 2004), 
the chimpanzee, Pan troglodytes (The Chimpanzee Sequencing and analysis consortium, 
2005), the European honeybee, Apis mellifera (Honeybee Genome Sequencing Consortium, 
2006) and even sponges, Amphimedon queenslandica (Sirvastava et al, 2010).  
The use of sequenced genomes spans further than just evolutionary comparisons, in 
terms of pathogen genomics, the advent of whole genome sequencing has changed the 
way any microbial organism is now researched. This increase of throughput allows easier 
comparisons between pathogenic strains and from pathogenic to non-pathogenic organism 
(Hu et al., 2011). The study of microbial genomics has allowed the development of 
vaccines, the exploration of the microbiome of the human digestive tract and to detect 
virulence/spread of disease (Kaper et al., 2004). This has allowed the research into 
‘metagenomics’- the study of communities of organisms, such as in the previous example 
of human micro flora reservoirs (Sommer et al., 2009). The tracking of great ape social 
groups paired with genetic profiling has allowed research into more social/conservation 
focuses areas, such as the fact that set populations exhibit large levels of inbreeding which 
will aid conservationists in restoring population numbers (Prado-Martinez et al., 2013). 
Agriculture is a great receiver from the work of genomic studies, a possible increase of yield 
in animal products or plant products are only going to be beneficial. For example plants can 
be selected for higher yield, lower cost, disease resistance and environmental resistances, 
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essential for an ever growing population under the changes of global climate change 
(Huang et al., 2010; Morrell et al., 2012). 
To best summarise the use of genomics is in the aftermath of the human genome 
project, where it was set out in light of results to understand all functional parts of the 
genome, to then apply this to the improvement of human life. To quote architects of the 
project (Collins et al., 2003a); 
“If we, like bold architects, can design and build this unprecedented and 
noble structure, resting on the firm bedrock foundation of the HGP 
[human genome project] then the true promise of genomics research for 
benefiting humankind can be realized.” 
1.2.1 Evolutionary genomics  
The use of comparative genomics allows the detection of genomic features which are 
similar (or contrasting) of organisms within the same species and organisms of varying 
species, this allows a phylogenetic and evolutionary pathway to be predicted. Over 
evolutionary time, DNA will differ as reflected by the process of natural selection to drive 
the progression of species and fill the diversity of life we see today (Ellegren, 2008; 
Diekmann & Pereira-Leal, 2015; Currat et al., 2015). The use of new high throughput 
techniques of recent years allows better coverage of the individual’s genome and the 
collective genome to resemble the population, with aid from computational tools, data can 
be quickly analysed with visualisation to increase efficiency of research (Bergman, 2007; 
Shendure & Ji, 2008). In reference of human evolution, genomic studies have underpinned 
the origin of lactose tolerance, originally presumed to be of European north west origin due 
to high lactase concentration, however modern computational modules suggest that it was 
in fact near east in origination 8000 years ago (Itan et al., 2009; Gerbault et al., 2011). 
Genome exploration into individual human populations has also revealed interesting allelic 
variants to deal with adaptation of environmental conditions, such as a high-altitude 
positive selection loci and resistance adaptability of select pathogens (Bigham et al., 2009; 






1.2.1.1 Chromosomal mechanisms of evolution and speciation  
Implementation of gross chromosomal changes over time can drive the formation of 
new species via the process of speciation (Livingstone & Rieseberg, 2004).  The formation 
of a new species requires reproductive barriers to exist to maintain the genetic/phenotypic 
differences established, allowing enough diversion to form a true new species 
(Dobzhansky, 1936; Conyne & Orr, 1989). Reproductive barriers can be caused by different 
means: in the method of extrinsic reproductive isolation, it shall cause a divergent selection 
process of populations due to ecological conditions, i.e. geographical features. Alternatively 
via genetic drift  intrinsic reproductive isolation can occur to drive speciation, genomic 
conflict and genetic incompatibilities within populations form this reproductive barrier 
splitting the population apart. Examples of causing genomic conflict include; inversions, 
gene duplication, transpositions, gene loss and underdominance (Rieseberg & Burke, 2001; 
Conrad & Antonarakis, 2007; Innan & Kondrashov, 2010). 
Inversions within chromosomes to drive speciation will be reflected within the 
karyotype (Kirkpatrick & Barton, 2006; Larkin, 2010). These chromosomal changes, such as 
inversions, can create post-zygotic barriers to reproduction such as the reduction of the 
fertility of chromosomal heterozygotes (heterokaryotypes) by suppressing recombination 
(Sturtevant, 1917; Dobzhansky, 1947; Dobzhansky, 1970; King, 1995). This reduction of 
recombination of chromosomes within a population will contribute to the division of said 
population and the formation of a new species (Felsenstein, 1981; Butlin, 2005).  
The process of chromoanagenesis (see section 1.3.4.2) in describing the event of a 
singular ‘macro mutation’/genomic rearrangement event, can drive evolution in a non-
pathogenic event as is typically associated with the formation of cancer genomes. A 
process of chromoanagenesis is via chromothripsis (section 1.3.4.2 and Figure 1.15). 
Chromothriptic events are found to occur within germline cells or during early embryonic 
development; within humans, complex but balanced genomic rearrangements, via 
chromothripsis, can be tolerated to result in perfectly viable live births (Pellestor et al., 
2014). The concept of chromoanagenesis fits with proposed models of evolution, opposed 
phyletic gradualism which relies on small changes over time to arise in new species. 
Evolutionary models such as the ‘hopeful monster’, summarising the generation of a new 
species upon birth (Goldschmidt, 1982) or the theory of ‘punctuated equilibrium’ have 
credibility if chromoanagenesis is to be found throughout evolutionary events (Goul & 
Eldredge, 1972). Yet the mechanisms and cellular pathways responsible for these events 
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are highly conserved throughout life (Pellestor, 2019), with reference to the previously 
described chromothripsis event, it could be seen as a short-term adaptation mechanism to 
quickly generate population variants in response to quickly changing selection processes. 
Further research should be expected to shed light on the possibility of chromothripsis as an 
evolutionary process (Pellestor & Gatinois, 2019). As explained in the further section of 
1.3.4.2, chromoanagenesis events are classically seen in cancers, however with the view 
that they could arise due to sudden selection pressure presence (aka cytotoxic drugs) a 
singular event to rapidly alter the genome, despite high cell death, could be beneficial as a 
survival strategy (Liu et al., 2014; Christine, 2018). These events have been somewhat 
eluded to in other organisms: within gibbon lineages there has been an insertion of a retro-
transposon within gene regions dealing with cellular cycle progression and chromosome 
segregation (Meyer et al., 2016), similar events as this appear at the origin of high rate 
chromothripsis like events presumed to cause the accelerated gibbon karyotype observed 
in different lineages (Carbone et al., 2014). Not just in the great apes, chromothripsis has 
been observed within marsupials (Deakin, 2018), S.cerevisiae (Anand et al., 2014), 
Tasmanian devil cancers (Deakin et al., 2012)) and even plants (Tan et al., 2015; Carbonell-
Bejerano et al., 2017). As these events are seen somewhat throughout nature, could it be a 
means to drive natural genetic variation observed?  Could be a means to drive natural 
genetic variation? 
1.2.2 Animal genomics 
Motile multicellular eukaryotes with separate differentiated tissue such as dedicated 
nervous tissue, apart from the sponges (Porifera) make up the kingdom of Animalia. Within 
the early vertebrate lineage more than 450 million years ago, two independent whole 
chromosome duplication events took place, referred to as the 1R and 2R event (Dehal & 
Boore, 2005; Nakatani et al., 2007; Putnam et al., 2008). Evidence of these duplicative 
events is evident within current human genomes as highly conserved genes exist in 
duplicate, such as glycolytic enzymes (Singh et al., 2015; Steinke et al., 2006). 
Reconstructive studies have retrospectively analysed multiple extant animal genomes to 
reconstruct a hypothesised Amniota genome (Sacerdot et al., 2018).This study takes these 
extant genomes to predict the chromosome number representative of populations in their 
respective evolutionary lineage. Pre-vertebrate ancestors (tunicates, i.e. sea squirts) were 
presumed to have 17 chromosomes, to double within the first whole duplication even to 
34, seven chromosome fusions were then undertook before the second whole duplication 
up to 54 chromosomes. Furthermore, between the jawed vertebrates (Gnasthostomata) 
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and the jawless fish (Cyclostomata) four further chromosome fusions took place to 
resemble the bony vertebrate (Euteleostomi) genome of 50 chromosomes, with presumed 
micro-chromosome ancestors. A third ‘fish’ specific genome duplication ‘3R’ event 
occurred in the bony/ray finned fish lineage (actinopterygii) to explain the large 
chromosome count of these animals, however during duplication most genes were lost or 
gained alternate functions which may explain the high dominance of this class within all 
‘fish’ shown by their evolutionary success and wide biological diversity (Meyer & Van de 
Peer, 2005; Near et al., 2012).  
Another interesting example of genomic development over the animal lineage is 
resembled in the Hox family of transcription factors. These factors are thought to be also 
duplicated in 1R and 2R events (Krumlauf, 1994; Wellik, 2009). Presumed to originate in 
choanoflagellates, the single cellular ancestors of Porifera (Wenger & Galliot, 2013), and 
shown as representatives of these transcription factor products in specification of Cnidaria 
(i.e. jellyfish and anemones) bodily features (Martindale, 2005).  In vertebrates, Hox genes 
are regulatory factors that specify cellular fate in the spacial axis of embryos, ensuring 
correct anterior/posterior skeletal structure and morphology (Amores et al., 1998).  In the 
event of deletions they shown to be lethal or concur with vast developmental issues (Kmita 
et al., 2005)). In evolutionary genomics, Hox clusters are seen in a singular copy within the 
invertebrate chordates opposed to mammals which have four clusters and zebrafish have 
duplicated up to seven clusters (Kappen & Ruddle, 1993). 
The means to detect conserved features or blocks of chromosome homology has 
traditionally been detected via the use of cross-species chromosomal painting (See section 
1.1.5.3). This painting methodology allows direct comparison of ‘like-like’ sequences seen 
across differing species to understand possible rearrangements and discover new 
configurations, these events that would give more insight into their evolutionary lineage 
and explain the diversity of mammals seen in life (Ferguson-Smith & Trifonov, 2007). To 
identify chromosomal events to be able to identify karyotype evolution lineages across all 
animals, and in particular mammalian orders, well help bring light upon interesting areas of 
evolutionary biology such as the evolutionary events underpinning the arrival of sex 






1.2.3 Avian Genomics 
Avian genomes are uniquely interesting by their stable karyotype and presence of 
microchromosomes (Burt, 2002). An important taxonomic group as they are filled with such 
rich phenotypic diversity and of great importance throughout human society. In respect to 
usefulness in human society, birds are of great importance for food production 
(approximately 20% of meat consumption), culturally significant in terms of prized 
racing/hunting birds and genetically of great interest due to neural/vocal functionality 
paired with the abundance of flight (Alexander, 2000; Griffin, 2007). Birds are host to 
multiple model species for research. The chicken is an easy to manipulate amniote used for 
developmental studies as well as genetic expression studies, the chicken was also the first 
fully sequenced avian species and as result is used extensively in genomic studies (Burt, 
2007). The pigeon, Columba livia, is important within cognitive and intelligence studies 
(Emery, 2005). Whereas the zebra finch, Taeinopygia guttata, a songbird used for 
exploration into non-mammalian auditory systems (Zeigler & Marler, 2004), with many 
members now having fully annotated genomes (International Chicken Genome Sequencing 
Consortium, 2004; Warren et al., 2010; Zhan et al., 2013; Jarvis et al.,2014).  
Among the amniotes the birds have some of the smallest genomes with multiple 
hypotheses attributed to this phenomenon, such as the adaptability towards flight (Hughes 
& Hughes, 1995). Somewhat conserved amongst the avian group is the karyotype, 
obviously with exception of some families such as the hornbills (2n=42) and the 
Corythaixoides (2n=136-142) (Christidis, 1990). Most birds have diploid numbers in the 
range of 74 to 86 chromosomes, and for the majority the avian karyotype appears to 
resemble one another (Griffin 2007). Exceptions to this karyotypic similarity are the grossly 
rearranged orders of the psittaciformes (parrots), the falconiformes (falcons) and 
accipitrids (eagles) (de Oliveira et al., 2005; Nanda et al., 2006; Tagliarini et al., 2011; 
Joseph et al., 2018), with most showing their microchromosomes fused to larger 
macrochromosomes. Comparative cytogenetics within the avian class with use of 
comparative paints has allowed easier comparison of chromosome homology and specific 
DNA markers generated to question microchromosomes (Lithgow et al., 2014; Romanov et 
al., 2014; Damas et al., 2017).  The use of paints does not allow the correct identification of 
hidden intrachromosomal rearrangements, as any inversions or duplications of 
chromosome material for example would not display a change of fluorescent pattern. 
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These hidden rearrangements are predicted to be found within multiple birds that have 
already been analysed via paint techniques and are an interesting avenue of possible 
research (Griffin et al., 2008; Skinner et al., 2009; Volker et al., 2010) 
1.2.3.1The Galliformes  
The galilformes are found worldwide with many well known taxa, such as the 
pheasianinae (the common pheasants), the quails (both old world and new world quails, 
Odontophoridae), cracinae (curassows), Meleagridinae (turkeys) and numididaes 
(guideafowls). See section 4, for more detailed information into the investigation of 
possible hidden intrachromosomal rearrangements for these birds. 
1.2.3.1.1 The Chicken 
The chicken (Gallus gallus) is of key importance within the genomic studies of the avian 
group. First sequenced in 2004 (International Chicken Genome Sequencing Consortium, 
2004) the chicken was the first bird to be sequenced and is typically used as a reference to 
compare newly sequenced birds to (Burt, 2007). With the chicken as a key research species, 
it has allowed important questions to be answered, one of which is the function of the 
bursa and the classification of B-cells (Glick et al., 1956).  The induction of the avian 
leukosis virus (ALV) caused the generation of the DT40 cell line (Baba & Humphries, 1984; 
Baba, 1985), a useful cell line that can be easily genetically manipulated allowing wide use 
for a variety of cellular based investigations (Malhotra et al., 2017)(Section 5.1). Use of this 
cell line has been invaluable in multiple studies (Sonoda et al 1998; Chi 2018) however it 
has fallen out of favour recently due to advances has in other means of genetic 
manipulation, (CRISPR). Regardless, the cell line is a useful tool to assess from a genomic 
point of view to assess chromosomal aberrations that may cause the tumorigenic state 
seen of the cell line. 
1.2.3.1.1.1 Nuclear organisation in chicken 
Chromosome territories within interphase state nuclei have been looked at in multiple 
species, an early investigation was performed in Indian muntjact due to its low 
chromosome count (2n=6 for females) allowing easy identification of chromosomes within 
the nucleus (Yang et al., 1995; Ferguson-Smith, 2011). The organisation and structure of 
genetic material in the 3D state of a working nucleus is essential for correct cellular 
functionality, with abnormal structure leading to disease phenotypes (Foster & Bridger, 
2005). With most studies focusing on mammals, avian interphase studies are not as 
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abundant (Skinner 2009b). However initial studies using singular BACs of 
macrochromosomes and microchromosomes have been performed to show an indication 
towards a nuclear periphery localization for macrochromosomes opposed to the gene 
dense microchromosomes which on average occupy a more central position (Skinner 
2009b). However with the use of single BAC’s, there is a requirement to somewhat 
introduce a methodology using multiple BAC’s to assess longer chromosomes (the 
macrochromosome) position and arrangement within a ‘working’ interphase nuclei to 

















1.3 The Biology of Cancer 
1.3.1 A brief overview of cancer  
Cancer is a disease that spans throughout all of human history (Hajdu, 2011), detailed 
in ancient Egyptian and Greek periods (Breasted, 1930; Karpozilos & Pavlidis, 2004) and 
evidence found of specific cancers in archaeological remains (Strouhal, 1976; Binder et al., 
2014). Genetic deviations have been thought of as the key mechanism that drives the 
prolific growth and malignancy of cancers since 1969, as suggested by Heubner and Todaro 
(Huebner & Todaro, 1969). More recently molecular genetics has progressed to a stage 
where the presence and gain of chromosomal aberrations, mutations in proto-oncogenes 
and tumour suppressor genes clearly drive tumour progression (Harris & Hirohashi, 1992; 
Bishop & Weinberg, 1996; Curtis et al., 2012). The term ‘cancer’ is a generic term used to a 
collective of diseases which share the property of abnormal and uncontrolled growth of 
self cells to spread into other areas of the body (WHO Cancer Control Programme, 2019; 
Cancer.gov, 2019; CancerResearchUK, 2019). Cancers are a separate group of neoplasms, 
every neoplasm can be seen as a group of cells that present with unregulated growth, such 
as hyperplasia or dysplasia, but not for the most part from into a ‘true’ cancer (Cancer.gov, 
2019). The initiation of cancer shows no symptoms, only during later periods of expansive 
cellular growths or metastasizes symptoms can arise. These typically nonspecific symptoms 
are attributed to other issues such as coughs to respiratory infections and changes of bowel 
habits to diet. These nonspecific symptoms and failure to immediately diagnose has seen 
cancer been regarded to as medicine’s ‘greatest imitator’ (Segen, 1992; Kufe & Pollock, 
2010; Del Paggio et al., 2017). 
 
The formation of cancers are, in no way, caused by a single step or event, it is 
estimated that each of the ~1013 cells of a human can have from tens of thousands of DNA 
lesions to one million changes to its DNA in a single day (Lodish et al., 2008; Jackson & 
Bartek, 2009), yet these have to be advantageous towards tumorigenesis and not repaired 
by normal cellular responses (Tomlinson et al., 1996; Croce, 2008). When looking at the 
rate of mutation in the human body, it is surprising we do not have more cancer across the 
population. With the estimate of at least one million mutations in a single cell per day, we 
would presume these were equally spread across all 23,000 protein coding genes and that 
some would be missed. With approximately 350 out of these 23,000 proteins coding genes 
are known to be attributed with cancers, the cancer rate should be tremendously higher 
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across our 1013 cells that what we currently observe (Frank, 2010). Thankfully the cell and 
body has systems in place, such as a multitude of internal cell checkpoints and a very 
specific immune system, we are not over encumbered with malignant cells. However when 
cancers do arise, they must overcome all of these ‘defences’ via formation of what is 
known as the ‘cancer hallmarks’. 
Proposed in 2000, and later reviewed and improved in 2011 (Hanahan & Weinberg, 
2000), Hanahan and Weinberg suggested the classification of hallmarks to “constitute an 
organizing principle for rationalizing the complexities of neoplastic disease” (Hanahan & 
Weinberg, 2011). The view conceptualizes the multistep process normal cells must undergo 
and evolve each hallmark successively to survive, become tumorigenic and eventually 
malignant. There is also the notion that a cancer must not just be understood by the traits 
shown by the cancer cells themselves, but by the ‘tumour microenvironment’ 
characteristics and tumour associated interactions (Hanahan & Weinberg, 2011). 
As mentioned previously, overruling cellular growth restrictions to provide 
uncontrolled growth is seen in all cancers and cells must sustain this unending division. 
Typically normal cells can respond to internal checkpoints to progress through cellular 
division, or can respond to external stimuli, such as growth factors or suppressors (Ullrich & 
Schlessinger, 1990). However cancer cells deregulate this widespread signalling pathway to 
ensure continuous propagation (Hynes & MacDonald, 2009; Lemmon & Schlessinger, 
2010). This can be achieved by the cancer cells either self stimulating by producing their 
own growth factors or via stimulation of normal cells within the tumour microenvironment 
to supply them with growth factors (Bhowmick et al., 2004; Cheng et al., 2008).  
 Alterations in growth factor receptors is another possible avenue taken, the alteration 
to induce constant signalling provides self-sustaining growth (Jiang & Liu, 2009; Davies & 
Samuels, 2010) and a deregulation of negative feedback systems, such as ras gene with Ras 
oncoprotein which would typically regulate that an input of growth signal is temporary or 
cellular senescence is performed (Bardessy & Sharpless, 2006; Collado & Serrano, 2010).   
To continue on the theme of growth, the cells must also become resistant to internal 
and external suppressor signals. Retinoblastoma-associated protein (RB) interprets both 
internal and external signals to allow the cell to progress through its cellular cycle (Burkhart 
& Sage, 2008), defects in this pathway is a means to allow cell cycle progression regardless 
of any suppressant signals.  
Inflammation and recruitment of associated inflammatory cells, (mast cells, 
neutrophils, B/T cells) has been shown to drive growth by release of tumour growth factor 
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EGF and chemo attractants/cytokines which induce a higher inflammatory state which can 
induce more tumorigenesis factors (Egebald et al., 2010; DeNardo et al., 2010). Invasive 
capabilities can be incorporated by use of these inflammation cells, as they typically release 
extracellular digestive enzymes (Qian & Pollard, 2010). Alongside this, the release of DNA 
damaging (therefore mutagenic) reactive oxygen species by these cells can increase their 
genetic instability and possibly inducing more malignant mutations (Grivennikov et al., 
2010). 
Internal signals from the cell would occasionally drive the cell towards apoptosis, a 
highly regulated and pre-programmed method to act as a safeguard against ill functioning 
cells (Adams & Cory, 2007). Stresses to induce apoptosis such as extensive irreparable DNA 
damage (Roos & Kaina, 2006) and oncoprotein elevated levels can be evaded by mutation 
of the apoptosis machinery. Examples of this include; the up regulation of anti-apoptotic 
Bcl-2 family (Reed, 1995; Adams & Cory, 2007), loss of TP53 function (Ozaki & Nakagawara, 
2011), increase of survival signal IGF-1/IGF-2 (Kooijman, 2006) and down regulating pro-
apoptotic factors BAX/BIM (Campbell & Tait, 2018). Likewise to apoptosis, autophagy also 
needs to be prevented as it would activate in response to high levels of internal cellular 
stress. Inactive autophagy pathway caused by mutations are shown to increase the levels 
of susceptibility to cancer in mice (White & DiPaola, 2009), indicating another barrier that 
must be overcome to develop a tumour.  
Tumour genomes are seen to have an increase in mutation frequencies, termed 
genomic instability (Lengauer & Kinzler, 1998). Genomic instability within tumours must 
exist in a manner to provide cancer cells with the means to drive tumour progression, 
opposed to waiting for natural DNA damage events to happen and be beneficial.  Genomic 
instability is the foundation feature of a cancer cell to gain every other tumour trait 
required to form into a developed cancer. Therefore it is essential for there to be a 
disruption to the genome (i.e. oncogenes/tumour suppressors) that can propagate across 
the ‘population’ successfully.  As previously described (section 1.14), cancers are seen in 
almost all chromosomal aberration types with key specific aberrations at particular sites of 
the genome indicative of gene areas, which when disrupted, favour tumour progression 
(Korkola & Gray, 2010).   
Other key hallmarks of cancer are shown in figure 1.11, such as promotion of 
angiogenesis to enable the growing tumour a steady income of resources to grow further 
and the induction of metastasis by invasive mechanisms activation. These are detailed 





















Personalized medicine in cancer is gaining traction to allow targeted therapies for 
individuals rather than a one size fit all approach guided by their genetic profile(Jackson & 
Chester, 2015).  Specific patterns of genomic imbalances can be found across tumours of 
various types, highlighting specific cancer genes yet also allowing clinicians to comment on 
disease progression and therapeutic choices used (Gebhart, 2004). Via the use of CGH and 
aCGH, a top down approach can be used to detect these patterns in individuals, such as 
copy number of particular genes which may be representative of the incidence of 
targetable oncogenes. However as previously discussed, this methodology can misinterpret 
results by the global approach used opposed to looking at the individual level which could 
miss key details, such as subpopulation aberrations (Pinkel & Albertson, 2005). Missing 
details in cancer diagnostics can be fatal as incorrect treatment, inability to detect 
subpopulations and presence of resistant tumours can lead to a cancer recurrence at a 
later date that could be unresponsive to previously used therapies (Landau et al., 2013; 
Pereira et al, 2016; Morris et al., 2016; Zhao et al, 2016). 
 
 
Figure 1.11. Cancer hallmarks and appropriate therapeutic targeting. 
The acquired capabilities of cancer needed to survive and eventually metastasize; each 
function can be gained via different biological means but can be summarized via 
observable phonotypical trait.  Surrounding each hallmark is an investigational or 














1.3.2 Causes of Tumorigenesis  
Disruption of multiple cellular processes is vital in the establishment towards formation 
of a malignant tumour, long has there been fascination over the underlying factors or 
agents responsible for these progressions. With an increasingly industrialised and 
globalised world, the rates of cancer have increased dramatically thought to be carcinogens 
released as a by-product of these processes (Vineis & Wild, 2014). New knowledge paired 
with education about cancer risk factors is thought to be able to reduce incidence of cancer 
by a third (Vineis & Wild, 2014), and in an ever developing world prevention opposed to 
cure is vital for a healthy populace. Here shall be a tour from original theories to modern 
day hypotheses from extrinsic environmental factors, biological agents to culminate with 
agents within the genome itself.  
1.3.2.1 Environmental Carcinogens  
Historically, the first theories about external influences or carcinogens arose from the 
observation that specific occupations of the time had higher incidences of specific cancers. 
In approximately 1770-80, chimney sweepers were seen to have an increased rate of 
cancer of the scrotum which was linked with consistent exposure to soot (Pott, 1775). 
Figure 1.12. Intracellular signaling networks of cancer cell regulation. 
A representation of example pathways from internal and external stimuli that 
regulate the ‘hallmark’ capabilities of a cancer cell. This highlights the crosstalk and 
overlap between different pathways and how individual and successive mutations 




Additionally around this same time, tobacco snuff was observed to be in association with 
the prevalence of nasal cancers (Redmond Jr, 1970). The later discovery of X-rays (which 
was a medical breakthrough in itself by the visualisation of bones without pain) (Röntgen, 
1896), radiologists would routinely use their own hands to calibrate and test their 
equipment to ensure correct working order. This would lead them to develop a new 
condition termed ‘radiodermatitis’ in the following days (Pitkin, 1903), which would result 
in eventually develop skin cancers in later years (Porter & White, 1907).  
The prevailing theories were that cancer could be caused by three different factors, 
chronic irritation, displaced embryonic tissue or an infectious agent/parasite (Oberling, 
1994). There was a need to experimentally induce a cancer with an ‘agent’ to disprove 
these theories. The first successful induction of cancer was performed on the ears of 
rabbits (as cancerous tissue was rarely seen here and must have been due to the influence 
of external/exogenous factors) (Yamagiwa & Ichikawa, 1918). This lead to eventual 
formation of cancerous lesions after years of tar applications with some eventually showing 
the presence of metastases (see figure 1.13) (Yamagiwa & Ichikawa, 1918). Following this 
research showing that an environmental agent could cause the formation of cancerous 
cells, the cancer inducing compound of tar was identified (Kennaway, 1995), and lead 
researchers to look into other professions and retrospectively. Subset of workers in the dye 
industry presented with high rates of bladder cancer, found to be due to long term 
exposure to β-napthylamine (Case et al., 1954), and high rates of lung cancers in miners 
was due to exposure of uranium, the very material they were mining (Wagoner et al., 
1965). World war one veterans and Japanese survivors of Hiroshima/Nagasaki atomic 
bomb explosions developed high rates of lung cancer and leukaemia in later life allowing 
retrospective conclusions about the cancer-causing effects of exposure to mustard gas and 
atomic exposure (Case & Lea, 1955; Folley et al., 1952). Exposure to radioactive material 
was identified again as a cancer causing agent years after exposure. USSR scientists 
identified an increased risk of liver, lung and bone cancers of those involved in 
research/exposure to plutonium and in nuclear plants (Koshurnikova et al., 1994; 
Koshurnikova et al., 1998), and after the Chernobyl explosion of 1986 to release radioactive 
iodine-131 into the atmosphere there was an increase of childhood thyroid cancers in 
surrounding regions (Kazakov et al., 1992; Shibata et al., 2001).  
Other examples of carcinogens include; diesel fume exposure (Garshick et al., 2004), 
ultraviolet radiation exposure (Ward, 1988; D’Orazio et al., 2013), a possible side effect of 
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hormone replacement therapies (Smith et al., 1975), the use of immunosuppressant 
azathioprine for organ transplant recipients (Penn et al., 1969), and cigarette/tobacco 
smoke (Evans, 1962; Doll & Hill, 1999). It is clear that there are large variations of 
carcinogens present in a modern day environment, with many taking years to come to 
fruition. In the aftermath of the collapse of the World Trade Centre (Li et al., 2012) many 
causative agents have been identified and most likely more will follow in time after delayed 
onset of cancers (Hutchings & Rushton, 2011; Rushton et al., 2012; Health and Safety 
Executive ,2018), yet there is now a requirement to investigate possible co-operative 
synergistic effects between multiple agents that could have carcinogenesis 
effects(Goodson III et al., 2015). However, modern investigations into carcinogens will 
likely see the reduction of cancers with application of: prevention strategies, identification 















Figure 1.13. Process of metastasis in typical cancer to colonize new sites  
Normal cells can undergo transformational changes to form a malignant tumour. 
From an in-situ cancer, further mutations can allow cells to escape extracellular 
confinement (such as the basal lamina). Cells can spread through the lymphatic system 
or the circulatory system to invade and colonise other tissues to form metastatic 
tumours.  (Based upon Steeg, 2003). 
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1.3.2.2 Infectious agents 
One of the original hypothesis of cancer induction was the action and presence of 
parasites (Oberling, 1944), thus it is unsurprising that research has been conducted to 
attempt to find an infectious agent as an underlying cause of cancer.  
Bacteria such as Helicobacter pylori has been noted to cause stomach cancer (Egi et al., 
2007; Peter & Beglinger, 2007) and a subclass of lymphoma (Morgner et al., 2000), 
however most other cases of bacteria associations with cancer have unclear relationship 
between the infection and tumorigenesis (Mager, 2006). The main area of research and 
interest has been on the influence of viral presence and as the causative agent, as it is not 
uncommon to see a cancer be attributed to viral infection (Carrillo-Infante et al., 2007).  
Many non-human viruses were isolated from animals shown to have various cancers 
such as the avian sarcoma leukosis virus (ASLV) in 1908 (Blackadar, 2016), the mouse 
leukaemia virus (Gross, 1951), feline lymphoma virus (Jarrett et al., 1964) and retroviruses 
found in nonhuman primates and cattle (Kawakami et al., 1972; Kettmann et al., 1975). It 
was only in the 1970’s that dedicated funding and research was aimed towards discovery of 
human specific oncogenic retroviruses (Gardner, 1994; Voisset et al., 2008).Although not 
the first oncogenic virus discovered, a retrovirus was discovered within a T cell lymphoma 
cell line (HLTV-1) (Poiesz et al., 1980) which was observed to integrate into its hosts 
genome before any expansion of tumour cells (Yoshida et al., 1984; Hinuma et al., 1981) to 
produce proteins tax and HBZ which induce cellular disruption and genetic alterations 
(Mesnard et al., 2006).  
The oncovirus Hepatitis B has been indicted in the formation of liver cancer 
(heptocellular carcinomas, HCC) (Szmuness, 1978). A study performed in Taiwan looked for 
hepatitis B indicators within healthy males, then retrospectively assessed many years later 
the prevalence of HCC, which was much higher in infected than those non-infected 
(Beasley et al., 1981). Due to the high levels of hepatitis B, government driven vaccination 
for this virus was introduced and saw a marked decrease in prevalence of childhood HCC to 
further give evidence that this is a true oncovirus (Chang et al., 1997; Chein et al., 2006). 
Hepatitis B is known to produce oncogenic proteins (Kim et al., 1991) and when integrated 
into the hosts genome is observed to increase the rate of chromosomal instability (Tokino 
et al., 1987), and typically seen in cases of HCC the recruitment of self-immune system cells 
to damage infected and un-infected cells (Chen et al., 2006).  
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Human papillomavirus (HPV) comes in approximately over 170 ‘types’ (Bzhalava et al., 
2013), it  is estimated to infect 12% of women worldwide at any single time (World Health 
Organisation, 2014) and is predicted that over 50% of US sexually active individuals will be 
infected with a type of HPV at some point in their life (Baseman & Koutsky, 2005). There is 
a strong association of HPV-16 and HPV-18 in cervix cancers, where these specific types are 
observed in 97-98% of all cervical cancer biopsies (Dürst et al., 1983; Boshart et al., 1984; 
Walboomers et al., 1999; Muñoz et al., 2003). Oncoproteins associated with these two 
have been shown to influence the degradation of p53 (Scheffner et al., 1990) and increase 
the rate of chromosomal instability (Boyer et al., 1996). Interestingly, the virus does not 
typically need to integrate into the host genome to replicate, yet has high incidence in 
cancer cells (Arias-Pulido et al., 2006; Pett & Coleman, 2007) showing an alternative 
oncogenic viral mechanism.  HPV vaccines are clearly shown to reduce the prevalence of 
cancers (Lehtinen et al., 2012). Long term retrospective population studies in the UK 
observed routine vaccinations for past 10 years for girls, to shown a reduction of 90% of 
pre-cancerous cells of the cervix (Palmer et al., 2019). 
Another virus (the first oncogenic virus discovered) associated with oncogenic 
properties is the Epstein-Barr virus (EBV) Epstein- Barr virus, which is reportedly seen in 
Burkitt’s lymphoma (Burkitt, 1983; Epstein, 1964; Henle et al., 1969), and nasal pharynx 
cancer (Ji et al., 2007). With EBV the action of microRNA’s on cellular metabolism is 
considered to be the malignant inducing pathway (Raab-Traub, 2012). Human 
immunodeficiency viruses (HIV) can be viewed as an indirect oncogenic virus due to high 
levels of Kaposi’s sarcoma associated with infections (Centers for Disease Control (CDC), 
1981; Bovi et al., 1986). Through the action of the HIV tat protein, cellular expression can 
be altered within immune cells to suppress immune system functions, activate apoptotic 
genes (which can cause genomic aberrations, see chromoanagenesis) and cause mass 
death of non-infected immune cells (Johri et al., 2011). With these functions in mind, it is 
not surprising that carriers of HIV develop cancers and that HIV can be seen as an oncovirus 
as a key hallmark of immune system survival has been bypassed.   
Other oncoviruses include; the Human T-lympotropic virus, the first discovered human 
retrovirus (Yoshida, 1982; Gallo, 2005), Hepatitis C (Houghton 1989), the Kaposi’s sarcoma-
associated herpes virus (Antman & Chang, 2000) and Merkel cell polyomavirus (Feng et al., 
2008).  Strong associations exist between presence of oncogenic virus and associated 
cancer, such as the example of Merkel cell carcinomas with 70-80% carcinomas presumed 
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to be caused by the Merkel cell polyomoavirus (Feng et al., 2008) and near 100% of cervical 
cancers attributed to papilloma viruses (Parkin, 2006).  
Some human endogenous retroviruses (HERVs) who’s remnants are left over within the 
genome over evolutionary time typically make up non-coding regions of the human 
genome with minimal or no purpose (Stoye, 2012). However, there are occurrences where 
there is increased expression of HERV in serum, melanomas and in particular breast 
cancers (Hohn et al., 2013; Schmitt et al., 2013; Wang-Johanning et al., 2014). Whether this 
is due to resurgence or reactivation of viral mechanisms or an effect of malformed 
expression due to the cancerous nature of malignant cells is still up for debate.  
1.3.2.3 Genetic contributions 
 Having described thus far the mechanisms of cancer induction via external stimuli, 
it is vital we explore and understand the endogenous factors of tumorigenesis. The 
formation of cancers is known to typically arise from ‘normal’ DNA mutation events 
induced by DNA damage (Kastan, 2008), as previously stated, the typical human cell 
receives tens of thousands of DNA lesions per day (Lindahl & Barnes, 2000) and if not 
correctly repaired they can lead to further mutations to become harmful to the cell or the 
organism as a whole. Typical physiological processes such as DNA mismatches during 
replication, DNA strand breaks (Hsieh & Zhang, 2017), hydrolytic reactions of the 
phosphodiester backbone or DNA bases (Shapiro, 1981; Gates, 2009) and reactive oxygen 
compounds from oxidative respiration or from immune cells at inflammation sites 
(Kawanishi et al., 2006). Clearly described thus far and a frequently recurring feature, the 
cancer genome requires genomic instability (Stratton et al., 2009). 
Typically, germline mutations are only seen in 1% of cancers and are the distinctive 
causative effect of highly aggressive tumours (Fearon, 1997), compared to the majority of 
other cancers which are sporadic in nature or are thought to have a hereditary component 
not yet identified (Lichtenstein et al., 2000). In the context of familial contribution to 
cancer, the correlation between distinctive cancer patterns and families is seen to be high 
(Goldgar et al., 1994; Hemminki et al., 2007). Examples of this include studies of families 
which have high incidence of prostate cancer (Zeegers et al., 2003), breast cancer 
(Collaborative Group on Hormonal Factors in Breast cancer, 2001) and colon cancer (Fuchs, 
1994). As it is hard to derive a definitive causative agent to link common cancers in family 
lineages due to typical shared experiences/exposures in reference to environmental 
influences, it is possible to perform a more crude Mendelian approach in search for ‘cancer 
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genes for high penetrance in cancers which seem to be inherited. Twin studies show that 
monozygotic twins (identical) have higher rates of developing cancer if their twin 
developed a cancer in life compared to dizygotic twins, indicating that there is somewhat a 
genetic disposition or mechanism at play (Page et al., 1997; Lichtenstein et al., 2000). 
 By use of Mendelian genetics, it is possible to look into these families for specific 
causative genes yet these only typically make up 5% of inherited cases.  The identification 
of BRCA1 and BRCA2 variations has an association with increased risk of breast cancers and 
ovarian cancers (Miki et al., 1994; Wooster et al., 1995; Welcsh & King, 2001). 
Understandably BRCA1 and BRCA2 are associated with correct DNA repair after double 
strand breaks events so it is of no surprise these are associated with the incidence of 
cancer risk. However it is only observed that between 3-8% of breast cancers actually carry 
a mutation in either BRCA1 or BRCA2 (Brody & Biesecker, 1998), and 18% of ovarian 
cancers has a mutated BRCA1 where 13% is inherited through the germline and 5% somatic 
mutations. Li-fraumeni syndrome is a classic example of an autosomal dominant hereditary 
disorder (Li & Fraumeni, 1969) that is characterized by early onset of a wide variety of 
cancers and a development of cancers throughout the life time of an individual (Hisada et 
al., 1998). This syndrome is associated to p53 mutations that can arise through novel 
mutations but is shown to be highly heritable (Varley, 2003). Typically, a tumour 
suppressor, expression occurs during cellular stress (DNA damage) to halt cell cycle 
progression to either direct DNA repair or induce apoptosis (Zilfou & Lowe, 2009). However 
in mutated forms this checkpoint is made redundant to possibly allow cells to divide 
uncontrollably. The mechanisms of inherited Li-fraumeni syndrome are heterozygous for 
p53 mutation with a high majority having missense mutations in the DNA binding domain 
to cause a decrease in efficiency of p53 to bind to DNA (Malkin, 2009). As this syndrome is 
autosomal dominant, this can happen due to the p53 mutant expressed is more stable than 
wild-type p53 and has a degree of interaction between mutant and wild type proteins that 
can suppress its function (Willis et al., 2004).  
An example of an inherited autosomal recessive defect is shown in xeroderma 
pigmentosum (XP) first described by Kaposi in 1882 (Kaposi, 1882), who also described 
Karposi’s sarcoma as a cancer of the skin from which its name derives. Not associated with 
a single mutation, XP typically has defects in nucleotide excision repair enzymes causing the 
effected individuals more susceptible to UV light (Kraemer & DiGiovanna, 2016). Multiple 
genes associated with XP represent separate groupings based upon phenotype expressed 
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which are derived by the mentioned different cocktail of mutated genes (Schubert et al., 
2014; Fassihi et al., 2016)). The 13 known genes are 
DDB2,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,ERCC6,ERCC8,GTF2H5,C7orf11,POLH,XPA, and XPC 
(DiGiovanna & Kraemer, 2012). Most of these genes are associated within pathways of 
nucleotide excision repair, with DDB2 determines initial lesion recognition in non-
transcribed DNA (Clement et al., 2010) and ERCC2/ERCC3 aid in unwinding the DNA in the 
region of damage to be repaired (Boyle et al., 2008). The multitude of genes involved 
reflects the median age of death with XP is 37 years or 29 years if an individual is a sufferer 
of particular gene defect combinations to have neurodegeneration (Kraemer & DiGiovanna, 
2016). Inherited factors are easy to identify within family with alleles of high penetrance, 
however this is much harder with common or more sporadic in nature cancers, where only 
risk loci can be presumed but nothing substantial can be concluded (Cunningham et al., 
2003; Chang et al., 2005)  with only 5 loci weakly correlated to prostate cancer (Zheng et 
al., 2008).  
It is clear thus far that the feature of genomic instability such as malformations in DNA 
repair mechanisms or regulatory pathways in cellular division being ignored, it is vital to 
reflect on what these specific DNA mutations bring about it directly cause a cancerous 
tumour. Many have been mentioned and mechanisms described so far in respect to 
specific conditions or aberrations, but here will be highlighted some of the more globally 
associated cancer genes, examples of oncogenes and the tumour suppressor genes. 
1.3.2.3.1 Oncogenes 
Oncogenes are typically viewed as a gene that somewhat can promote the 
development of cancer by increasing cellular growth/division. Precursors to oncogenes 
‘proto-oncogenes’ are normal genes that typically allow normal cellular 
grown/proliferation which are unsurprisingly essential for bodily function.  Whence 
acquiring a means of altering the proto-oncogenes function to induce a tumour, it becomes 
recognized as an oncogene (Todd & Munger, 2001). This activation can be brought about in 
three different modes. Firstly by a mutation in DNA sequence within the coding region or 
regulatory region, by an increase amount of the protein concentration (such as via 
increased expression, mRNA modifications or gene duplication –see section 1.14-) or by a 
chromosomal translocation event (either to a new position with higher expression or by 
interjecting into expression of another gene- again see section 1.1.4-).  
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One of the first oncogenes discovered was a small GTPase, the Ras family, 
compromising of H-Ras, N-Ras and K-Ras (Reddy et al., 1982; Bos, 1989). Mutations in the 
ras genes can eventually lead to the production of Ras proteins in an activated state, these 
proteins are involved in signal transduction pathways to induce cellular growth and survival 
genes to activate (Hilgenfeld, 1995; Goodsell, 1999) (Figure 1.12). Even though there are 
many other members of the Ras subfamily (Wennerberg et al., 2005), these three 
mentioned Ras proteins are implicated in many types of cancer (Bos, 1989), these are the 
most commonly found oncogenes in human cancer at 20-25% prevalence and up to 90% 
prevalence in pancreatic cancers (Downward, 2003).  
An aberrant form of the c-myc gene is also found in a large variety of cancers, from 
lymphomas, leukaemia, breast cancers, blastomas and small cell lung cancers (Felsher & 
Bishop, 1999). As part of the myc family, c-myc is a regulatory gene that code for 
transcription factors, some of which are actively involved in cellular division, growth (Rahl 
& Young, 2014) and DNA replication (Dominguez-Sola et al., 2007; Gearhart et al., 2007). 
Translocation aberrations of chromosome 8 (location of c-myc) is seen in almost all cases of 
Burkitt lymphoma (Dalla-Favera et al., 1982; Finver et al., 1988), and general up regulation 
of this gene is seen in carcinomas across the body due to its high number of downstream 
targets (Figure 1.12).  C-myc is typically over expressed in the majority of human cancers, 
and is seen to be a direct cause of at least 40% of these tumours (Dang et al., 2009), 
whereas in other tumours it is seen as a downstream effect of other activated oncogenes 
up regulating its function to push growth forward (Miller et al., 2012).  
Mentioned in passing in previous sections, the Philadelphia chromosome is formed 
from a translocation event between chromosome 9 and 22, commonly seen in chronic 
myeloid leukaemia cells (Nowell & Hungerford, 1960; Kang et al., 2016). The proto-
oncogene ABL1 on chromosome 9 is translocated to the BCR gene on chromosome 22, the 
outcome of this translocation is the production of a BCR-ABL1 fusion gene to encode the 
oncogenic protein BCR-ABL1 (Collins & Groudine, 1983; Hagemeijer, 1987).  The exact 
breakpoint regions is known to be variable (Score et al., 2010), but will involve the required 
regions of both genes albeit with different variations of the fusion protein which can act as 
a marker for different forms of leukaemia (Pane et al., 1996; Li et al., 1999). The BCR-ABL1 
protein has an elevated tyrosine kinase activity, normally to activate other signal pathways, 
yet unsurprisingly alike other oncogenes this hybrid protein actively maintains signal 
pathways for proliferation, resistance to apoptosis and preventing differentiation in cancer 
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cells (Lugo et al., 1999; Sattlermc & Griffin, 2003). This oncogenic protein also infers 
increased genomic instability, to encourage formation of double strand breaks by 
stimulating single strand repair processes unnecessarily (Cramer et al., 2008; Fernandes et 
al., 2009) and increasing enzymes involved in double strand breaks to ensure survival yet 
promote this genomic instability cancers rely on (Slupianek et al., 2011).  
1.3.2.3.2 Tumour suppressor genes 
With the view that proto-oncogenes push the development of cellular growth, we 
observe that there are regulatory systems in place to antagonize this drive to prevent the 
uncontrolled and ill-timed proliferation. Tumour suppressor genes are genes that 
somewhat protects the cell from the progression into cancer either by repressing the cell 
cycle or promotion of correct apoptosis (Sherr, 2004), initially shown by somatic cell fusion 
experiments indicating an existence of genes that could restrain tumour development 
(Harris et al., 1969; Stanbridge, 1979). Tumour suppressor genes functions can be classified 
into several categories where examples of genes may overlap between functions. As 
stated, the continuation of the cell cycle and promotion of apoptosis are two categories 
followed by acting as a link between the progression of the cell cycle and DNA damage, 
repair of DNA damage themselves and lastly cell adhesion detection (contact inhibitors for 
example) (Hirohashi & Kanai, 2003; Sherr, 2004). 
The first classic suppressor gene identified was linked to retinoblastoma typically 
caused by a mutation in the gene RB or RB1 located on chromosome 13q14 (Noel et al., 
1976), to give rise to a malformed retinoblastoma protein (pRb) (Murphree & Benedict, 
1984), now understood to be one of the most important centres of cellular signalling 
(Weinberg, 1995; Du & Pogoriler, 2006). Manifesting in a rare cancer of immature retina 
cells in children, retinoblastoma was hypothesized to be caused by inherited mutations 
(Kundson Jr, 1971; Kundson Jr, 1973). Observed in retinoblastoma are two patterns of 
formation, a bilateral early onset tumour or sporadically later in life and typically only in 
one eye. Interestingly the bilateral early onset patients typically had a familial pattern of 
this disease indicating an inheritable element opposed to the unilateral sporadic patients 
not (Kundson Jr et al., 1976; Francke & Kung, 1976). This method of inheritance allowed 
formation of the ‘two hit hypothesis’ (Kundson Jr, 1971; Kundson, 2001) which 
hypothesizes that both alleles of a tumour suppressor gene was required must be knocked 
out in separate mutative events to cause a complete loss of function. However, there are 
known exceptions to this rule, such as p53’s self-repressive functionality (Baker et al., 1990) 
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or genes which require two non-mutated alleles, haploinsufficiency (NF1 as an example in 
neurofibroma (McLaughlin & Jacks, 2002), and holoprosensephaly, a incorrect formation of 
the forebrain due to the haploinsufficiency for Sonic Hedgehog (Nanni et al., 1999).  The 
theory of ‘two-hit’ is appropriate for retinoblastoma as individuals who inherit one copy 
need only sustain one mutation, hence the expression of early life bilateral tumour 
formation (Kundson Jr, 1971; Kundson, 2001) opposed to two mutations required for 
sporadic formation. Furthermore, follow-up studies of hereditary and non-hereditary 
survivors showed that hereditary retinoblastoma acts as a higher risk factor for new 
cancers over time as compared to sporadic (Kleinerman et al., 2005). pRb restricts the cells 
ability to leave G1 phase and enter S phase (see section 1.1.3.2) (Goodrich et al., 1991) as it 
can bind to inhibit transcription factors such as E2Fs, which regulate multiple genes 
required for DNA replication (Funk et al., 1997; Nevins, 2001; Trimarchi & Lees, 2002), so 
unsurprisingly in mutated versions of the RB gene this function is suppressed allowing S 
phase promoting factors to proceed unchecked. 
Another key tumour suppressor gene is TP53 which codes for the p53 protein. As 
already discussed in previous sections this gene is associated with the majority of cancers 
(Nigro et al., 1989; Ozaki & Nakagawara, 2011), Li-Fraumeni syndrome (Malkin et al., 1990) 
and multiple chromosome aberrations involving chromosome 17 (Salido et al., 2005; Zedan 
et al., 2015). The role of p53 is well understood (Levine & Oren, 2009) and is vitally 
important in tumour development as it was shown to infer a 100% penetrance cancer 
phenotype in TP53-null mice (Brož & Attardi, 2010). P53 can detect a wide variety of 
cellular stresses such as DNA damage, hypoxic conditions, cell cycle abnormalities, 
ribosome dysfunction and other oncogene expression. This serves to limit the division of 
cells (Kundson, 2001; Vousden & Prives, 2009) at G1 and G2/M phase (Mercer et al., 1990; 
Diller et al., 1990) by its functionality as transcription factor with its transactivation domain 
(Zhu et al., 1998) that can bind to specific DNA regions (Kern et al., 1991; Zauberman et al., 
1993; Kitayner et al., 2006). The regulation of p53 by protein kinases that detect stress 
factors, such as MAPK family members which detect externally induced stresses (Wu, 2004) 
and others which detect genome integrity (Ciccia & Elledge, 2010), increases the half-life of 
p53 in cells and forces the conformational change to act as a transcription factor by utilizing 
its transactivation domain to activate expression of multiple genes (Brooks & Gu, 2010). 
Examples of targets of p53 are as follows; p21 inhibits cyclin dependent kinases to halt cell 
growth/drive into cellular senescence, G0 (Brown et al., 1997) amongst other cell cycle 
arresting agents (El-Deiry, 1998), opposed to other targets which induce apoptosis as pro-
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apoptotic genes, Bax and PUMA (Green & Kroemer, 2009). More than 50% of human 
tumours contain either a mutation or deletion in TP53 to therefore be associated with 
genomic instability (Hollstein et al., 1991; Schmitt et al., 2002). The importance of p53 has 
been shown in studies that have restored its functionality causing a degree of regression in 
tumours (Ventura et al., 2007).  
1.3.2.3.3 Epigenetics and microRNAs  
Structural changes within chromatin subunits influences the ability of genes to be 
activated or silenced, such as via histone modification or DNA methylation which can allow 
or prevent transcriptional machinery access to coding regions.  Epigenetic modifications are 
kept during cellular division, and can be inherited by offspring. A common example of 
epigenetic silencing is the process of a totipotent embryo cell becoming modified to a 
pluripotent cell then further specialization to specific cell/tissue types, a process that 
requires permanent silencing of genes (Mitalipov & Wolf, 2009). 
In reference to cancer formation, epigenetics has been shown to play a large role in 
formation and repression of cancers (Jones & Baylin, 2002; Egger et al., 2004; Sharma et al, 
2010), with more modern understanding is that cancer cells show global epigenetic 
abnormalities paired with genetic mutations (Jones & Baylin, 2007). During all stages of 
cancer progression epigenetic modifications have been shown to play roles to promote the 
cancerous phenotype (Feinberg & Vogelstein, 1983; Feinberg et al., 2006), and even 
initiate. Some cancers typically have more silencing markers associated with oncogenes as 
compared to specific DNA mutations effectively causing a larger gene silencing effect 
(Vogelstein et al., 2013). As described within colon cancer, more heavily methylated CpG 
islands coupled with oncogenes were found to not be methylated in adjacent healthy 
mucosa cells indicating the vast change of epigenetic features comparing cancer cells to 
their healthy progenitors (llingworth et al., 2010; Wei et al., 2016).  
microRNA’s are small non coding RNAs that are seen to regulate the expression of 
genes via post-transcriptional silencing. The specific bases that the microRNAs possess 
allow it to pair with messenger RNA to induce silencing as double-stranded RNA (dsRNA) is 
tagged for destruction by nucleases and prevention of integration into the translational 
machinery of the ribosome (He & Hannon, 2004; Morris & Mattick, 2014), the presence of 
dsRNA is also an indicator for viral infections so it is not surprising the cell has a dedicated 
and good response to the presence of dsRNA (Gantier & Williams, 2007). As compared to 
normal tissue cells, the levels of microRNAs expression in malignant tumour cells show 
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large changes during this tumorigenic state (Lu et al, 2005). Typically microRNA’s regulate 
genes associated with transcriptional regulation, proliferation, apoptosis and the cell cycle, 
so understandably a disruption in the levels of microRNAs expression will give rise to 
tumour generating effects.  An example of a microRNA implicated in tumorigenesis is miR-
127. miR-127 targets the production of BCL6 (BCL6 acts as a repressor of transcription via 
binding directly to DNA to silence genes), and this is shown to be down regulated in 
prostate and bladder tumours (Saito et al., 2006) preventing the action of BCL6 and 
increasing expression of its targets. Another microRNA down regulated in cancer cells is 
miR-101; this inhibits the translation of protein group EZh2. EZh2 is associated with histone 
methylation which is used to silence genes (Viré et al., 2006) and this protein itself is shown 
to be linked to high expression in cancers as it inhibits tumour suppressor genes 
epigenetically (Kim & Roberts, 2016). Unsurprisingly the down regulation of its microRNA 
suppressor, miR-101, is seen in bladder carcinomas (Friedman et al., 2009) causing a subset 
of tumour suppressor genes being down regulated as expected.  
Alternatively, there is the incidence of oncogenic microRNAs. One such is miR-21. This 
microRNA regulates the expression of protein PTEN, a tumour suppressor gene within the 
ATK pathway that ultimately prevents the cell from dividing too rapidly (Chu & Tarnawski, 
2004). PTEN is seen to be lost in 70% of prostate cancers (Chen et al., 2006) indicating its 
tumour suppressor nature. Alongside this within glioblastoma it is observed that miR-21 is 
instead up regulated (Chan et al., 2005) to decrease the levels of PTEN in the cell and 
therefore disallow a level of control around cellular division.  
1.3.3 The treatment of cancer 
The treatment of cancer has undergone many improvements over the past few 
centuries of medical knowledge and research, cancer treatment depends on the type of 
cancer, where it is located, at what stage the cancer is and general health of the patient. In 
some cases a single treatment is required with no follow-up, and some patients require 
long lasting repetitive treatments typically in a specific personalised combination (Cancer 
Research UK "Treatment for cancer”, 2019  Cancer.gov “Treatment for Cancer", 2019). 
Here shall be a demonstration of multiple treatment types currently used for various types 
of cancers and how can be beneficial or disadvantageous.  
The Ebers papyrus dating back to 1550 BC is one of the oldest medical ‘textbooks’ in 
current existence to display the best-preserved record of ancient Egyptian medicine 
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(Brested, 1930). A 110 page scroll detailing a vast plethora of knowledge of ‘current’ 
medical treatments of the time, from recognizing the heart is the centre of blood 
circulation, to expulsion of disease causing demons. This papyrus is the first known 
recorded text that references the surgical treatment of tumours with accompanied 
methodologies (Sullivan, 1996). Obviously, surgical techniques over the past few 
millenniums have made somewhat progress yet it still maintains its status as a core 
treatment methodology for modern day cancers. Surgery may be the singular treatment 
needed, if the cancer has yet to metastasise and is located to a singular non-essential organ 
(e.g. testicular, breast, skin) it is likely that surgery would completely remove all cancerous 
cells from the body in one go. With this in mind, in theory it would be possible to remove 
all solid cancers from the body via surgery, however realistically speaking this is not an easy 
process. To minimize the risk of recurrence of the tumour, typically healthy tissue is cut 
away around the tumour and analysed until no presence of malignant cells are visible. If 
every cancer cell is not removed there is a high chance that this will simply reform into a 
secondary tumour.  
Another treatment primarily against solid tumours (but also can be used against 
leukaemia/lymphoma) is radiation therapy. Different cancer types respond differently to 
radiation damage so can require higher dosage of radiation for effective treatment, such as 
melanomas are considered rather radio-resistant for treatment yet can have a beneficial 
effect as a palliative option (Maverakis et al, 2015). The principle of radiation therapy is the 
use of targeted high energy particles, such as photons, aimed at cancerous cells to induce 
sufficient breakages across their genetic material to prevent growth and hopefully cellular 
death. X-rays are commonly used as an external beam aimed at multiple angles towards 
the tumour through the patient to reduce unnecessary damage to healthy tissues and 
induce more damage in the cancerous ones. Other particles used may be in the form of 
protons, neutrons or heavy positive ions as they all have different levels of energy loss 
across distance travelled through tissue, with the aim of the highest energy loss being 
localised to the tumour and not to the surrounding tissue, again another means to prevent 
unnecessary damage. Alternatively, radioactive treatment can be induced from inside of 
the body by administration of a radioactive source as a liquid or solid with aim to pass near 
the tumour. An example of this is auger therapy, by the use of low level electrons released 
in high dosage via the auger effect (a high energy electron falling to a low electron state to 
release energy either by light or into another electron which is emitted, the auger electron 
(Meitner, 1922) opposed to the use of high energy particles which has systemic side 
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effects. With conjugation of an emitting molecule (a heavy atom) to another molecule with 
specific affinity to cellular compartments, delivery of low energy electrons can be focused 
on one particular area of the body rather than a systemic effect. This conjugation and 
affinity is also required as the electrons emitted only have a short range of travel 
(nanometres). 
Once viewed as the pinnacle of treatment for many cancer types, angiogenesis 
inhibitors are used to prevent the formation of new circulatory network being formed from 
malignant stimulation from tumours (Folkman, 2004), effectively starving the growing 
tumour of resources in a hypoxic environment (Hayden, 2009). The use of angiogenesis 
inhibitors alongside other cancer therapeutics in combination therapy is seen to still reduce 
cancer morbidity and mortality (Bagri et al., 2010). However the downsides of angiogenesis 
inhibitors, such as excessive bleeding and increase of blood clots, can be life threatening for 
cancer patient users (Akl et al., 2017). 
The use of systemic cytotoxic drugs to destroy rapidly dividing cells describes the 
treatment of chemotherapy. The administration of intracellular agents intended to inhibit 
cellular division and induce irreparable stresses to trigger apoptosis is the main aim for 
chemotherapy. Understandably more rapidly dividing cells such as cancers, bone marrow 
or hair follicles are more susceptible to the effects of these drugs. The efficiently of 
chemotherapy is dependent on the type of cancer present, leukaemia can be cured via 
chemotherapy (Nastoupil et al., 2012; Freedman 2012), whereas brain cancers do not 
respond well (Rampling et al., 2004) and some cancers it is inappropriate to use cytotoxic 
drugs, such as skin cancers. Dosages are required to be calculated correctly, too low of a 
dose and it will simply be ineffective against the cancer yet comparatively too higher of a 
dose will increase the cytotoxic effect on normal body cells more to the dislike of the 
patient coping with side effects (Gurney, 2002; Corrie, 2008). One type of cytotoxic drug is 
alkylating agents, with some of the oldest examples being mustard gas used in WW1 to the 
multiple chemotherapy drugs in use today (Corrie, 2008). These drugs cause the addition of 
alkyl groups to DNA, RNA and proteins within the cell impairing cellular function. In 
addition, these drugs can covalently bind to a DNA strand multiple times thus preventing 
cellular machinery from correct DNA replication as it cannot cope with intra-strand linked 
DNA to abort cell cycle process (Siddik, 2002; Lind, 2008). An example of a direct DNA 
damaging compound is the cisplatin family of drugs. These direct DNA binding platinum 
based cytotoxic drugs are used in many different cancers, such as breast, bladder, lung, 
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brain, neuroblastoma, and ovarian. In particular it has very good success rates improving 
the survival of prostate cancers (Einhorn, 1990).  However, it is noted that patients can 
relapse with cisplatin resistant tumours following treatment using this drug (see section 
1.3.4). Proposed methods of resistance of this drug include an increase of efflux proteins to 
expel the drug from the cell, the reduction of cellular uptake, detoxification of the drug, or 
further mutations in the apoptotic or DNA repair pathways to remedy the effects of the 
drug (Stordal & Davey, 2007).  
Another division of cytotoxic drugs are classified as the anti-microtubule agents, which 
indicative of their name, prevent the action of microtubule proteins α-tubulin and β-tubulin 
(Rowinsky & Donehower, 1991). Within anti-microtubule agents there are two classes of 
drugs, the vinca alkaloids which prevent formation of microtubules and the tazanes which 
prevent disassembly. As we know microtubules are essential for separation of chromatids 
during mitosis (see section 1.1.3.2) understandably these drugs prevent mitosis completion 
to arrest the cell and eventually trigger apoptosis (Yue et al., 2010). The vinca alkaloids are 
an example of a naturally produced plant based product as they are found within the 
Madagascar periwinkle, Catharanthus roseus (Jacobs et al., 2004). An example of a vinca 
alkaloid and a natural product of C.roseus is the cytotoxic drug vincristine (Keglevich et al., 
2012). Suitable for use in acute lymphoblastic leukaemia, acute myeloid leukaemia, 
Hodgkin’s disease, neuroblastoma and small cell lung cancers, vincristine binds to the 
tubulin proteins preventing the formation of microtubules to prevent chromosome 
separation during metaphase and therefore induce apoptosis (Jordan, 2002). 
Unfortunately, in a similar fashion to cisplatin, resistance can arise in tumours to cause 
relapse. One proposed mechanism is the over expression of the p-glycoprotein pump to 
increase efflux of this drug out of the cell preventing interaction with forming microtubules 
(Sui et al., 2012; Breier et al., 2013).  
Other systemic cytotoxic drugs used are the antimetabolites. This group of drugs 
disrupt DNA and RNA synthesis as their structure is comparable to a nucleobase (Parker, 
2009), the presence of these drugs in the cell can directly block enzymatic reactions 
required for DNA or incorporate itself into the DNA polymer formed. The anti-cancer action 
of these drugs arises from the blocking of DNA interactions thus preventing mitosis from 
occurring, or alternatively if inserted into DNA can induce DNA damage due to structural 
damage caused to trigger apoptosis of the cancer cell.  Lastly, toposiomerase (TOP) 
inhibitors target TOP1 and TOP2 which typically aid in the unwinding of DNA during 
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replication by inducing breakages to release tension build-up. Inhibitors can prevent 
TOP1/2 action in different ways, they can have an inhibitory feature to prevent the 
unwinding of DNA altogether physically barring exposure of DNA bases to replicative 
machinery, or encourage the breakage of DNA that TOP1/TOP2 typically regulate an then 
prevent re-ligation causing widespread DNA breakage (Goodsell, 2002). 
Unlike drugs that non-specifically attack all of the hosts cells, targeted therapies rely on 
the use of precise drugs for individual cancer types indicated by their specific markers 
expressed (Syn et al., 2016). One such classification of a targeted therapy is the drug 
imatinib, this drug occupies active sites of tyrosine kinases, in particular the oncoprotein 
BCR-ABL’s active site (see Philadelphia chromosome in section 1.3.2.3.1 and section 6.1.1) 
(Deininger & Durker, 2003) as well as c-kit and PDGF-R (Iqbal & Iqbal, 2014). The use of 
monoclonal antibodies also constitutes as a targeted therapy, these antibodies can either 
stimulate the patient’s immune system into action to target malignant cells by 
identification of a biomarker or deliver a chemical/radioactive dose to the specific location 
of the tumour. A good example of a monoclonal antibody is ramucirumab, this antibody 
binds to the extracellular domain of VEGFR-2 to prevent activation via ligands VEGF-A, 
VEGF-C and VEGF-D (Wadhwa et al., 2003). By blocking the activation of VEGFR-2, leads to 
inhibition of VEGF tumour angiogenesis as the VEGF ligands are typically secreted from 
malignant cells to promote angiogenesis (Vennepureddy et al., 2017). 
1.3.4 Cancer Genomics  
The association between genome and expressed phenotype was long debated until 
rediscovery of Mendelian inheritance by demonstrating that the variation and inheritance 
of alleles are responsible for the phenotypic variation we see across populations (Fisher 
1919). As previously discussed, there are plenty of examples of genetic diseases caused by 
individual or a sub set of alleles, but to determine the underlying genes at fault in common 
diseases (or common cancers) are very likely to be a multitude of minor gene interactions 
multiplied by the external environmental factors at play to cause this disease (Guttmacher 
et al., 2004; Manolio & Collins, 2007). The detection of underlying genes or polymorphisms 
within cancer cases is possible, such as this blunt approach worked for bladder cancer 
(García-Closas et al., 2005; García-Closas et al., 2011). Yet for prostate with a known good 
gene target, the associated androgen receptor highly and frequently expressed in 
aggressive tumours (Lee, 2003) shows a large variation within this gene within cancer 
patients and healthy control patients (Schatzl et al., 2002; Lindstr m et al., 2010), 
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furthermore, when studying (relatively speaking) isolated ethic-groups displaying the same 
cancer type, there was still no correlation to be seen between cancer features and 
displayed genetic variation (Gallagher et al., 2010).  
These studies show that cancer traits, and cancer susceptibility, are not controlled by 
specific polymorphisms or individual point mutations that can be detected across 
populations, this highlights the need to look across the whole genome to make 
associations, of course the use of multiple genome wide association studies has shown the 
detection of cancer–related trends.  The region of 8q24 has now been implicated in many 
types of cancers. Firstly identified within European and African American prostate cancers 
(Amundadottir et al., 2006; Freedman et al., 2006) with a novel polymorphism detected 
(Haiman et al,. 2011) and to be further implicated in prostate cancer with other 
independent polymorphisms found at this site (Haiman et al., 2007; Yeager et al., 2009). 
These other types of cancers show risk markers that have been associated at this same site, 
including; colorectal cancers (Tomlinson et al., 2007), bladder cancers (Keimeney et al., 
2008) and leukaemia (Crowther-Swanepoel et al., 2010). An exciting result from genome 
wide studies was that >90% of disease associated polymorphisms are found within non-
coding regions of the genome, somewhat surprising as the premise was to look for 
variations within gene coding regions (Hindorff et al., 2009; Hirschhorn, 2009), yet also 
somewhat expected knowing that most human variation at the DNA level is within non-
functional regions (estimates put 3-5% of single polymorphisms as functional (Collins et al., 
1998)).  However, detection of individual polymorphisms between individuals would be 
expensive, in-able to detect very rare variations found and most importantly miss structural 
variations, such as the previously discussed translocations/inversions/deletion etc (Manolio 
et al., 2008). It is this structural variation that is attributed to the larger number of ‘base 
pair differences’ and variation amongst populations than single polymorphisms (1000 
Genomes Project Consortium, 2005). As explained, the use of whole genome studies has 
led to the identification of many causes of specific cancers and seen as beneficial to 
perform, however cancer cells within a tumour display heterogeneity and this must be 






1.3.4.1 Heterogeneity of cancer  
As cancers are known to exhibit genome instability, it would be incorrect to presume 
that each cycle of division would yield identical products as the first ‘progenitor’ cell 
(Schmitt et al., 2012). This differentiation event would yield a tumour with distinctively 
different features, in the phenotype and genotype, of different sub-clonal populations 
(Fidler & Hart, 1982). Each cancerous event is a unique evolutionary process where 
multiple heterogeneous malignant cell clone populations arise via mutation events due to 
deregulation of their tumour suppressor feature. These cells would compete against one 
another in the tumour microenvironment for resources, space, nutrition, waste 
management, ability to metastasise and the ability to resist chemotherapy drugs (Nowell, 
1976; Merlo et al, 2006; Yachida et al., 2010; Campbell et al., 2010; Greaves, 2010; Ding et 
al., 2012; Gerlinger et al., 2012; Greaves & Maley, 2012). Unsurprisingly, with this 
evolutionary theory being applied to the development of cancers, evolutionary 
methodologies are being explored to best understand this phenomenon (Peinta et al., 
2008; Stearns, 2012; Nesse & Williams, 2012). However, it is also hypothesised that the 
disproportionate sharing of oncogenic products during cellular replication could drive cells 
phenotypically apart post-mitosis, indicating that heterogeneity seen across tumours may 
not entirely be describable by genomic alterations alone (Czerniak et al., 1992).  
The issue of heterogeneity within cancers as stated is that it allows a higher frequency 
of varied alleles in the population to make the ‘species’ more resistant to environmental 
pressure changes. A higher indication of tumour heterogeneity is associated with poorer 
clinical outcome (Dagogo-Jack & Shaw, 2018). The higher variety of genetic diversity within 
the tumour environment, can predict this poorer clinical outcome by indicating a faster 
progression towards malignancy to reduce patient survival time period. The genetic 
heterogeneity seen is indicative of that ability of new adaptive hallmarks to be generated 
to drive tumour progression (Mroz et al., 2015; Andor et al., 2016). 
 Tumours sampled at initial biopsy may not represent the true tumour population 
(Bedard et al., 2016) and in the event of a recurrence or metastasis it is not routine to 
perform another biopsy (Bedard et al., 2016). Instead treatment is based upon the 
biomarkers identified from the initial biopsy (or equivalent) which may not resemble the 
recurrent cancers cellular makeup (Bedard et al., 2016). In the example of breast cancer, 
the presence or absence of oestrogen receptor expression determines treatment and 
prognosis. Lack of oestrogen receptor lowers response to tamoxifen or aromatase 
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inhibitors (Early Breast Cancer Trialists’ Collaborative Group, 2011) and is associated with 
worse prognosis (Lindstrom et al., 2012). However, the difference in expression of this 
receptor between initial and succeeding tumours, that may appear years after primary 
tumour treatment, is observed in 7-25% of patients (Amir et al., 2012; Thompson et al., 
2010). Another example of melanomas, BRAF mutation is used as a biomarker for 
prognostic and predictive uses as is seen in more than 80% of melanoma cases (Davies, 
2002; Bhatia et al., 2015) and associated with a more malignant phenotype has a 4-25% 
difference in prevalence of initial biopsy result compared to a subsequent tumour results 
(Colombino et al., 2012). The lack of detection of these ‘evolved’ tumours will cause 
incorrect treatments to be administered and a decrease of survival.  
Clonal heterogeneity as seen by changes of DNA content and chromosomal 
abnormalities can be seen in initial tumours before metastases formation (Fidler & Hart, 
1982; Coons et al., 1995) via FISH, reported in breast cancers (Yoon et al., 2012)) and 
gastro-oesophageal cancers (Starczynski et al., 2012). Tumours are assessed based upon 
the median ‘biomarker’ detected (Figure 1.9) to determine treatment strategy, the failure 
to detect sub-populations may be the cause of the drug resistant tumours seen in 
secondary tumours (Turner & Reis-Filho, 2012; Rye et al., 2012; Tougeron et al., 2013; Bai 
et al., 2013). Incorrect assessment of the primary tumour will act as an advantage selective 
measure for subpopulations that are treatment resistant, as they are free to continue with 
less competition within their microenvironment, allowing for more growth, more 
divergence and possibly more malignant features. Multiple studies have confirmed this as 
they have shown that treatment resistant sub-clones have been present, albeit at a minor 
frequency, in the primary tumour (Roche-Lestienne et al., 2003; Shah et al., 2009; Diaz., et 
al 2012; Shah et al., 2012; Morrissy et al., 2016). With a better model of cancer diagnosis at 
the initial tumour it would be possible to characterise the subpopulations within this 
tumour, eradicate low frequency resistant clones before they become the primary sub-
population and monitor the clonal dynamics over time (Aparicio et al., 2013). The use of 
chemoresistant cell lines, either taken from biopsy or generated in a laboratory setting, is a 
vital tool to estimate these heterogenic conditions as they must poses a ‘biomarker’ 
distinguishing them from the non-resistant population. 
To better explain the heterogeneity of tumour cells, there are two currently accepted 
models that most likely act in tandem to different degrees across different tumour types 
and environments (Shackleton et al., 2009). 
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1.3.4.1.1 Clonal evolution/ Somatic evolution 
The proposal that neoplasms, both pre-malignant and developed malignant cells, 
evolved by a natural selection means via the clonal evolution model, first being 
summarised in 1976 (Nowell, 1976; Merlo et al., 2006). From a single malignant cell, single 
mutations are acquired via ‘tumorigenic’ processes, as described throughout this section. 
To allow natural selection to take place the malignant or pre-malignant cells require variety 
in population (via genetic or epigenetic means) and sub-populations to have a heritable 
selection advantage over others in the specific tumour microenvironment, ultimately 
swaying the ratio of subpopulation frequencies throughout the tumour (Merlo et al., 2006; 
Swanton et al., 2012). The constant changing of the tumour microenvironment itself is 
shown to be tumorigenic (Chen et al., 2015; Wang et al., 2017) such as cells, or cellular 
populations, must compete for resources such as space, oxygen availability and waste 
processing.  Understandably, a subpopulation that has an advantageous trait that can be 
inherited will comparably outperform other subpopulation derivates to generate more 
daughter cells. Clearly seen, the increased genetic diversity of the tumour is critical for 
overall survival, as seen throughout nature (Merlo et al., Fernandez et al., 2016). 
Applying this Darwinian process of selection to tumour cells (Greaves & Maley, 2012), 
cancer therapies (particularly chemotherapy) are a means of artificial selection via human 
interaction. As most cancer deaths are caused by clones which are therapeutically resistant 
(Greaves & Maley, 2012), subpopulations with mutations that can infer a drug/multidrug 
resistance will propagate to form the representation of the next ‘generation’/tumour in the 
event of a relapse. The cellular causes of drug resistance will vary greatly between tumours 
(Gottesman, 2002) , and can form in a multitude of tumour types (Azam et al., 2003; 
Engelman et al., 2007; Murugaesu et al., 2015).  The increased mutation rate by the cancer 
cells innate genome instability further fuels the likelihood that a drug resistant clone will 
appear in the population, to proliferate with low competition and is shown to lead to faster 
malignancy development (Axelrod et al., 2006; Worsley et al., 2016; Sun et al., 2016; 
Fortunato et al., 2017).   
Initial tumour evolution in the ‘clonal evolution’ theory is thought to occur by two 
different methods. In the view of a linear expansion, sequential ordered mutations are 
accumulated over time stepwise causing the expansion of tumour cells. Observed is a single 
population collectively acquiring hallmarks and is most likely only seen in initial 
tumorigenesis as this process is not seen in developed malignant tumours (Gerlinger et al., 
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2012). For example, it is more likely that cellular regulation initially is aberrant, such as a 
benign neoplasm, followed by other features such as genomic instability to give rise to a 
more varied population. This development into a varied population is representative of 
branched expansion (Figure 1.14), the second methodology observed. Via generation into 
multiple subclonal populations through means as described above (Swanton, 2012), the 
tumour now has the means to drive distinct branches which would eventually yield in the 
generation of advantages/resistances to align with the concept of natural selection 
(Swanton, 2012; Gerlinger et al., 2012).  
1.3.4.1.2 Cancer stem cells 
An alternative view of cancer development brings the notion that the wide spread 
epigenetic changes seen in cancer cells development is unlikely to occur in a random 
fashion to then accumulate inside a tumour via selection (Sharma et al., 2010; Greaves, 
2010). The cancer stem cell model proposes that epigenetic changes which typically occur 
in normal stem or progenitor cells are the earliest events in cancer formation (Feinberg et 
al., 2006). Furthermore, the fact that these epigenetic aberration events are notably seen 
to be very early events in cancer development (Cui et al., 2003; Matsubayashi et al., 2003; 
Sakatani et al., 2005; Peters et al., 2007)(Figure 1.14). 
The self-immortalisation of stem cells is seen by silencing genes involved in renewal 
capacity is observed in cancers (Jones & Baylin, 2007), an aberration in silencing of these 
replication controlling genes gives rise to the infinite renewal capacity proposed in this 
model. These immortal stem cells, or abnormal precursor cells, can be subject to genetic 
mutation events to form the basis of tumorigenesis (Baylin & Ohm, 2006), and go on to 
reflect a high expression of pluripotentency typically seen in embryonic stem cells 
(Widschwendter et al., 2007; Werbowetski-Ogilvie et al., 2009). 
This stem cell model is able to describe the heterogeneity found within tumours. Initial 
formation creates a small population of pre-malignant cells able to maintain their stem cell 
properties indefinitely to give rise to a malignant population when influenced by additional 
genetic mutations at any time (Jones & Baylin, 2007). These cells are hypothesised to exist 
within the tumours as a distinctively different population in a low proportion of the 
tumour, typical therapies used to treat tumours may not be effective against these 
persistent cells to generate new cells, such as in the case of relapses or metastasises (Reya 
et al., 2001) (Figure 1.13). The removal of an initial tumour population without removal of 
the cancer stem cells will simply allow the stem cell to produce a genetically different 
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malignant cell to grow and propagate into a secondary tumour. In the event of therapy, 
cancer stem cells are thought to be more resistant to typical cytotoxic drugs used (Zhao, 
2016), either by the up regulation of DNA repair proteins or slow division cycles, features 
that classic adult stem cells are shown to possess. Again, the use of already diverged 
chemo-resistant cell lines is helpful for use in studies exploring cancer stem cells theories as 
they may contain sub-populations of increased ‘stemness’ that generate these resistant 
populations. 
There is somewhat of a debate about the existence of cancer stem cells, evidence 
against cancer stem cells is the fact that some tumour cells display no signs of ‘stem’ like 
properties across the whole cancer (Gupta et al., 2009). Some query the origination of the 
stem cell itself, is it a malformation in a true stem cell as current models predict via 
epigenetic malformations or simply from non-malignant cells gaining the ability to self-
renew to give appearance of a stem cell which display a level of phenotypic plasticity (Nouri 
et al., 2017). However, there is current evidence of cancer stem cells found in leukaemia 
(Bonnet & Dick, 1997), breast cancer (Al-Hajj et al., 2003), colon cancer (O’Brien 2007), 
prostate cancer (Lang et al., 2009), melanoma (Civenni et al., 2011) and many more 
(Shackleton et al., 2009).  The presence of multiple cell types found in heterogeneous 
tumours can currently only be explained by the presence of stem cells (Bonnet & Dick, 
1997), unless multiple tumours from multiple body sites that have all formed malignant 
metastasising properties are in play. 
However, it is most likely that tumour heterogeneity is best explained by a combination 
of models, an incremental ‘random’ mutation pattern and the cancer stem cell idea (Wang 
et al., 2014) as both examples have to be shown in tumour heterogeneity, more research 






















1.3.4.2 Chromoanagenesis, Chromoplexy and chromothripsis  
The advent of next generation sequencing from tumours and diseases arising from 
complex chromosomal rearrangements has identified complex rearrangements to occur 
within chromosomes in a single cellular event (Holland & Cleveland, 2012). As previously 
described, cancer is typically driven by single mutation events and single chromosomal 
rearrangements to give individual functions that collect over time to form a true cancer 
(Hanahan & Weinberg, 2011; Vogelstein et al., 2013). However recent studies show that a 
single ‘phenomenon’ can occur whereby tens to hundreds of genomic rearrangements can 
occur simultaneously (Stephens et al., 2011) in many different types of cancers 
(Kloosterman et al., 2011; Rausch et al., 2012; Molenaar et al., 2012).  Interestingly, the 
frequency of chromoanagenesis is higher, as compared to all types of cancers, in specific 
types of tumours, such as neuroblastomas (Molenaar et al., 2012), colorectal cancers 
Figure 1.14. Theories of establishing progressive tumour heterogeneity 
Graphical representation of two models that explain the increase of heterogeneity 
in tumours. A), Clonal evolution to yield a polyclonal/polygenic tumour, selection based 
upon treatment allows resistance subpopulations to survive and form a new 
heterogeneous population in a relapse. B), Cancer stem cell model showing cancer stem 
cells (stars) are only able to replicate indefinitely and can generate a heterogeneous 
population. Upon treatment these stem cells have resistance and can seed new 




(Kloosterman et al., 2011), bone cancers (Stephens et al., 2011), AMLs and Sonic-hedgehog 
medulloblastoma (SHH-MB) (Rausch et al., 2012). Unsurprisingly, the presence of 
chromoanagenesis in tumours typically yields poor survival rates due to correlation with 
more aggressive tumours (Hirsch et al., 2013; Notta et al., 2016; Rücker et al., 2018), 
however presence of complex chromosomal events can be used as a biomarker for 
prognosis and patient outcome (Forero-Castro et al., 2016; Luijtenet al., 2018).  
Chromothripsis is the term given to describe ‘chromosome shattering’, a methodology 
that could explain the highly aberrant chromosomes formed during chromoanagenesis in 
one single event (Stephens et al., 2011)(see Figure 1.15). Expected during chromothripsis, 
the chromosome should shatter i.e. multiple double strand breaks, to be immediately 
followed by aberrant DNA repair (Stephens et al., 2011).  The presence of whole 
chromosome micronuclei are correlated with large levels of DNA damage leading to 
multiple chromosome breaks and incorrect rejoining (Hatch et al., 2013). Micronuclei are 
thought to occur when a whole chromosome is lagging during anaphase/telophase due to 
previous errors in the mitotic process, and not included within the main nucleus when its 
membrane reforms (Fenech et al., 2011). Experimentally, micronuclei can be used to 
induce double strand breaks in specific chromosomes (Cveticanin et al., 2009), and the cell 
can survive with the presence of micronuclei and it is possible for contained DNA to be 
replicated during the next mitotic cycle (Terradas et al., 2010).  However this replication is 
thought to be defective and lagging due to a lack of correct nuclear conditions/enzymes, 
forcing a disrupted replication and multiple double strands breaks to be formed. This DNA 
damage is not detected, due to the lagging nature so misses cellular checkpoints (Giunta et 
al., 2010), causing more stress and fragmentation to the chromosome. The resulting 
fragments can be rejoined, in a most likely erroneous way (Figure 1.15) and these 
chromosomes could be reincorporated into the main nucleus of the cell to survive multiple 
generations (Crasta et al., 2012). Where chromothripsis concerns the shattering of only one 
chromosome, the thought that this process happens in a micronucleus where a singular 
chromosome can be present and undergo stress pairs well (Forment et al., 2012). The 
telomeres during mitosis can become vulnerable due to the loss of their protective 
terminal regions, to cause fusion and formation of a di-centric chromosome. The di-centric 
chromosome during mitosis can have multiple spindle fibres attached and tension pulling it 
to opposing daughter cells, to create a chromatin bridge between cells. When 
decondensing paired with nuclear membrane reformation, incorrect membrane formation 
will cause exonucleases within the cytoplasm to sporadically cut the chromosome into 
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single strands to resolve the stress event, effectively causing the fragmentation event 
(Maciejowski et al., 2015). Alternative theories about the methodology of chromothripsis 
occurring are possibly, the presence of ionizing radiation (Maher & Wilson, 2012) or the 
result of aborted apoptosis (Tubio & Estivill, 2011). Another structural aberration typically 
found in chromothripsis malformed chromosomes is the presence of vast clusters of point 
mutations around breakpoints, termed Kataegis, seen as a “thunderstorm” event as which 













In normal cells, this level of mass genomic damage would typically undergo apoptosis 
(Holland & Cleveland, 2012). However as unsurprising as it is, in cancers where 
chromothripsis is thought to have occurred the regions of the genome affected are 
associated with cell cycle control, DNA damage, proliferation and apoptosis regulators (Cai 
et al., 2014; Notta et al., 2016; Rücker et al., 2018).  It is quite possible that chromothripsis 
events outside of these genomic regions may happen, yet it is understandably hard to 
observe as the cells would not survive to be able to be observed. However, cells that do 
survive can show the ability to generate multiple hallmarks in one genomic mutative event.  
Figure 1.15. Comparisons of Chromothripsis and Chromoplexy  
Shown is a representation of chromosomal rearrangements created by 
chromoanagenesis. A) Chromothripsis, showing a single event to shatter the 
chromosome, followed by reorganization, deletions, inversions and duplications when 
repaired. Right) Chromoplexy, showing chromosomes undergoing a single 
reorganization event to create multiple malformed chromosomes; also during this 






Typically, it is thought to be seen in early tumorigenesis to be a large initial driver of 
malignancy, however studies have shown that the chromothripsis event can be late and 
insignificant in the cancer’s phenotype (Kovtun et al., 2015), or it is a marker shown in late 
tumour aggressiveness (Bassaganyas et al., 2013). 
The presence of chromothripsis has been detected in a wide variety of cancers 
including; medulloblastoma (Northcott et al., 2012), acute myeloid leukaemia (Rausch et 
al., 2012; Bochtler et al., 2017), bladder cancer (Morrison et al., 2014), and in many more 
examples (Luijten et al., 2018).  The rate of chromothripsis events is somewhat of a 
discussion point, recently it was seen to only occur in up to 4% of all cancers (Cai et al., 
2014), yet it reported much higher for specific cancer types such as neuroblastoma and 
bone cancer (Stephens et al., 2011). The variation seen in reports fuels the discussion about 
frequency of these events, yet reasoning might be that a concise consensus on how to 
categorise chromothripsis events hasn’t been ratified at the time of these studies (Rode et 
al., 2016).  
The incidence of chromothripsis is highly associated with the inactivation of p53 
(Rausch et al., 2011; Cai et al., 2014; Fernandez-Banet et al., 2014; Bochtler et al., 2017). As 
previously described, the action of p53 is vital for the cellular response for DNA damage to 
induce cellular cycle arrest, DNA repair and/or apoptosis (Lane, 1992), those with germline 
TP53 mutations consistently shown massive genomic aberrations with appearance of a 
chromothripsis event (Raush et al., 2012), especially in childhood cancers (Gröbner et al., 
2018). Using neuroblastoma as an example, consistent chromothripsis has been observed 
(Molennar et al., 2012) and typically is associated with poor prognosis and aggressive 
tumours,such as with the deletion of FANC (Molennar et al., 2012). However, the 
association with chromothriptic events may not be fully penetrant in regards to TP53 
mutation, as cells with wild-type TP53 have been observed with the presence of 
chromothripsis (Cohen et al., 2015) and conversely not all tumours with incorrect TP53 
shown chromothripsis (Fernandex-Banet et al., 2014). 
Outside of cancers, chromothripsis has been reported within the germline of patients 
that display a delay in development or dysmorphic features (Chiang et al., 2012; Plaisancié 
et al., 2014; Gamba et al., 2015; Anderson et al., 2016), and even events can be beneficial 
as shown as a spontaneous cure WHIM syndrome by deletion of the disease causing double 
negative allele (McDermott et al., 2015).  Chromothriptic events are not a human 
phenomenon, it has also been reported in cancers within Tasmanian devils (Deakin et al., 
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2012) and natural events within plant genomes (Tan et al., 2015; Carbonell-Bejerano et al., 
2017), relating back to a possible beneficial evolutionary aspect of this mechanism of mass 
genome restructuring. 
Alternatively to chromothripsis, chromoplexy (Figure 1.15) is understood as another 
mechanism of mass chromosomal rearrangement that occurs as a single event in cancers. 
Chromoplexy is defined as a build up of linked translocation events involving multiple 
chromosomes in a singular event resulting in chromosomal rearrangements that show little 
in the way of copy number variation (Baca et al., 2013; Shen et al., 2013).  Chromoplexy 
was first described in the study of prostate cancers with a indication of presence in up to 
40% of cases (Baca et al., 2013), as indicated by previous research that prostate cancer was 
typically shown to have frequent large scale translocations resulting in oncogenic fusion 
proteins (Tomlins et al., 2005) . Furthermore, within these prostate cancers, point 
mutations were seen to be low and chromosomal rearrangements high (Taylor et al., 2010; 
Barbieri et al., 2012), concluding that the presence of genome rearrangements being the 
main driver of tumour development.   
The mechanisms behind the formation of chromoplexy is less well understood as 
compared to that of chromothripsis, associations between common oncogenic fusions 
noted within prostate cancer cells which are caused by double strand breaks (Haffner et al., 
2010) is somewhat consistent with the idea that chromoplexy is thought to be a result from 
inconsistent deletion/rejoining mechanisms (Fukami et al., 2017) and association with open 
chromatin configurations during times of transcriptional DNA-damaging processes (Baca et 
al., 2013; Lin et al., 2009). 
The presence of chromoanagenesis challenges the view that tumour establishment via 
gradual mutation events are required and instead a single catastrophic event could be 
enough to initiate a cell to progress to a malignant state. The presence of chromoplexy and 
chromothripsis indicate that tumour progression may not be linear and have large bouts of 
sudden alteration that could explain the heterogeneity seen across cancer cells (Cai et al., 
2014). Baca et al., 2013 concludes in their paper which terms ‘chromoplexy’, that “The 
characterization of clonal progression and chromoplexy in emerging large panels of cancer 
genomes may provide insights into tumor initiation and progression that impact cancer 
detection, prevention, and therapy.”, and indicates this level of cancer development would 




1.3.5 Non human models for cancer 
There is somewhat of a tradition in using the mouse or rat as universal model 
organisms for biological research, and likewise explicit use within cancer research. Being 
very short lived animals have a rapid reproductive rate and are very prone to cancer, a 
great choice for a model species. However, for studies exploring the mechanisms behind 
innate cancer resistance they offer very little use. Other animal models are more beneficial 
towards this aim of exploring resistance mechanisms. We can look towards long-lived 
mammalian species instead which may provide new insights towards prevention strategies 
rather than treatments, which are plentiful but have serious side effects to the organism 
(Cleeland, 2012.). It would be expected that longer lived mammals have evolved strategies 
which allows a reduction in observed cancer rates, for example mice have a high incidence 
of cancer, +50% (Lipman, 2004) where as several other species are known to be resistant to 
cancer, such as the naked mole rat, elephant and bowhead whale (Seluanov,2018). 
Different species require different ‘hits’ for malignant cells to arise as compared to humans, 
(Gonzalez, 2010) and possess varying levels of telomerase to solve issues arising from 
incomplete replication of chromosome ends by DNA polymerases (de Lange, 2009) leading 
to incorrect expression and reactivation to immortalize tumours (Kim, 1994). To 
summarise, the larger and long lived the animal, more mechanisms exist (and therefore 
more ‘hits’ required) for tumours to be formed (Tian, 2018). The naked mole rat 
(Heterocephalus glaber) is a small bodied yet long living rodent with a maximum lifespan of 
32 years in captivity (Buffenstein, 2002) is found to be highly resistant to cancer and 
therefore of high interest within research (Buffenstein, 2008; Liang, 2010). A phenomenon 
that occurs within naked mole rat cellular cultures is very early contact inhibition, slowing 
their growth rate in culture (Seluanov, 2009), an example of a possible mechanism towards 
cancer resistance as cellular proliferation is arrested at earlier stages.  Unfortunately, this 
will make the use of naked mole rat as a model organisms harder to generate material for 
research use.  
Blind mole rats (Spalax ehrenbergi) again are another example of a long lived rodent 
that shows resistances to cancers (Gorbunova, 2012). A resistance mechanism arises 
through concerted cell death, where after a set number of population doubling a culture 
will die through necrotic and apoptotic processes by a large rise of INFβ (Gorbunova, 
2012).Clearly this is a useful mechanism for the organism, but not for culturing cells. 
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Other non-human examples include the elephants, which have expanded their copy 
number of TP53 genes as pseudogenes to confer some anti-cancer properties (Abegglen, 
2015; Sulak, 2016) and long lived whale species which show examples of positive selected 
DNA repair genes such as ERCC1 and UCP1  (Keane, 2015). However the process of 
obtaining primary cultures, maintaining adequate growth will incur high resource input and 
costs due to the bespoke nature of the cells themselves and the conservational status of 
some of these animals. By understanding the mechanisms behind these different species 
and retroactively applying them to human specific medications or prevention strategies 
could lead to new methods of cancer treatment or prevention, a worthwhile field of 
research but high costs may impair this (Xia & Chen, 2011).  
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1.4 Thesis rationale 
The techniques of cytogenetics have evolved over the past century to allow us as 
researchers and medical professionals to perform in-depth analysis on specific genomes, to 
study diagnostics, comparative genomics and cancer progression amongst other things. 
From evolutionary studies to medical diagnoses, the use of fluorescent techniques has 
understandably been a key driver within these fields, as it allows the user to visually 
interpret the data. A new methodology that can aid in these fields would allow researchers 
an alternative to expensive next generation sequencing technologies that can visually and 
quickly provide results. A successful new fluorescent methodology should be able to 
perform in these areas: be a cheaper/more efficient alternative to current FISH 
technologies, demonstrate an increase of throughput/reliability of results, be applicable for 
use in evolutionary studies and be worthwhile to use in ‘non-typical (i.e. malformed cell 
lines -cancer) studies.  The work within this thesis aims to firstly provide an exploration into 
optimisation of the FISH protocol and establishment of a new methodology, alongside 
distinctive studies across these mentioned research areas that can use this protocol to 









As described in 1.1.5 methods, cytogenetic techniques have advanced over time with a 
large emphasis on a computational based approach within recent years (Figure 1.16). This 
has effectively left traditional in situ hybridisation methodologies out of focus without 
much improvement, bar industry improvements to reagents. With the focus towards a 
‘bottom-up’ visualisation of the genome via NGS’s short read approach opposed to the 
Figure 1.16. Publications using either bulk sequencing or single cell sequencing 
techniques 
 Transcriptome data from bulk analysis of cells derived from tumour tissues fail to 
accurately detect the tumour heterogeneity and subpopulations present. The graph 
indicates the variation in the number of publications reported using whole exome 




‘top-down’ visualisation of chromosomal structure via traditional techniques, possible 
incorrect conclusions’ could be drawn. As shown in multiple studies throughout section 1, 
the use of FISH is required alongside NGS to confirm results. If the throughput of FISH was 
increased paired with a decrease of cost, the ratio of NGS methods to FISH methods may 
balance out with FISH being a new cost-effective option.  
Within section 1.2.3.1, the Galliform order has great importance within research due to 
G.gallus being the avian model organism of choice for multiple reasons. Within the field of 
comparative genomics however, the rest of the galliform order has been somewhat 
overlooked as with research concluding with the fully sequenced turkey (M.gallopavo) and 
chromosomal paint studies indicating a rather uneventful progression over evolutionary 
time for other members. Here calls for a study into the intrachromosomeal rearrangements 
which paint based studies can miss, to detect any further rearrangement hidden to 
previous knowledge. As also described (1.2.3.1.1.1), microchromosomes have been 
indicated to reside centrally in the nucleus with macro-chromosomes residing in the 
periphery. This hypothesis can be further explored alongside chromosomal studies with the 
generation of a new FISH methodology. 
With chicken being a useful model organism (1.2.3.1) to derive useable cell lines from, 
there is somewhat of an imprecise karyotypic description of the useful DT40 cell line. With 
use of DT40 has diminished with the advent of CRISPR systems, it is still a useful model cell 
line to explore the genomic structural changes when inducted into a malignant state. As 
per section 1.3.2.2, the research into oncogenesis via oncoviruses is a worthwhile area to 
explore; with the DT40 cell line being induced by AVL genomic rearrangements may be 
found. As per section 1.1.5, the need for speed and efficiency in FISH methodologies is one 
of the major requirements and drawbacks from matching current NGS technologies. Here 
also shall be demonstrated how a new FISH methodology can be used to improve current 
technologies created to improve efficiency. 
As per section 1.3.4.1, current opinion of cancer heterogentiy highlights the need to 
develop newer methodologies that can assess the heterogeneity of cancer populations. 
Currently, methods can lack the specificity to detect small sub-populations that derive from 
the ‘modal’ population. This modal population is used to assess the details of the tumour 
and may not be an accurate representative. Methods such as M-FISH and SKY are possible 
avenues, but due to the high cost of equipment and reagents paired with the questionable 
results provided they are not suitable for sustained use in a modern cytogenetics 
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laboratory. By using currently established neuroblastoma cell lines (UKF-NB3), and 
derivative cytotoxic lines (rVincristine/rCisplatin), it is possible to observe these at a 
cytogenetic single cell level to; assess heterogeneity within the population, detect key 
aberrations that could infer resistance or act as molecular markers and provide an up-to-
date cytogenetic assignment. 
1.5 Thesis Aims 
With reference to the rationale set about from the previous section, the aims of the 
thesis are thus: 
Aim 1: To generate a new FISH based methodology that can decrease current costs and 
improve throughput which is applicable for all FISH research areas, but particularly to apply 
to other aims in this study. 
Aim 2: To use the above methodology (or adaptations of it) a) to detect 
intrachromosomal rearrangements within the macrochromosomes of the Galliform order 
in five species and b) to formulate a methodology to determine folding patterns and 
location within interphase state nuclei for Gallus gallus macrochromosomes. 
Aim 3: To analyse the karyotype of the DT40 cell line, to assess heterogeneity and 
detect any novel chromosomal aberrations using adaptations of the new FISH methodology 
developed. 
Aim 4: To analyse the human cancer cell line UKF-NB3 (neuroblastoma) alongside its 
derived cytotoxic resistant cell lines, UKF-NB3-rCisplatin/UKF-NB3-rVincristing to detect 





2. Materials and methods 
2.1 Materials 
2.1.1 Chromosome preparation 
2.1.1.1 Chromosome preparation from culture 
Cells were harvested at 70-90% confluence and mitotic doublets seen and abundant 
before harvesting was carried out of culture flasks. To each individual flask colcemid 
(Gibco) was introduced at 1ug/ml and incubated at their previous environments, 37oC for 
mammalian and 40oC for avian, for one hour.  Medium was aspirated and rinsed with 
HBSS(Fisher) to then  be followed by each cell culture subjected to a brief trypsin-
EDTA(Fisher) exposure (37oC for 2-3 minutes) to detach cells, and use of HBSS to rinse and 
neutralise the effect of trypsin.  
This was then followed by a hypotonic treatment of 75mM KCL for 15 minutes at 37oC, 
and have repeated washes of a 3:1 mixture of glacial methanol:acetic acid with 150 G 
centrifugations to aspirate supernatant and re-suspend cell pellet formed in fresh 
methanol:acetic acid mixture until the sample is cleaned of debris.   
Sample quality and metaphase index was observed by fixation onto a glass slide with 
3:1 methanol:acetic acid and stained with DAPI in VECTASHEILD antifade medium (Vector 
Laboratories) 
2.1.1.2 Chromosome preparation from Human blood 
Sample was taken from a consenting adult human male via typical phlebotomy means 
into a standard sodium-heparin coated tube. The sample was then cultured in PB-MAX 
karyotyping medium (invitrogen) at 37oC 5%CO2 for 72hours, to have cell division arrested 
with the introduction of colcemid (Gibco) at 1ug/ml for 35 minutes before a hypotonic 
solution of 75mM KCL was introduced. Repeated washes were performed with a glacial 3:1 
methanol: acetic acid until sample was sufficiently clean of debris and cytoplasmic 
elements. Sample quality and metaphase index was observed by fixation onto a glass slide 





2.1.2 Cell cultures 
2.1.2.1 Avian cells 
All avian samples used within this thesis were from egg derived cultured fibroblasts (5-
7 day old embryos) or from skin biopsies. Cells were subject to collegenase treatment to be 
cultured at 40oC, 5% CO2 in alpha MEM (Fisher) with 10% (FBS) fetal bovine serum (Gibco) 
and 1% L-Glutamine-Penicillin-Steptomycin solution (10mg/mL) (Sigma). 
2.1.2.2 Cattle cells 
Cattle ovaries, of mixed age and breed, were delivered in phosphate buffered saline 
(PBS) at 38oC within 6 to 8 hours of culling from a local abattoir (Charring meats, Charing, 
UK). A biopsy was taken from the surface of the ovary tissue and subjected to a collegenase 
treatment for 4-6 hours. The sample was then to be cultured in 20% FBS (Gibco) alpha 
MEM (Fisher) with 1% L-Glutamine-Penicillin-Steptomycin solution (10mg/mL) (Sigma) at 
37oC 5% CO2 until 70/80% confluent to then be harvested (2.1.1.1.). 
2.1.2.3 DT40 
Cell line was cultured, donated and received from the laboratory of Noel Lowndes 
(Queen’s University, Belfast), in the form of a frozen cell culture delivered overnight by 
courier. Re-suspended in alpha MEM (Fisher), supplemented with 10% fetal bovine serum 
(Gibco), 1% L-Glutamine-Penicillin-Steptomycin solution (10mg/mL) (Sigma) at 37oC and 5% 











2.1.2.4 Human Cancer lines 
Cell line 
name 


































All human cancer cell lines were grown in Iscove’s modified Dulbecco’s medium (Fisher) 
supplemented with 10% fetal bovine serum (Gibco), 100 IU/mL penicillin - 100 mg/mL 
streptomycin (Gibco) at 37oC 5% CO2 until harvest and kindly donated by the Michaelis Lab, 
further information can be found in Kotchetkov el al, 2005. 
2.1.3 Fluorescent Probes 
G.gallus probes were selected from BAC clones of the CHORI-261 library (ranging in 
sizes from 150,000 kb to 200,000 kb) and B.taurus in similar fashion from the CHORI-240 
library, inserted into E.coli stocks to be subject to collection via mini prep (Qiagen) which 
was then directly labelled via standard nick translation with either FITC-fluorese-in-12-UTPP 
(Roche) or Texas Red-12-UDP (Invitrogen) prior to purification using a nucleotide removal 
kit (Qiagen) 
Alternatively, probes were purchased from Cytocell in pre-mixed solutions (probe and 
hybridisation buffer) and used as per manufacturer’s instructions, a table of which can be 
seen in section 9 (appendix) and a chromoprobe multiprobe chicken device (Cytocell) which 
can be seen in detail in section 5.2 and figure 5.1. 
 
Table 2.1. List of Human derived cancer cell lines used in this study 
Details of the human cell lines used within this study, UKF-NB-3 will be referred to 
as the ‘parental’ cell line as UKF-NB3rVCR10 and UKF-NB3rCDDP1000 are children cell 




2.2 Methods  
2.2.1 Fluorescence in situ hybridisation (FISH) 
2.2.1.1 Standard FISH 
Metaphase preparations from cell culture or blood samples were re-suspended to be 
fixed onto clean condensation covered microscope slides using fresh 3:1 methanol:acetic 
acid solution and allowed to dry.  Slides were then dehydrated through an ethanol series at 
room temperature (2 minutes for each wash, 2XSSC (saline-sodium citrate buffer), 70% 
ethanol, 85% ethanol and 100% ethanol).  
Probes were then diluted with a formamide based hybridisation buffer HybI (Cytocell) 
and respective species hyblock (Insight Biotech), chicken for avian experiments, cattle for 
cattle specific experiments. Human specific repetitive sequence blocker was already mixed 
in the pre-mixed purchased probe mixtures from Cytocell. These probes were then applied 
to the dried metaphase slides on a 37oC hotplate in order to denature both DNA strands of 
both target and probe (Figure 1.6) before sealing with cover slip and rubber cement. This 
now probe-sample mixture was denatured simultaneously at 75oC for 2 minutes to then be 
moved into a humid hybridisation chamber at 37oC for their required hybridisation time 
(typically an ‘overnight’ hybridisation time of 12-16 hours).  Hybridisation time is detailed in 
the specific experimental sections as investigated in section 3.  
Post hybridisation, coverslips and rubber cement was removed and washed for 2 
minutes at 72oC in 0.4XSSC, and then had a 30 second wash in 2xSSc with 0.05% Tween 20 
at room temperature, only ‘same species’ i.e. identical species as probe DNA origin 
required the first 2 minute stringency wash. Alternatively, when Zoo-FISH was performed 
the first wash was omitted and instead the 30 second wash was undertaken in place. Slides 
were then counterstained using VECTASHEILD anti-fade medium with DAPI (Vector labs) 
and allowed to resolve in the dark for 10 minutes.  
In experiments that used the ‘Cytocell chromoprobe multiprobe chicken device’, 
metaphase preparations were instead dropped and fixed onto the 24 chamber slide 
provided by the kit and probes were rehydrated on the 24 slot device using HybI, to both 
be merged before denaturation aligned to their corresponding boxes and configuration.  
The device required 5 minute denaturation at 75oC and hybridisation in a 37oC water-bath 
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in their provided hybridisation chamber. Post hybridisation steps are the same as standard 
FISH as seen above.  
2.2.1.2 IQ FAST Fluorescence in situ hybridisation 
Use of the fast buffer was near identical to the standard FISH protocol, albeit with a 
few minor adjustments. At the stage of denaturation, the sample was denatured at 90oC 
for five minutes and transferred to a hybridisation chamber at 45oC for 60-90 minutes.  
Post hybridisation, the first wash of using 0.4xSSC at 63oC for 10 minutes is followed by 
a 37oC dH2O wash for one minute, at each stage the slide was vigorously agitated by 
movement up and down inside the jar. Before counter stain can be applied, the slides went 
through another ethanol series (70%, 80% and 90% ethanol all for 2 minutes) and allowed 
to dry. Counterstaining and visualisation is identical to other FISH procedures 
2.2.1.3 Multilayer FISH  
The multilayer FISH (mlFISH) methodology can be seen in more depth in section 3.4 and 
in flowchart form in figure 3.7. 
The multilayer slides were identical to the standard FISH protocol seen above yet 
requires additional post analysis steps to continue the iterative method. When visualising, 
absolute positions on the slide were saved and imported each time the experiment was 
required to be imaged, via usage of an automated stage and compatible image software, 
Smartcapture 3 (Digital scientific UK). 
After final collection of images from the slide, a pre-wash of 2xSSC with 0.05% Tween 
20 for approximately 30 seconds was performed to remove the coverslip and residual DAPI 
from the slide, this was followed by immersion into 72oC ddH2O for a minute. Upon 
removal agitation the slide by removing the slide in and out of the 72oC ddH2O jar a few 
times, to be fully submerged and re-emerged at each step. 
At this stage, slides were then prepared to re-enter the ‘standard’ FISH method into the 





2.2.2 FLpter measurements 
The means to measure FLpter is discussed in section 4.2.1 where their usefulness is 
compared for this study. 
2.2.2.1 Manual measurement  
Flpter scores (first used as a standard means to measure chromosome position, (Lichter 
et al., 1990) were manually measured using the segmented line feature within ImageJ 
(version 1.50g, W.Rasband, National institutes of Health, USA, https://imagej.nih.gov/ij/), 
points were selected upon start of the chromosome, at each probe location and a final 
measurement upon reaching the end of the chromosome to give =2+n (n being number of 
unique probes) number of points as distances from the first point. Each chromosome in 
each metaphase was measured individually and given an unique identifier. 
2.2.2.2 Automatic measurement 
Using an automated FLpter measuring script (In house, B.Skinner), it was possible to 
insert a merged 3 colour FISH image and have the script to give an output measured FLpter 
values after the user has clicked the path of the chromosome needed to be analysed. This 
script is currently limited to 5 points and works within ImageJ in a similar fashion to the 
segmented line tool, yet splits the image according to RGB value and measures where the 
‘white’ position is found upon the users selected path. 
2.2.3 Chromosome Interphase Plotter (CIP) 
The chromosome Interphase Plotter was designed within Microsoft office Excel 2007 
(Microsoft) using user generated data retrieved from ImageJ. 
Images, chromosomes and probes were given set identifiers upon post-merging.  
Merged metaphase images were taken into ImageJ and points was selected upon probe 
locations observed, maximum of 16 probes (2n, 8 each) and given set X and Y co-ordinates. 
These coordinates were then inputted into the set excel tables and chromosomes were 
calculated and plotted automatically in text short hand.  
By using ImageJ, the centre of mass was detected by use of an inbuilt tool as well as 
area/diameter recorded for each individual metaphase. 
Lines connecting points were then drawn on manually using Design 4 (Microsoft) as 
governed by the output of the plotter. 
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2.2.4 Imaging software and hardware 
Images captured were done so by using an Olympus BX61 epifluorescence microscope 
with cooled CCD camera and relevant filters for probes used in this study.  
Software used for all experiments requiring microscopy imaging was SmartCapture 
(Version 3, Digital Scientific, Cambridge, UK). 
2.2.4.1 Merging of Images 
Images were compiled and given false colouration using GIMP (GNU Image 
Manipulation Program, 2.82, 2018, S.Kimball P.Mattis. GIMP development team) manually 
using raw channel outputs from SmartCapture 3. 
DAPI images were inserted and colour levels were then curved to eliminate low level 
background DAPI fluorescence and each probe layer was inserted sequentially aligned to its 
paired DAPI channel. Each probe layer was automatically applied to a threshold using 
GIMP’s inbuilt tool to give each signal to appear as ‘white’ on a ‘black’ background, these 
‘white’ sections were easily selected using GIMP’s selection tools and assigned a false 
colour and the black layer removed to see the probe location on the chromosomes. Each 
DAPI layer after this was then layered on top of the original DAPI aligning chromosomes 
perfectly and new probe layers were added on at this stage until the image was full of all 
required layers. The intermediate DAPI layers were then hidden to give a single DAPI layer 










3. Improving FISH technology to facilitate more rapid, 
cost-effective multiplex results (specific aim 1) 
3.1 The formalities of FISH hybridisation 
As pointed out in the main introduction (section 1.1.5), while FISH technology has 
advanced in many areas, the composition of the hybridization buffer has hardly changed. 
The ability to multiplex experiments is somewhat limited by the expense of dyes (other 
than the standard red and green), and time-consuming steps and the complexities of 
multiple hybridizations and dye mixing (Ridolfi et al., 2000; Yaziji et al., 2004).  
While using formamide as the basis for a hybridization buffer has proved highly 
successful, the “if it isn’t broken, don’t fix it” approach may well be impeding the use and 
adoption of alternatives. From a chemical point of view, there may be better alternatives to 
formamide an organic solvent.  It has been well-documented the effect organic solvents 
have on biomolecules (Cordone, et al., 1980), oligonucleotides require a relatively non-
aqueous media to function, essential for intracellular concentrations and typically created 
by high presence of macromolecules and osmolyte compounds.   
Organic solvents solvated by water reduce the amount of free water, charge the 
dielectric permittivity (degree of electrical polarization) (Garlid, 1999; Luby-Phelps et al., 
1999; Cuervo et al., 2014) and are observed to interrupt the level of hydrogen bonding, 
polarity and hydrophobicity of DNA, dependant on organic solvent used. These 
adjustments bring about conformational changes in DNA stability and the kinetics of 
hybridization.  The introduction of an organic solvent will generally destabilise nucleic acid 
base paring and interruption of hydrophobic stacking interactions between bases and thus 
bring down the temperature of DNA’s melting point (Yakovchuk et al., 2006; Šponer et al., 
2013).  The addition of an organic solvent to polynucleotides shall result in precipitation 
dependant on the ratio of organic solvent to water, length of polynucleotide and properties 
of the organic solvent itself, again this area is well researched (Mel’nikov et al., 1999; 
Bonner & Kilbanoc et al., 2000; Stanlis 2003).  
Typically, formamide is the organic solvent of choice to lower the melting point of DNA 
in standard ISH experiments (McConaughy et al., 1969; Blake et al., 1996), however within 
the context of cross species hybridization (zoo-FISH), and whole genome hybridization, a 
longer hybridization step is required (Kallionieme et al., 1992). The current theory is that 
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organic solvents destabilize the hydrophobic stacking of bases (as mentioned previously) 
thus reducing temperature of denaturation, opposed to interfering with the hydrogen 
bonding of complementary strands. It is imperative to look into alternative organic solvents 
that possess the same base de-stacking potential as formamide but a reduction of 
hydrogen bonding potential to propel the denaturation reaction forward and not interrupt 
with the annealing of probe DNA. By conferring to parameters devised to predict if one 
material will dissolve into another to form a solution, the Hansen solubility parameters 
(Hansen, 1967) assign three parameters to molecules to describe different energy in 
various intermolecular bonds; dispersion forces, dipolar intermolecular forces and 
hydrogen bonds between forces.  The closer these parameters are together, the more likely 
they form a solution (Hansen, 1967) (Table 3.1). 
Indeed, other molecules and organic solvents have been tested as alternatives to 
formamide for DNA denaturation, such as; urea (Sinigaglia et al., 2018), trehalose 
(Mathlouthi, 2013), propylene carbonate (Matthiesen & Hansen, 2012), DMSO (Markarian 
et al., 2006), dimethylformamide and acetonitrile (Tateishi-Karimata & Sugimoto, 2014). 
Some alternative organic solvents have yielded successes when applied to in situ 
experiments, in particular ethylene carbonate (Matthiesen & Hansen, 2012; Golczyk, 2019). 
By reflection of each organic solvents Hansen’s solubility factors (Table 3.1) it would be 
possible to theoretically predict an alternative organic solvent that has similar properties as 
formamide, similar van-der-Walls and dipolar intermolecular forces, yet with a reduction in 
hydrogen bonding potential.  With the reduction of hydrogen bonding, it is hypothesized 
that it shall reduce hybridisation time to fit in with the hypothesis that the time 
requirement of this step is constrained by the annealing of the base DNA to the newly 









Table 3.1. Hansen’s Solubility parameters for various organic solvents 
Reported organic solvents that could be a replacement for formamide in FISH based 
hybridisation buffers, where δD = energy from Van-der-Waals forces between 
molecules, δp represents energy from dipolar intermolecular force between molecules 
and δH represents energy from hydrogen bonds between molecules. The key aspect is 
to note similar δD and δp as to formamide yet not δH as this is viewed as the ‘lagging’ 
component of hybridisation of probe to DNA target.  
Organic Solvent δD δp δH 
Ethylene Carbonate 19.4 21.7 5.4 
Formamide 17.2 26.2 19.0 
DMSO 9.0 8.0 5.0 
Acetonitrile (methyl cyanide) 7.5 8.8 3.0 
Dimethyl Formamide 17.4 13.7 11.3 
Urea 20.9 18.7 26.4 
Methanol 15.1 12.3 22.3 
Ethanol 15.8 8.8 19.4 
Isopropanol 15.8 6.1 16.4 
Ethylene Glycol 17.0 11.0 26.0 



















In regards to thesis aim 1, a new organic solvent that can reduce the time taken for 
hybridization experiments should increase throughput of FISH, in same species and cross 
species experiments. With this in mind, the first aim of this chapter was to test the 
hypothesis that there are alternatives to formamide based buffers that can significantly 
shorten hybridization times. Secondly, changes in methodology of FISH may be viable in 
terms of effectively of experiments and this shall be explored via the use of two 
commercial buffers in typical FISH experiments and Zoo FISH experiments, culminating in 
devising a new low-cost high throughput FISH methodology. 
 
This chapter is thusly divided into 2 sections 
a. Exploring the option of different hybridization buffers to test the hypothesis that 
there are better alternatives to formamide based buffers. This section sub divides 
into two areas; 
a. FISH testing of buffers made in the lab 
b. Direct comparison of formamide vs. non-formamide based commercial 
buffers 
b. Development of a low-cost, multiple probe strategy.  This section subdivides into 
three sections 
a. A newly developed multilayer FISH method 
b. The effect on how the multilayer method affects probes and preparations 











3.2 Exploring the option of different hybridisation buffers 
3.2.1 The recipe for good FISH 
The first part of the exercise was to establish whether the various solvents were 
capable of producing a solution that, by necessity, contains dextran sulphate to be a fit for 
purpose hybridisation buffer. Multiple organic solvents were selected from table 3.1 based 
upon their Hansen’s’ solubility factors being, ethylene carbonate, DMSO, acetonitrile and 
dimethylformamide, alongside the typical hybridisation buffer solvent formamide. These 
solvents were tested in a variety of conditions and concentrations (of NaCl and dextran 
sulphate). Initial results indicated that dimethylformamide, acetonitrile and DMSO disrupt 
the dissolution of dextran sulphate in the presence of a high salt concentration. Their 
counterparts of formamide and ethylene carbonate can effectively form a working solution 
at any concentration, and are the key components of commercially available buffers.  
In house synthesised buffers were tested in a variety of conditions and concentrations 
however presented with poor levels of hybridisation throughout with even the ‘home 
made’ formamide and ethylene carbonate buffer failing to produce viable/useable signals, 
whereas commercial buffers - HybI and FAST-  worked alongside in identical conditions 
consistently(>95%). With the inability to convenitnetly reproduce commercially available 
buffers, the possiblility of forming a newer cost effective methodology with primary focus 











3.3 Comparison of commercial buffers for FISH analysis  
Following on from the attempts to make alternative organic solvent-based buffers, 
attention was then turned to commercially made buffers, one formamide based (HybI, 
Cytocell) and one ethylene carbonate based (FAST, DAKO). Typically, all FISH hybridisation 
buffers are formamide based so a selection of a reputably high formamide based buffer, 
HybI was selected to be tested alongside relatively new yet expensive ethylene carbonate 
based buffer from DAKO which reportedly can work within the hour as compared to the 
‘overnight’ requirement of typical formamide based buffers.  
As the time of hybridisation is the key difference with the protocol of these buffers, it 
was decided to query the formamide buffers ability to successfully hybridise using reduced 
time for the hybridisation stage, then to compare to the FAST buffer. 
As described, two key usages of cytogenetics are for medical diagnostics in ‘same 
species’ hybridisations and for chromosome mapping of ‘like-species’ across evolutionary 
time and distance. A means to test these two buffers in light of cytogenetic usages was 
conducted in order to justify a change of protocol for further work. 
3.3.1 Same species comparison of hybridisation times  
  Initial experiments to compare the buffers has indicated that HybI can successfully 
hybridise probes with high efficiently (>= 95%) as shown in figure 3.1, with indication that 
there is a moderate amount of successful hybridisation at  40 minutes and even less 
success at 20 minutes hybridisation with no evidence seen at 10 minutes or 5 minutes. 
With the initial results thus far on HybI indicating similar decreased times for 
hybridisation, the emphasis will now shift and focus on the ability of these two commercial 
buffers in tailored experiments which would be typical of a cytogenetics lab and influence 






Figure 3.1. Metaphase frequency of successful hybridisation using HybI at 60 
minutes and under time-points. 
A), Bos taurus metaphase with successful probe hybridisation (chromosome 2, P-
terminus Green, Q-terminus Red) using standard FISH procedure with hybridisation 
time shortened to 60 minutes. B), The frequency of successful hybridisation 
(characterised by two chromosomes with two coloured probes on each) on 
aforementioned metaphases at the greatly lowered hybridisation time points of 60 
minutes and under, using HybI with its specific methodology.  
Repeating the experiment using this time the FAST buffer and its methodology, yet 
changing the hybridisation time points to be comparable to the HybI results seen in figure 
3.2, we can indentify that the FAST buffer does not exhibit the drop off of successful 
hybridisations that HybI expresses. With all time points tested having a successful 
hybridisation rate of above 90%, (60 minutes 100%, 40 minutes 95%, and 20 minutes 95%, 
total n=60).  
Results thus far show that the variation between the two buffers for same species 
hybridisation at greatly reduced hybridisation times is considerable, yet a more quantifiable 
scheme of measuring hybridisation quality is required to further pinpoint buffer quality for 
this genre of experiments, especially when discussing and experimenting on cross species 




















Many means of semi-quantifying data was trialled, such as grading scales and recording 
software defined automatic capture times yet the most fruitful measurement of scale was 
found to be forcing set exposure times on metaphases known to have successful signals. 
This method effectively lowers the overall level of light entering the camera, theorizing that 
if the signal can be seen with a low level of light then the signal must be stronger therefore 
hybridisation is of higher quality.  The amount of light captured by a lens (camera in this 
case) is directly proportional to the area of the aperture, something here which cannot be 
easily changed, yet the exposure time which governs how long the aperture mechanism is 
open can be directly controlled by the software, enabling a means to control the light levels 
entering the camera.  
It was noted that the higher limit for FITC and Texas Red filters for this particular 
hardware set up (Figure 3.3) was deemed to be an exposure time of 5 seconds, an ideal 
higher limit cut-off, where if signal is not identifiable within the 5 second exposure time it is 
deemed to not have successfully hybridised. Set time points were then selected limited by 
pre-set levels via the software (SmartCapture 3, Digital Scientific UK) in near equal 
decreasing increments of roughly half the previous at each step (5 seconds, 2 seconds, 1 
second, 0.5 seconds, 0.1 seconds and 0.05 seconds). 
Figure 3.2. Metaphase frequency of successful hybridisation using FAST at 60 
minutes and under time-points.  
A), Bos taurus metaphase with successful probe hybridisation (chromosome 2, P-
terminus Green, Q-terminus Red) using standard FISH procedure with hybridisation 
time shortened to 60 minutes. B) The frequency of successful hybridisation of B.taurus 
metaphases at the lowered hybridisation time points using the FAST buffer and its 














With level of exposure time being the precedent for quality of hybridisation, a more direct 
comparison between different experimental procedures can be observed.  Figure 3.3 shows 
the variation of required exposure times for this same species section of buffer comparison 
and stress testing (n=88). Here we see that although both buffers have comparable success 
rates for 1 hour hybridisations (Figure 3.1 and Figure 3.2), we can see a large shift of 
exposure time between the two samples, the FAST buffer manages to achieve the majority 
of their metaphase samples in the lowest time frame of 0.05 seconds exposure (55%) 
whereas HybI at this time point failed to achieve this higher standard with its modal 
exposure time being 1 second (57%), X2 =21.6 > p(11.070), indicating a significant 
difference between methods at this time frame. The decreasing success rate of HybI (Figure 
3.1) somewhat follows suit with the frequency pattern observed; where the modal values 
drop from 1 second, 1 hour hybridisation down to 2 seconds for 40 minutes and 20 
minutes. Statisitcal analysis follows suit in showing that there is no significant difference 
between the methodologies used at these time points. For 40 minutes X2 =4.01 > p(7.815) 




Figure 3.3. Metaphase frequency of signal identified at various forced exposure 
time points upon B.taurus using same species probes. 
Histograms showing the percentage frequency of metaphases which show 
identifiable signal at the lowest exposure time point. Top, using the FAST buffer at 
incremental hybridisation time points, bottom, identical experiments yet using HybI as 
buffer at the same time increments. Lower exposure time (0.05 seconds) is noted to 




3.3.2 Zoo-FISH comparison of hybridisation times 
 As discussed, cytogenetic research uses FISH as a means of identifying and validating 
cross species genomic mapping from species to species. Within this experiment Struthio 
camelus (common ostrich) metaphase preparations are used with G.gallus BACs conjoined 
with fluorophores as probes to again test these two commercial buffers for their 
effectiveness to hybridise said probes in shortened time frames (n=52). BAC clones were 
selected from a universal probe set which derived from multigenome alinment 
computational algorithms intended to act as a means to rapidly anchor PCFs (predicted 
chromosome fragments) to chromosomes as described in Damas, 2017. Zoo FISH 
hybridisation is typically performed over three days yet here we shorten this to two days 
and one day hybridisation, similar to same species FISH we would predict a high percentage 
of successful hybridisation for the ‘standard’ timeframe (>=95%). The connotation ‘day’ is 
referred to an overnight hybridisation i.e. initiated on one day and stopped the next 














Figure 3.4. Metaphase frequency of successful hybridisation over 2 days using 
HybI on S.camelus using G.gallus probes 
A), S.camelus metaphase with probe hybridisation (chromosome 2, P arm, 
assignment 172N3 Green, Q arm assignment 44D16 Red) using standard FISH procedure 
with hybridisation time changed to two day hybridisation. B) The frequency of 
successful hybridisation of S.camelus metaphases at the lowered hybridisation time 
points using HybI buffer and its methodology for zoo-FISH. Note, BAC 172N3 is assigned 
to the distal portion of the P arm in G.gallus and in S.camelus, the green signal seen in 
the image is a repetitive region (centromere) being falsely indicated and overshadowing 
the correct signal. Upon examination of images the correct signal can be seen via 





Results from variation of HybI on a cross species hybridisation does not vary to the 
degree same species FISH varies, with 1 day having a success rate of 93% and 2 days having 
a success rate of 86% as seen in figure 3.4. A somewhat similar outcome to FAST buffer 
within the same experimental parameters, 1 day hybridisation had a success rate of 87% 











Likewise, the use of set exposure times can further delve into the effectiveness of these 
buffers across shortened typical hybridisation periods. A similar pattern across the 1 day 
hybridisations can be observed, as both buffers perform similar across the set exposure 
ranges averaging at 1.9 seconds +- 0.51 S.E.M for HybI and 2.0 seconds +- 0.5 S.E.M for 
FAST. Yet results across the 2 day hybridisations (Figure 3.5) yield differing quality. It can be 
noted that HybI has a higher count for lower exposure time cut offs where FAST averages 
out much lower, 0.8 seconds +- 0.37 S.E.M and 1.7 seconds +- 0.47 S.E.M respectively, 
indicating that even with similar percentage success rates, HybI can produce better 
hybridising conditions at this two-day hybridisation time as compared to the FAST buffer.  
 
Figure 3.5. Metaphase frequency of successful hybridisation using FAST over 1 day 
and 2 day hybridisations 
A), S.camelus metaphase with successful probe hybridisation (chromosome 2, P 
arm, assignment 172N3 Green, Q arm, assignment 44D16 Red) using standard FISH 
procedure with hybridisation time changed to two day hybridisation using FAST buffer. 
B) The frequency of successful hybridisation of S.camelus metaphases over 1 day and 2 




Figure 3.6. Metaphase frequency of signal identified at various forced exposure 
time points upon Struthio camelus (common ostrich) using G.gallus probes 
Shown, histograms representing four different hybridising environments; two 
selected different buffers (HybI, Cytocell, Top and FAST, DAKO, Bottom), alongside two 
different hybridisation times (1 day hybridisation, left and 2 day hybridisation, right). 
Exposure time for the microscope camera was forced at the time points shown and 
selected metaphases imaged at each point; metaphases are categorized based upon the 
lowest exposure time image where there is clear identifiable probe signal in the correct 
position, guided by an automatic exposure image. Lower exposure time is theorized to 















With results being fairly comparable for both same species and zoo-FISH in terms of 
overall success and neither being statistically significant from one another. For 1 Day X2 
=0.29 > p(7.815) and 20 minutes X2 =5.93 > p(9.488) 
 It is important to note other differences in the actuality of both buffers. At time of 
testing the FAST buffer was a new and expensive product which equalled out to ~£40 per 
reaction whereas HybI in comparison costs ~<£0.50 per reaction. 
 Given that work contained in later chapters uses pre-mixed HybI probes, devices 
intended and designed specifically to use the formamide based buffer and cross species 
comparative genomic work, coupled with the fact that the producer of HybI, Cytocell, 
collaborates with this and likewise projects, the cost of buffer solution is near zero.  




3.4 Development of the Multilayer FISH method 
As pointed out in the introduction, there have been many attempts to produce 
multicoloured FISH.  The advantages of this approach are self-evident.  Visualization of 
multiple target on the same preparation can be very useful e.g. if there are few cells 
available for analysis, if each cell in a population of potentially karyotypically different or if 
multiple targets need to be analysed on the same chromosome e.g. for BAC ordering 
purposes.  As outlined in section 1.1.5, beyond red and green dyes, fluorochromes can be 
prohibitively expensive, single hybridizations of multiple probes can be more 
temperamental than one or two colour (often requiring much higher concentrations of 
probe, which increases the cost), and the mixing of dyes (e.g. red and green to produce 
yellow) can yield inconsistent results.  
In order to address this, this study involved the creation of a relatively new 
methodology of FISH (in reality a variant and combination of previously tried strategies). 
The intention was for it to be relatively cheap, high throughput, rapid, and allow for 
visualization of multiple targets. Understandibly, the current FISH methodology is the rate-
limiting step in creating chromosome level genome assemblies and it was with this in mind 













3.4.1 Methodology of Multilayer FISH 
A reappraisal of current FISH technology led us to the conclusion that, with modern 
microscope hardware and software improvements, it is entirely feasible to return to the 
same cell saved on any individual slide and re-observe it. This paired with the evidence that 
probe DNA held in place by hydrogen bond pairing can easily be removed and new DNA 
probes hybridised to the same preparation, I pursued the strategy of a multilayered FISH 
(mlFISH) approach, involving two dyes at a time in three or four rounds of hybridization as 
follows. 
3.4.1.1 Removal of previously hybridised probes  
In creating the protocol the following considerations were taken into account: Probes 
must be sufficiently removed to not display residual signals in later hybridization rounds. 
Each individual layer must have their own unique signals from the fluorophore(s) chosen 
for that ‘layer’ and should not have any interference from previous signals that may be the 
same fluorophore yet at a different position on the metaphase. It is also essential that the 
stripping process does not interfere with the metaphase preparation so they can easily be 
located and imaged for the next iteration of the multilayer cycle.  
After some experimentation, it was established that complete removal of signal caused 
by residual hybridized probe DNA could be achieved with a prewash of 2xSSC and 0.05% 
Tween 20 for 2 minutes to allow gentle removal of immersion oil, cover slip and counter 
stain (typically DAPI). Following this a stringency wash, aka ‘strip wash’ (100% ddH20, at 
72oC) for 30 seconds to 60 seconds with agitation upon removal effectively removes all 
fluorophore signals from the sample with no observed damage to the chromosomes in the 
preparation.  These changes to the protocol are outlined further in table 3.2 and the 








TABLE 3.2. Differences in methodology within multilayer FISH 
Here described, the multilayer methodology steps which are different to classical 
FISH experimental procedure paired with their resulting change to the sample as 





3.4.1.2 The Iterative Cycle of Multilayer FISH 
A standard model of mlFISH was produced visually in flowchart form as shown in figure 
3.7. The method follows the similar standard FISH methodology, yet has the iterative cycle 
element after microscopy where the user can remove probes as previously mentioned and 
insert the slide into the pre-ethanol dehydration stage as if they were freshly prepared 
samples. It was observed that there is mild deterioration in chromosome morphology, 
increasing within each cycle, creating a limit on how many times it is practicable to go 






Method Step Resulting change 
Clean slide with 2xSSC + 
tween (Pre Wash) 
Removes immersion oil and counter stain (DAPi) from previous 
imaging round, allows the cover slip to be floated off the slide 
with minimal disturbance to the metaphase preparation 
High temperature ddH20 
wash 
A high stringency wash (no ionic molecules present, i.e. salt) to 
remove all strongly bound probes from the chromosome 
preparation, and rehydrates the slide 
Agitation when removing 
the slide 
Flushes any probes that may still attached by mechanical 
action 
Rinse in increasing 
concentration of ethanol 
With the washes taking place, the slides are hydrated and need 
to be dehydrated for effective hybridisation to occur for the 
next round of FISH 
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Figure 3.7. The Multilayer FISH iterative protocol shown in Flowchart form  
A flowchart following standard shape meanings describing the process a user must 
go through to perform multilayer FISH. Note that the process is similar to standard FISH 
allowing experienced users to use this technique if it would serve fit for purpose in their 
experiments. Estimated time is displayed next to each step in the process to show the 































5-10 min + 




3.4.2 The effects of Multilayer FISH on metaphase preparations and 
probes 
The process of mlFISH is not the most gentle on samples as the conditions, such as 
temperature, are constantly changed. The purpose of this experiment was thus to ask what 
is the quality of the preparation and the hybridization signal under the same conditions and 
multiple stripping and re-probing. In order to maintain consistency two commercially 
available Human centromeric probes were used (Human centromeric 8 and human 
centromeric 12) in alternate red and green in consecutive hybridization layers. 
In layer 1 (green 8, red 12), 100% showed the correct number of signals, in layer 2 (red 
8, green 12) 95 % of metaphase showed the correct number of signals.  A slight 
deterioration in metaphase quality was noted. In layer 3 (green 8, red 12) 92% of 
metaphases the correct number of signals. Significant deterioration in metaphase quality 
was noted however chromosomes were still visible and distinct.  Signal quality was also 
noticeably less bright by visual inspection. On the basis of the above, and after some 
experimentation, the decision was taken not to routinely include a fourth layer. It was also 
concluded via further visual inspection and later testing, interphase quality deteriorated 
the same rate as metaphase quality yet likewise with metaphases, the signals were still 
highly visible and distinct (see results from section 4., 5., and 6.). 
Figure 3.8 shows an example of a H.sapiens metaphase describing the above results, 
albeit with a atypical low level of metaphase distortion across layers. Figure 3.9 shows 
much more typical distortion of the metaphase across the layers, this time G.gallus is the 
sample.   Furthermore, there appeared to be no obvious pixel shift of signals from one 
preparation to the next, giving me confidence that a three layer, six probe strategy could 




Figure 3.8. Multilayer FISH does not cause probes to incorrectly position after 
additional layers 
A Human, Homo sapiens, metaphase preparation showing centromere locations for 
chromosome 8 (FITC 1st+3rd image, Texas red 2nd image) and chromosome 12 (FITC 2nd 
image, Texas red 1st+3rd) Left to right, images in columns are each layer starting with the 
first on the left moving right. Top row; combined image from each raw colour channel 
obtained. Second row; shown is the raw Dapi (blue) channel for each layer showing no 
major distortion to the metaphase preparation. 3rd row; Raw FITC channel (green) 
output showing the levels of probe intensity across the metaphase, note that the first 
and last images occupy the same position on the sample and the second shows no 
signal at these locations. Last row; similar to the third yet using the red channel (Texas 
red), again note that the signal is on the same location within the first and third layer 










Given that the overall shape and structure of the metaphase was maintained 
throughout a three layering process (and signal position/brightness was not significantly 
compromised), the final stage of the process was to develop a protocol for 6 probe rapid 
hybridization involving two fluorochromes only, Hyb I as a buffer (as established above) 
and subsequent capture and re-capture of the same metaphase. In order to re-locate the 
same cell, the automated stage on the microscope hardware was used. In order to 







Figure 3.9. An exemplar schematic of a three layered FISH image   
A G.gallus metaphase prepared with six differing BAC based probes with three 
different FISH iterations using identical fluorophores (Texas red (red) and FITC (green)) 
at different positions along chromosome 3. Top, the three layers of combined three 
channel images produced via fluorescence microscopy (1000x) moving in increasing 
layer from left to right.   Bottom, the ‘merged’ combined metaphase with ‘false’ 
colouration to each unique probe, green = First layer FITC, red = Second layer Texas red, 
Yellow = second layer FITC, Purple = second layer Texas red, aqua = third layer FITC, 




3.5 Limitations of the Multilayer Method 
While, for most experiments, six probes in three layers were considered sufficient, an 
obvious question was how many layers could we feasibly apply before no (or a negligible) 
signal was seen at all.  
An assortment of BAC probes were arranged for chromosome 1 of chicken (G.gallus) in 
a way that allowed successive layers to be hybridised and stripped until the experiment 
failed, in this experiment using dual colour FISH, 9 unique layers were hybridised with the 
BACs from chicken chromosome 1 indicated in Table 3.3.  
Position Start pos. End pos. Hex code RGB BAC ID 
1 875,622 1,046,980 FF0000 255,0,0 89C18 
2 20,538,145 20,775,062 F54C00 245,76,0 89G23 
3 29,623,402 29,863,423 EB9300 235,147,0 119K2 
4 34,010,417 34,242,656 E2D400 226,212,0 120J2 
5 65,968,509 66,176,072 A2D800 162,216,0 36B5 
6 71,546,463 71,784,301 5ACF00 90,207,0 25P18 
7 77,066,050 77,273,343 18C500 24,197,0 125F1 
8 98,389,770 98,619,006 00BC23 0,188,35 118M1 
9 110,513,385 110,771,740 00B259 0,178,89 18J16 
10 120,693,003 120,889,688 00A889 0,168,137 29N14 
11 132,642,594 132,847,168 008B9F 0,139,159 9B17 
12 140,904,296 141,166,019 005495 0,84,149 168O17 
13 146,261,866 146,502,123 D0238C 0,35,140 83O13 
14 155,895,248 156,124,183 080082 8,0,130 107E2 
15 166,741,351 166,944,259 2D0079 45,0,121 58K12 
16 172,851,270 173,851,270 4C0D6F 76,0,111 184E5 
17 190,251,863 190,251,539 660066 102,0,102 98G4 
 
  
Table 3.3. BAC information and ordering for G.gallus chromosome 1 for multiple 
Multilayer FISH rounds 
Showing the position along chromosome 1 for G.gallus for owned BAC probes, 
detailing their start position and end position (according to distance from the p-
terminus), with corresponding clone ID. The relevant hexadecimal and equivalent RGB 




Figure 3.10. The maximum layer count achieved using current methods. 
Five layers on a single G.gallus metaphase showing positions of 10 different probes, 
with reference to table 3.3. This also shows the quality / state of the metaphase and 
probe clarity between layers to fully form the final five layer image on the right.  In total 
11 channels, 10 false colouration of probe signal and one final DAPi layer for 
chromosome identification. 
After the first layer of FISH was performed, metaphases were captured and positions 
saved and total recorded, and layers were repeatedly added onto the metaphases until an 
absence of metaphases were seen or no specific signal was observed. The metaphase drop 
out was as follows; First layer n=50, second layer n=41, third layer=40, third layer n=39, 
fourth layer n=39 and final fifth layer n=31 (a total of 62% survival of decay). Whereas, 
specific probe signal was not directly correlated to metaphase survivability as n=11 was 
useable for merging and analysis, (22% success rate at 5 layers). Further layers provided 
negligible results with no conclusive probe signals seen and even more decay of 
metaphases was observed. An example metaphase as described here is shown in figure 
3.10 and a more detailed isolated chromosome image is detailed in figure 3.11 with arrows 














Figure 3.11. Five layered chicken chromosome 1 in more detail 
Increased resolution of the merged five layered image from figure 3.10. Right, 
Arrows are used for clarity and visibility with numbering signifying the appropriate 

















3.6 Discussion   
3.6.1 Exploration into alternative buffers 
Overall, this study was successful in its objectives to re-examine the FISH procedure 
and emerge with a novel, fit for purpose protocol. The setback of not being able to 
generate sufficient signals using homemade buffers was not an unproductive endeavour. 
The commercial formamide based buffer Hyb I showed a significant improvement and is 
sufficient enough for most purposes currently faced and we were fortunate to have a ready 
supply of it. The carbonate-based buffer (Matthiesen & Hansen, 2012) certainly was 
effective, but not significantly more so than Hyb I, but was prohibitively expensive for 
routine use (costing £40 for a single assay, at time of experiments). Through attempts to 
synthesise new buffers the lesson learned was that it was more difficult than one might 
imagine. Formamide was clearly wisely chosen and even attempts to switch to de-methyl 
formamide (theoretically a better solvent with near identical energy from van der Waal 
forces, a greatly reduced energy from hydrogen bonding, critical for the ethylene carbonate 
buffer, yet lower dipolar energy forces which would an ideal area to query next), did not 
even progress past the stage of even making a soluble buffer. While it presumably would 
be possible to synthesise a carbonate buffer like the commercial one used in this study, this 
proved not to be possible (at least in my hands with available time and resources). The 
“take home message” was to continue with Hyb I. 
The precise composition of Hyb I is a trade secret of Cytocell Ltd however personal 
communication reveals that it is formamide based and benefits from being rigorously batch 
tested on an industrial scale with a wide range of probes.  
3.6.2 Comparison of commercial buffers  
With the formulation of ‘home made’ hybridisation buffers being somewhat of a 
fruitless endeavour, the question of how well the differing commercial buffers with 
differing organic solvent basis can increase throughput for common cytogenetic 
experiments. Outlined in this chapter, it is demonstrated the usefulness of both buffers 
(Hyb I- formamide, FAST – EC) for same species FISH and Zoo-FISH/cross species FISH. Quite 
an unexpected outcome was the development of an ‘in-house’ system of testing buffers 
which could be applied for testing newer buffers should they be developed in the future. 
Overall results across these experiments does indicate that Hyb I is more reliable in cross-
species hybridisation experiments and the EC based buffer unsurprisingly works better at 
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lower hybridisation times. However, it does show the reliability of a well made commercial 
buffer where Hyb I can somewhat compete with a newer, albeit more expensive, buffer in 
regards to quick hybridisation testing (Figure 3.1). 
In reflection on the methodology used to assess the two buffers, it would be 
recommended that a more rigorous grading criteria be developed as this is very hard to 
achieve with current methods available. The idea of using the software derived ‘auto-
capture’ time showed little success where metaphase/image usability would not correlate 
to this variable. Furthermore the algorithm used to determine the auto-exposure time cut-
off/selection is within the capturing software itself and could easily vary based upon 
current hardware used adding to uncertainty of results. From this a more reliable way of 
assessing probe strength, i.e. hybridisation success, was to manually restrict the exposure 
time allowing only set quantities of fluorescent light to be received by the camera, 
governed by probe availability on the sample. Again this is a questionable means of testing 
as it poses the question of does the level of fluorescent light received necessarily equate to 
better probe binding/hybridisation conditions?  
In light of results from this section, it was clear that Hyb I was suitable enough to carry 
forward throughout the rest of the thesis experiments. The use of a cheaper as reliable 
buffer commonplace in cytogenetic laboratories would gain favour for those wishing to 
follow the multilayer methodology outlined in the rest of this thesis.  
3.6.3 The novel Methodology of Multilayer FISH 
The creation and refinement of the multilayer methodology of FISH has here 
demonstrated a means of improving yields in a simple and effective way. Outlined in table 
3.4, common limitations of FISH are listed with multilayer FISH justifications as use of an 







Limitation of FISH mlFISH Counterpoint 
Low number of fluorochrome analysis at any 
one time 
Experiments can be organised to reuse the 
same colour fluorochrome at different 
positions 
Low number of metaphases present, i.e. 
valuable cell sample or poor cell 
harvest/growth 
The same metaphases can be reused for 
different experiments 
Metaphases are of poor quality Few metaphases are required to generate a 
final merged image 
Fluorophore reagents are expensive to 
generate probes 
The number of experiments required to get 
the same results as typical FISH is far smaller 
thus using less reagents 
Metaphases vary within the sample due to 
growth and harvest conditions introducing 
error when comparing metaphases 
This error is eliminated as there is no 
variation as the same metaphase is used for 
the multitude of layers 
Laboratory and analysis time needed to 
produce a wide set of data 
mlFISH can reduce the time taken in the 
laboratory and on the microscope as less 
slides are used, yet analysis time is 




These simple but worthwhile changes to the traditional FISH protocol can dramatically 
reduce the cost of FISH, one of the main disadvantages against its use (Huber et al., 2018). 
This reduction is achieved by reducing the amount of probes required for a large 
comparative study, for example probe ‘A’ would only have to be used once per 
metaphase/sample rather than ‘n’ times, with ‘n’ being the number of other probes used. 
Probe ‘A’ would otherwise have to be paired with probe ‘B’, probe ‘C’, probe ‘D’ and so on 
in multiple experiments which increases probe usage and experimental time required, 
another cost saving feature. The idea that a sample may become irreplaceable, such as a 
transgenic mutant within genetic screening processes for the food industry. The animal 
would be culled immediately to reduce cost, however from a research standpoint it is a 
very valuable phenomenon with now no means to gain more material. The use of 
multilayer FISH somewhat removes this experimental limit by increasing usage of 
remaining material. Again, the use of only two fluorophores further reduces costs required, 
yet also lessens pre-experimental planning issues as there is no need to work out tricky 
combinations of specific colour probes to specific loci which can result in redundant probes 
only being used a handful of times. The fact that a single metaphase can be used for a 
Table 3.4. Limitations of traditional FISH with resolutions found in the multilayer 
method 
Limitations reported as why the ‘classic’ FISH methodology is unequipped for a 
modern-day laboratory setting and how these points are remedied with the use of the 
multilayer method.  
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whole experimental question reduces some uncertainties with traditional FISH. Now the 
metaphase variability between experiments is removed, which could lower ranges of 
results seen during analysis.  
For a worked coasted example. As a hypothetical estimation on the monetary and time 
cost of hybridising six probes to a single human chromosome, by the multilayer method (six 
probes on one metaphase, ‘3 rounds’) or by traditional FISH (two probes per metaphase, 
unique combinations with cheapest probe combination, 15 ‘rounds’ total). An 
approximation of cost per probe, (as outlined in sections 2.1.3 and 2.2) for reagents only 
(probe manufacturing, hybridisation buffer and species relevant repetitive sequence 
blocker) is £1.40 for a FITC labelled probe and a £1.65 for a Texas red labelled probe per 
‘round’ of FISH. The multilayer methodology requires three of each probe, totalling at 
£9.15 for a single chromosome study. Opposed to this, the traditional method requires 15 
rounds for all six probes to be in unique combination with one another, using the cheapest 
fluorophore combination (as much FITC as possible) costs approximately £45.75 for the 
chromosome study. In terms of time, preparing a single slide vs. 15 slides is somewhat 
troublesome to directly compare. For example, using Figure 3.7 as a guide for timings, the 8 
minute ethanol series will not be multiplied 15 times as this can be performed 
simultaneously in the same time frame and the multilayer method will not gain time here. 
Where time is saved on is repeated rounds of microscopy. Per slide of traditional FISH 
would take approximately 20/30 minutes to get enough metaphases of good quality 
imaged, with 15 slides this will be approximately 6/7 hours of microscopy time. The 
multilayer method initially takes time but time is saved by reliance on saved positions on a 
mechanised stage to speed up subsequent microscopy. For this example, the total 
microscopy time for multilayer FISH would be approximately 2 hours. Post microscopy, 
analysis time will vary greatly dependant on skill/experience of the user and the 
computational aids they have access to, this is further discussed in section 4.2.1. 
3.6.3.1 The effects of Multilayer FISH protocol  
The ‘re-FISH’ process within the multilayer methodology is shown not to distort the 
cellular preparations. This allows determination of results with confidence as there is little 
to no detriment to the sample based upon what ‘layer/cycle’ the sample is on.  As clearly 
seen in figure 3.8, the movement of probe is incalculable from the first FISH stage to the 
last. In traditional FISH it is notable that chromosomal morphology is distorted by the 
classic ‘fuzzy edge’ feature as caused by rapid denaturation interfering with DNA-histone to 
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scaffolding protein structure, more so with extra rounds of denaturation (Figure 3.10), 
somewhat making a limit on the amount of cycles a sample can withstand.   
The introduction of more stringent washes was a clear route to take to remove 
previously bound probes. This process is shown to have no effect upon sample quality, as 
we would expect in molecules only held on by hydrogen bond interactions. Standard FISH 
requires a post hybridisation stringency wash, typically 0.4% SSC at 72oC, to remove weakly 
bound probes and sharpen correct signal. By taking the principle that a high ionic solution, 
such as in the hybridisation buffer, helps stabilised the negatively charged DNA backbone 
and also aids in to stabilise the probe DNA- chromosome DNA hybrid, then a lower ionic 
environment shall destabilise this hybrid and allow disassociation of the probe DNA to 
occur. Furthermore, an environment lacking relatively any ionic component should cause 
complete destabilisation of the hybrid compound thus causing removal of the fluorophore 
attached to the probe into the surrounding solution. These checks allow the confident use 
of multilayer FISH as the methodology of choice for further biological questioning in the 
field of cytogenetics.  
3.7 Conclusion 
The necessity of a good protocol and quality reagents in FISH is commonplace in 
cytogenetic laboratories. As with many processes however a reappraisal is often required.  
In retrospect to the buffer comparison tests, a more rigorous set of control samples 
would be essential to validate this concept of testing further. As a recommendation, a set 
of human metaphases with commercially made probes as the golden standard of ‘perfect 
materials’ to test either homemade buffers or newer commercial buffers. Likewise, a 
generation of cross-species panels would be useful if the focus is more on evolutionary 
genomic studies, metaphases from species that increase in evolutionary 
distance/increasing diversity using probe targets of known homology. With better 
predefined criteria to judge metaphase/probe quality paired with controlled blind 
marking/grading of images would further added to the validity of these tests.  Regardless, 
the creation of a preliminary buffer comparison test has shown good results to influence 
the methodology of all future chapters.  
The multilayer methodology is not without its own downfalls. This approach is 
technically hard as requires an experienced cytogenetic scientist and understanding of 
multiple pieces of software (for microscope control and image merging/analysis), alongside 
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the ‘all eggs in the same basket’ approach where time and reagents can be wasted if later 
layers fail to hybridise correctly. As seen in the 5th layer of chicken chromosome 1 stress 
testing, the viability of end metaphases was 22%, comparing to amount useable after initial 
hybridisation. However, this is exciting to see as it represents a wide pool of very specific 
BAC’s being used to give lots of information in a short period of time. Compared to 
traditional methods which would require each probe to be tested individually with one 
another, represented by this equation with ‘n’ being number of probes,  n=(n*n)-n it would 
equate to 90 simple experiments against a single more arduous  challenging multilayer 
experiment.  
It is a error filled task to correctly predict the exact complete cost of a modern day 
cytogenetics lab using the traditional method against the multilayer method, as we would 
have to discern; labour costs, general lab consumable costs, the running costs associated 
with use of a fluorescent microscope (in regards to bulb wear, fluorescent filter cube costs, 
immersion oil and maintenance) and possible software licensing costs. But with the 
example outlined in 3.6.3, we can see that the ‘per experiment’ cost of the multilayer FISH 
method greatly reduces the overall cost due to the reduction of fluorophore usage, where 
a single two colour test costs £3.05. For a general formula in an ideal situation (i.e., all 
probes currently exist in the correct and cheapest fluorophore combination), the cost for 
multilayer two colour FISH would be £3.05 times the number of layers opposed to in 
traditional FISH compromising of  £3.05 times ((n*(n-1))/2, where n is the number of 
probes required.  To put a price on individual metaphases cannot be comprehended, as 
some may be ‘priceless’ as they could be irreplaceable (such as in the event of novel 
genomic mutations) or from hard to source organisms (see 1.3.5) 
It is clear to be seen that the multilayer FISH method gains in efficiency in throughput 
the more probes that are needed to question a given sample, with reduction in time and 
money the user will have higher gratification for hybridisation techniques for their research 
projects. With this in mind, the multilayer methodology has been applied to other 






4. Using the Multilayer FISH Strategy to Improve Our 
Understanding of Galliform evolution (specific aim 2) 
4.1 Cytogenetics of the aves   
Gene mapping using cytogenetic techniques was first employed to map individual 
clones, once isolated, to chromosomes (Lichter et al., 1988).  As explained in the main 
introduction however its main utility for modern genomic efforts in recent years is as either 
confirmation for the reliability of newly assembled genomes or de-novo mapping to 
chromosomes of scaffolds generated by next generation sequencing. In either event, the 
use of multi-colour strategies has been largely under-explored in this context, but would 
nonetheless potentially find utility for visualization of the order of several probes 
simultaneously, at a decreased cost to previous cytogenetic methods.  
As the avian genome is relatively small as compared to mammals (Schmid, 2000; Smith, 
2000; Habermann et al., 2001), hypothesised due to evolutionary requirements of flight as 
allows a higher degree of energy conservation (Hughes, 1995). Members of the aves have a 
characteristic stable karyotype pattern (Masabanda et al., 2004; Griffin, 2007) consisting of 
around 10 macrochromosomes and approximately 30 gene rich microchromosomes 
(Habermann et al., 2001; Burt, 2002) (Section 1.2.3). These microchromosomes are seen to 
be relatively gene-dense as compared to macrochromosomes and appear to be highly 
conserved across the avian lineage (Skinner, 2009a; Griffin 2008). Comprehensive 
interchromosomal rearrangements are reported in only a small number of groups such as 
parrots and falcons (Seibold-Torres et al., 2015; Nishida et al., 2008; Nanda et al., 2007; 
Joseph et al., 2018; Damas et al 2007).  
The identification of similar morphologies of the karyotype was first achieved through 
typical banding pattern techniques, such as G-banding (Takagi & Sasaki, 1974; Ansari, 1986) 
to be further improved by the creation of fluorescent linked whole chromosome paints 
which were necessary to light up a whole chromosome (Griffin et al., 1999) which allowed 
a more rigorous means to facilitate the physical mapping of the avian genome (Schmid et 
al., 2000).  An example is the comparative painting between the chicken, G.gallus, and the 
emu, D.novaehollandiae, which identified high homology between the nine largest 
macrochromosomes (Shetty et al., 1999) 
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The Galliform order is well studied, as G.gallus is a key model species, thought to be 
most similar to the avian ancestor (Romanov et al., 2014). An early study of homologs 
between chicken and Japanese quail showed no interchromosomal rearrangements 
(Kayang, 2006), and it is generally agreed that most of these macrochromosomes 1 to 9 
(including Z) have direct homologs in most other bird species (Griffin 2000, first report, 
Griffin et al 2007; Damas et al., 2018). Notable exceptions among the Galliformes (Figure 
4.1) include a fission of the ancestral chromosome 2 to form turkey chromosomes 3 and 6 
and a fusion to form a sub-metacentric chromosome present in chicken and at least 2 quail 














Figure 4.1. Phylogenetic Tree of Galliformes studied in this thesis with notable 
inter-chromosomal changes 
Phylogenetic tree of the galliform species used within this study, arrows depict 
already categorized gross chromosomal changes over evolutionary time.  
Note, Coturnix chinensis has recently been re-grouped into the Excalafactoria 




(Red jungle fowl (chicken) 
(Japanese quail) 
(Chinese quail) 
Fusion to form chromosome 4 
Fission of chromosome 2 
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In interphase nuclei, the organization of the avian chromosomes is well described. The 
microchromosomes occupy a central position, whereas the macrochromosomes cluster 
around the nuclear periphery (Haberman et al 2001). This in fact fits both classic models of 
nuclear organization (size-based and gene-density based) given that the 
microchromosomes are far more gene-rich.  Skinner et al (2009a) provided evidence that 
the gene-density based model was more likely by analysis of relatively gene poor 
microchromosomes. The clear organization of the whole chromosome territory however 
raises the question of whether intra-chromosomally, the organization is similarly conserved 
i.e. that the chromosome territory organises itself consistently each time. If this were the 
case, then it would be possible to map the order of clones on interphase nuclei and thus 
negate the need to prepare metaphases for genome assembly studies. The need for 
dividing cells to make metaphase preparations is one of the impeding factors  
With the above in mind, the purpose of this chapter was twofold and thus split into two 
sections 
- In regards to aim 2.1: To develop a multilayer FISH protocol specifically designed to 
map clone order (and hence interchromosomal and intrachromosomal 
rearrangements) in Galliform chromosomes 1-5. 
 
- In regards to aim 2.2: To use a version of the above and thence develop an 
interphase chromosomal predictive finding tool to better understand chromosomal 









4.2 Galliform chromosome rearrangements  
Using a multilayer strategy of 3 sequential layers, each with 2 colours, results 
demonstrated that the following questions could be addressed. 
1): Are all the signals seen on the same chromosome? 
Results showed that, immediately, the user can see if the probes used localise to the 
same chromosome of choice in the new species of bird. An observation of ‘splitting’ 
indicating either fission of fusion of an ancestral chromosome can be identified easily by all 
six probes not co-localising to the same chromosome. 
2): Are all the signals in the same order as G.gallus? 
As pseudo colours are applied to each unique probe in the panel, results show that it is 
relatively easy for the user quickly to identify any intra-chromosomal rearrangements such 
as inversions by visual inspection rather than relying on FLPter measurements. 
3): Are the signals the same distance across the chromosome compared to a chicken 
reference? 
This approach allows a more rigorous examination where the FLpter scores are 
generated to detect any minor difference across the chromosome that may not be 
apparent with a brief examination of the signals. 
4.2.1 Measuring FLPter: script vs. Manual measurements 
In the materials and methods (section 2.2) usage of a script for measurement of FLPter 
values in a mlFISH strategy is described. In order to establish that the method was 
equivalent to the “standard” manual approach of measurement of FLPter values from 
individual experiments, the two approaches were compared as shown in figure 4.2. 
Identical images for G.gallus chromosome 2 panel, merged multilayer images and 
unmerged two probe images, were measured manually and automatically (outlined in 
detail in the method section 2.2.2) to give FLpter scores for the identical probe locations. 
As seen in figure 4.2, the recorded probe positions do match, yet what is observed also is 
that there is a much larger inconsistency in the variance of the automated script measured 
sample. This is depicted as error bars showing the standard deviation and confirmed by a 
series of Paired two sampled, two tailed T-Tests (Probe A, p=0.0025; Probe B, p=0.0046; 
Probe C, p=0.0288; Probe D, p=0.003; Probe E, p=0.2371; Probe F, p=0.0316; Length, 
p=0.0003, See appendix). All measurements must have failed the T-test to show that there 
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Figure 4.2. Probe position placements for G.gallus chromosome 2 measured via 
different methods 
FLpter scores obtained by manual reading (blue) and via an in house automated 
script (red), on G.gallus chromosome 2 using probes outlined in table 4.2. Error bars are 
given as standard deviation in respective colours. Identical images were used to obtain 
scores then averaged across all recorded data for chromosome 2 for both measuring 





























is no difference between the methodologies tested; only probe E had a higher p value than 
the standard 0.05 significance level. The variance is larger in samples measured ‘last’ (the 
last layer, which has the most chromosome distortion as previously reported), especially 
seen in probe assigned ‘C’ as this was a probe used in the 3rd round of multilayer FISH. 
As rounds of multilayer FISH increase the script incorrectly interprets the length of the 
chromosome, generating a more erroneous score associated to the probe at that point on 
the chromosome. Here we see the scores do average out to their expected value, governed 
by the manual reading of the six-layer image. However, this level for same species FISH sets 
a worrying precedent for cross species FISH where the large variance could hide or 
incorrectly report position changes as compared to the chicken. 
The results therefore suggest that using the FLpter script could possibly lose precision 
for the following experiments, with the increase of time taken to measure each sample (1 
image for manual and 3 images if using the script), from this point on manual 













4.2.2 Genome organisation in Galliform chromosomes 1-5  
In the following diagrams and tables, for each chromosome, the BAC ID and genomic 
position are given. In the initial layer approx n>50 metaphases for G.gallus, and n>20 
metaphases for other species (due to lower mitotic index) were captured.  Metaphases 
washed and then re-layered with the next pairing of probes in the standard multilayer 
iterative approach to generate a multitude of merged metaphases as seen in figure 3.9  for 
each species used in this study, 3 metaphases of varying quality selected are subsequently 
shown from overall pool of merged metaphases.  
After merging, metaphases were then analysed manually to give averaged Flpter scores 
for each point across the chromosome and then cross compared to G.gallus. Using a 
chromosome plot point, FLpter values can be plotted against one another according to 
distance and probe to be directly measured against the reference of chicken. 
4.2.2.1 Chromosome 1 
For chromosome 1 (Table 4.1, Table 4.6), the BAC order remained the same in all 5 
species.  The relatively different position of probe B (yellow) in Japanese quail is suggestive 
that there may be a rearrangement in this region beyond the resolution of this system 
(Figure 4.3, Figure 4.4) 
Probe ID Start Position End position 
BAC ID 
(CH261-) 
(A) 875,622 1,046,980 89C18 
(B) 65,968,509 66,176,072 36B5 
(C) 98,389,770 98,619,006 118M1 
(D) 132,642,594 132,847,168 9B17 
(E) 146,261,866 146,502,123 83O13 




Table 4.1. Probes used for metaphase chromosome analysis for Galliform 
chromosome 1 
G.gallus BACs from the ‘Chori’ library, selected based upon position upon 
chromosome one of G.gallus, Probe ID with colour corresponds to the appropriate 
graph and false colour applied to signals seen in images. Start position and end position 
display the base number on which the BAC spans along the chromosome 
(approximately 200,000 bp); and BAC ID is the associated identifier associated with the 








Figure 4.3. Merged metaphase images of five galliformes using selected G.gallus 
chromosome 1 BACs 
15 individual metaphases, 3 per species shown, displayed with hybridised G.gallus 
chromosome 1 probes outlined in table 4.1 with corresponding false colouration of 
probe signal seen. G.gallus (first row) is shown as a control to display expected position 
on that species with possible variances seen in other species, with descending rows 
being differing species. Images were merged according to the protocol outlined in 











































Figure 4.4. Probe point plot for galliform chromosome 1 for five species, and 
corresponding chromosome schematic 
A)- Probe position measured as FLpter values and averaged across all metaphases 
obtained using probes outlined in table 4.1. Each individual species has a corresponding 
colour seen, and colours assigned to each probe correspond to false colours applied to 
related metaphase images. Error bars are given as S.E.M. 
B)- Generated schematic chromosomes for each species by using metaphase FLpter 
data generated in this study, all relative to G.gallus chromosome 1. Position of coloured 
band corresponds directly to FLpter scores generated and colour corresponding to 





4.2.2.2. Chromosome 2 
For chromosome 2 (Table 4.2, Table 4.6), the system identified an inversion of probes B 
and C present in Chinese quail only as well as the well described centric fission in turkey to 
form 2 chromosomes (Figure 4.5, Figure 4.6) 
Experiment ID Start Position End position 
BAC ID 
(CH261-) 
(A) 5,936,192 6,131,770 169N6 
(B) 29,361,223 29,588,465 186J5 
(C) 43,177,303 43,412,434 50C15 
(D) 103,580,339 103,809,599 169E4 
(E) 128,029,292 128,240,032 44H14 












Table 4.2. Probes used for metaphase chromosome analysis for Galliform 
chromosome 2 
G.gallus BACs from the ‘Chori’ library, selected based upon position upon 
chromosome two of G.gallus, Probe ID with colour corresponds to the appropriate 
graph and false colour applied to signals seen in images. Start position and end position 
display the base number on which the BAC spans along the chromosome 
(approximately 200,000 bp); and BAC ID is the associated identifier associated with the 
sequence used as a probe.  Six probes in total, A to F. 
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 Figure 4.5. Merged metaphase images of five galliformes using selected G.gallus 
chromosome 2 BACs 
15 individual metaphases, 3 per species shown, displayed with hybridised G.gallus 
chromosome 2 probes outlined in table 4.2 with corresponding false colouration of 
probe signal seen. G.gallus (first row) is shown as a control to display expected position 
on that species with possible variances seen in other species, with descending rows 
being differing species. Images were merged according to the protocol outlined in 
































Figure 4.6. Probe point plot for galliform chromosome 2 for five species, and 
corresponding chromosome schematic 
A)- Probe position measured as FLpter values, obtained using probes outlined in 
table 4.2. Each species has a corresponding colour. Error bars are given as S.E.M. 
 A clear inversion can be seen for probe B(purple) and C(orange) for 
E.chinensis(green line) as compared to the other species.  
B)- Generated schematic chromosomes for each species by using metaphase FLpter 
data generated in this study, all relative to G.gallus chromosome 2. Position of coloured 
band corresponds directly to FLpter scores generated and colour corresponding to 
assigned probe. Labels on ‘Turkey’ represent corresponding chromosomes assignment 





4.2.2.3 Chromosome 3 
For chromosome 3 (Table 4.3, Table 4.6), the system identified no rearrangements in 
all 5 species (Figure 4.7, Figure 4.8) 
Probe ID Start Position End position 
BAC ID 
(CH261-) 
(A) 106,508 289,139 115J5 
(B) 25,940,915 26,171,148 160I6 
(C) 40,872,930 41,111,215 97P20 
(D) 65,843,346 66,066,979 17B14 
(E) 95,661,126 95,801,606 169K18 








Table 4.3. Probes used for metaphase chromosome analysis for Galliform 
chromosome 3 
G.gallus BACs from the ‘Chori’ library, selected based upon position upon 
chromosome three of G.gallus, Probe ID with colour corresponds to the appropriate 
graph and false colour applied to signals seen in images. Start position and end position 
display the base number on which the BAC spans along the chromosome 
(approximately 200,000 bp); and BAC ID is the associated identifier associated with the 








Figure 4.7. Merged metaphase images of five galliformes using selected G.gallus 
chromosome 3 BACs 
15 individual metaphases, 3 per species shown, displayed with hybridised G.gallus 
chromosome 3 probes outlined in table 4.3 with corresponding false colouration of 
probe signal seen. G.gallus (first row) is shown as a control to display expected 
position on that species with possible variances seen in other species, with descending 
rows being differing species. Images were merged according to the protocol outlined 
































Figure 4.8.  Probe point plot for galliform chromosome 3 for five species, and 
corresponding chromosome schematic 
A)- Probe position measured as FLpter values and averaged across all metaphases 
obtained using probes outlined in table 4.3. Each individual species has a corresponding 
colour seen, and colours assigned to each probe correspond to false colours applied to 
related metaphase images. Error bars are given as S.E.M.  
B)- Generated schematic chromosomes for each species by using metaphase FLpter 
data generated in this study, all relative to G.gallus chromosome 3. Position of coloured 
band corresponds directly to FLpter scores generated and colour corresponding to 





4.2.2.4 Chromosome 4 
For chromosome 4 (Table 4.4, Table 4.6), interchromosomal rearrangements were 
identified with probes A and B appearing on a different chromosome to the others in 
chicken and the two quails (Figure 4.9, Figure 4.10). This is the well described fusion that 
appears convergent during avian evolution. The relatively lower position of these two 
probes in Japanese quail suggests a further rearrangement although the nature of this 
cannot be determined using this system. Intrachromosomally, the probe order remains 
unchanged in all five species.  
Probe ID Start Position End position 
BAC ID 
(CH261-) 
(A) 4,024,168 4,195,906 83E1 
(B) 15,369,304 15,591,613 111A15 
(C) 30,671,456 30,924,202 18C6 
(D) 43,256,005 43,521,139 185L11 
(E) 65,099,056 65,344,197 85H10 






Table 4.4. Probes used for metaphase chromosome analysis for Galliform 
chromosome 4 
G.gallus BACs from the ‘Chori’ library, selected based upon position upon 
chromosome four of G.gallus, Probe ID with colour corresponds to the appropriate 
graph and false colour applied to signals seen in images. Start position and end position 
display the base number on which the BAC spans along the chromosome 
(approximately 200,000 bp); and BAC ID is the associated identifier associated with the 








Figure 4.9. Merged metaphase images of five galliformes using selected G.gallus 
chromosome 4 BACs 
15 individual metaphases, 3 per species shown, displayed with hybridised G.gallus 
chromosome 4 probes outlined in table 4.4 with corresponding false colouration of 
probe signal seen. G.gallus (first row) is shown as a control to display expected position 
on that species with possible variances seen in other species, with descending rows 
being differing species. Images were merged according to the protocol outlined in 
































Figure 4.10. Probe point plot for galliform chromosome 4 for five species, and 
corresponding chromosome schematic 
A)- Probe position measured as FLpter values and averaged across all metaphases 
obtained using probes outlined in table 4.4. Each individual species has a corresponding 
colour seen, and colours assigned to each probe correspond to false colours applied to 
related metaphase images. Error bars are given as S.E.M.  
B)- Generated schematic chromosomes for each species by using metaphase FLpter 
data generated in this study, all relative to G.gallus chromosome 4. Position of coloured 
band corresponds directly to FLpter scores generated and colour corresponding to 






4.2.2.5 Chromosome 5 
Chromosome 5 (Table 4.5, Table 4.6) appears to be near identical across all species 
examined (Figure 4.11, Figure 4.12) 
Probe ID Start Position End position 
BAC ID 
(CH261-) 
(A) 5,387,924 5,581,233 49B22 
(B) 10,219,524 10,389,786 122F8 
(C) 25,301,609 25,488,411 78F13 
(D) 26,734,106 26,902,004 2I23 






Table 4.5. Probes used for metaphase chromosome analysis for Galliform 
chromosome 5 
G.gallus BACs from the ‘Chori’ library, selected based upon position upon 
chromosome five of G.gallus, Probe ID with colour corresponds to the appropriate 
graph and false colour applied to signals seen in images. Start position and end position 
display the base number on which the BAC spans along the chromosome 
(approximately 200,000 bp); and BAC ID is the associated identifier associated with the 








Figure 4.11. Merged metaphase images of five galliformes using selected G.gallus 
chromosome 5 BACs 
15 individual metaphases, 3 per species shown, displayed with hybridised G.gallus 
chromosome 5 probes outlined in table 4.5 with corresponding false colouration of 
probe signal seen. G.gallus (first row) is shown as a control to display expected position 
on that species with possible variances seen in other species, with descending rows 
being differing species. Images were merged according to the protocol outlined in 
































Figure 4.12. Probe point plot for galliform chromosome 5 for five species, and 
corresponding chromosome schematic 
A)- Probe position measured as FLpter values and averaged across all metaphases 
obtained using probes outlined in table 4.5. Each individual species has a corresponding 
colour seen, and colours assigned to each probe correspond to false colours applied to 
related metaphase images. Error bars are given as S.E.M.  
B)- Generated schematic chromosomes for each species by using metaphase FLpter 
data generated in this study, all relative to G.gallus chromosome 5. Position of coloured 
band corresponds directly to FLpter scores generated and colour corresponding to 
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Decrease in C.Quail 












Decrease in C.Quail 












Decrease in C.Quail 












Decrease in C.Quail 















































































Table 4.6. All tables for every chromosome with probe’s FLpter score 
All tables shown correlate to probes used outlined in the previous section, each cell 
contains FLpter score for the probe on respective species with standard error of the 
mean displayed alongside. In the case of chromosome fissions (Turkey 2 and 4, Guinea 
fowl 4) merged scores have been displayed as if the chromosomes are ‘stacked’ as if 




4.3 Development of a Chromosome Interphase Plotter for 
chromosomal nuclear arrangement 
Previous work on paints gives general region/territory within the nuclei yet no means 
of direction or specific region identification. However there is a need to improve on this to 
encapsulate the chromosome territory indication direction and multiple bands on the 
chromosome in de-condensed state via an ‘automatic’ measuring system. 
  
Using the multi-layered approach, it is possible to detect, give direction and order to 
chromosomes within the nuclei more specifically as compared with previous exploration 
using whole chromosome paints (Griffin et al., 1999). It is then possible to ask multiple 
questions, such as is there a specific direction/orientation of the chromosome in question, 
or do the chromosomes express a linear direction or are they overlapping themselves? 
From this we can ask, what happens when things go wrong within the cell, for example 
partial chromosomal translocations to affect fertility or mass chromosomal deformity in the 
event of a cancerous cell.  
  
As shown, it is currently possible to plot BACs along the chromosome within a 
metaphase preparation, to give direction, orientation and distance, and this can easily be 
applied to work within interphase nuclei as well. 
4.3.1 Interphase specific Multilayer protocol 
FISH protocol was identical to previous section outlined in section 4.2.2, using identical 
probes with respective ordering and false colouration. Final merged images were imported 
into Microsoft Design4 (Microsoft) in original state with no resizing staying true to original 
pixel state as captured during microscopy. Here imposed coloured circles were placed 
centrally over signals seen in each interphase cell and bounding nuclear drawn over the 
perimeter seen. As seen in figure 4.13, not all interphase cells are taken into this stage as 
they do not exhibit the full count of signals required, in the case of chromosome 3 shown 
here, requires 2 of each individual 6 probes up to a total of 12.  
From this importing into ImageJ with no re-sizing to then calculate the exact position of 
each probe as exact X Y co-ordinates. Other data can be retrieved such as centre of mass, a 
built-in function contained within ImageJ, and then diameter of the nuclei, taken in 
multiples across the nuclei going through the centre of mass.  
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Figure 4.13. Multilayer G.gallus chromosome 3 interphase nuclei with schematic 
representation of chromosome folding pattern. 
A) final six layer merged image of typical G.gallus interphase stage nuclei using 
aforementioned probes in table 4.3 in corresponding colours.B) schematic 
representation of signals and nuclear boundary as observed from the final six layer 
merged image, only nuclei are brought to this stage if they exhibit all required signals 
(12, 6x2 chromosomes) C) schematic representation of the nuclear position and 
direction of G.gallus chromosome three in this example after being processed through 
the nuclear predictive path-finding tool.  
After the chromosome path finding tool (explained shortly) had been run, black arrows, 
again seen in figure 4.13, were inserted within Microsoft Design4 to show final 
chromosome orientation and direction between probes used for each chromosome for 
user visualisation. Post path finding, analysis was carried out on a selected population of 
chromosomes/interphase nuclei. From n>50 images each containing from 2~5≤ individual 
nuclei approximately 100≤ nuclei (therefore 200≤ individual chromosomes) were brought 
forward to path finding stage. From this medial length was calculated and inter-quartile 
ranges used as a corrected range of normal nuclei as to account for those nuclei which 
were of incorrect orientation of plain of view, which would yield a dramatically adverse 
total length and morphology. Chromosomes studied that had at least n=50 at this point 





4.3.2 Mechanics of the Path-Finding Tool  
There was a requirement of a means to automatically predict the correct path of two 
chromosomes using all probe signals seen in the interphase nuclei, as manual human 
prediction gave conflicting and debatable results for chromosomes that were localised near 
to one another. Here shown are the underlying mathematical principles used to calculate 
and assign probes to their correct chromosome and therefore path. 
In order to calculate the total number of chromosome pairs that will needed to be 
calculated (where N to be number of chromosomes, and R to be number of probes along a 
single chromosome) firstly the total number of permutations the two chromosomes might 
have using all probes needs to be calculated, to then be divided by number of 




The total length of a chromosome can be represented as the distance from each point 
to the next, starting from the known initial point represented as ‘A’ up to a final point, i.e. 
‘E’ if the experiment uses 5 probes.   
                                                            
As data exists as positional (X,Y) co-ordinates, the distance between the first point 
along the chromosome ‘A’ and the second point ‘B’ can be found using this formula; to be 
repeated for each point pairing.  
                            
However, with each nucleus possessing two chromosomes the total distance needs to 
be calculated twice, using unique probes and their co-ordinates.  
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This ‘total combined’ must be calculated multiple times according to the total 
permutation number first generated, each using a different combination of probes as 









Finally, each ‘total combined’ shall be sorted in order of size and the shortest 
combination selected as the true path of the two chromosomes presented within the 
nucleus, to best represent the path of ‘least resistance’ with two chromosomes of similar 
size.  
Currently, the path-finding tool exists as sheets within Microsoft excel (Microsoft), see 
figure 4.15, where the X Y co-ordinates retrieved from ImageJ can be inserted into 
respective tables and each permutation can be calculated and compared to one another to 
then output two text strings of the correct ordering of probes for the two respective 
chromosomes.  
Figure 4.14. Graphical outlines of three different permutations of the interphase 
chromosome path-finding tool of five probes. 
With a known order of probes; red, yellow, green, aqua and purple, different 
arrangements can be deduced from two sets of probes if no other identifiers are 
present, probes are assigned ‘a’ or ‘b’ and in the case of five probes, 32 permutations 
(16 pairs) are calculated, here 6 (3 pairs) unique permutations are shown.  
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The path-finding tool is currently set up to accept chromosomes with probe count =5 
(32 permutations 16 pairs), =6 (64 permutations and 32 pairs) and although not used =8 

















Figure 4.15. Excel screenshot of working example of the interphase chromosome 
path-plotting tool using a G.gallus chromosome 3. 
Here shown, a working example of previously discussed theory of chromosome 
path-plotting in an interphase nuclei with six probes. With six probes used a total of 64 
permutations (32 pairs) are generated and calculated from inputted co-ordinates 
(ImageJ) and a text string of the correct outcome is displayed, here path ‘aaaaaa’ and 




Figure 4.16.  Multiple multilayer G.gallus interphase nuclei with schematic 
representation of chromosome folding pattern. 
From top to bottom displays a different chromosome (3, 4 and 5) on G.gallus using 
aforementioned probes in previous sections. From left to right, seperations show a 
representation of each different stage in the path finding process. Initially displaying the 
initial merged image to a schematic representative then finals a plotted chromosome 
schematic drawing. Scale bar, 10uM, all images are to the same scale. 
  
4.3.3 Interphase chromosome analysis 
Once interphase chromosomes were correctly associated and given direction (Figure 
4.16), it was then possible to perform analysis to detect any trends in patterns of nuclear 
organisation. Using mathematical and trigonometric means, a high amount of data can be 
retrieved from a rather simplistic methodology from probe positions and little data from 























Whilst data generated is fruitful, patterns and trends relating to nuclear organisation 
remain unclear even using high chromosome count for analysis (n≥50), few trends could be 
concluded. One clear conclusion is that these macrochromosomes generally occupy the 
outer periphery of the nuclei and stay there, consistent with previous reports (Haberman et 
al 2001). Somewhat interestingly, chromosomes examined do show a trend in their folding 
pattern, when chromosome angle is corrected for, which is shown in the next section in 






Figure 4.17. Overview of final schematic interphase nuclei with overlay of data 
marks. 
A fictitious representative example of a single chromosome within an interphase 
nucleus, indicated by five probes (A to E), with regions that data can be obtained from. 
Distance from each probe to the next can be obtained by measuring the distance 
between points(black), Centre of mass can be obtained(yellow), and diameter(black 
dotted) to yield area/perimeter. Probe distance from centre/periphery for territories 
can be measured again by distance of line (light green dotted). Chromosome angles 
between probes and angles around centre of mass can also be obtained (orange). 
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4.3.4 Intricacies of macrochromosome folding.  
4.3.4.1 Normalisation of chromosomes 
In order to process the data generated from fully ‘pathed’ interphase chromosomes, it 
was necessary to normalise the chromosome orientation to the same plane/direction 
rather than being determined by random assortment of where they were on the slide when 
captured, demonstrated in figure 4.16 and figure 4.18. Each chromosome undergoes a 
transformation and rotation, to have identical start positions and identical ‘direction’ for 
first to second probe, then to be ‘flipped’ so that each chromosome path starts ‘forward’ 
along the +X axis and flipped again if required if the third probe resides along the -Y axis so 
that all chromosomes fold ‘left’. These new transformed normalised co-ordinates can now 













Figure 4.18. Graphic example of how to normalise chromosome data for analysis   
A possible chromosome configuration with known order of probes (=5) has unique 
X,Y co-ordinates according to data retrieved from ImageJ. (1)Black, is the initial 
chromosome before translation from original position to new position anchored by first 
point at 0,0. (2) Blue, translated chromosome in same orientation with the first point 
anchored at 0,0 with angle from second point(red circle) to X axis expressed as Θ 
(theta). (3)Green, rotated chromosome about point 0,0 (first probe point) for every 
probe point according to previously discovered Θ to give a final normalised 
chromosome.  (4) Not shown for clarity sake, the chromosome may be flipped if its 
second point (red circle) has ‘-x’ coordinate so all second points are along a 1D plane. 
(5) Again not shown, the chromosome can be flipped again if the third point (purple) 




4.3.4.2 Folding arrangements of G.gallus chromosome 3, 4 and 5 
After normalisation, the most common folding pattern of each chromosome can be 
identified, at least n≥50 individual chromosomes were used and plotted on graphs using 



















Figure 4.19. G.gallus chromosome 3 interphase common folding pattern 
Averaged positions of chromosome probes (table 4.3, 6 probes) for chicken 
chromosome 3 within the nucleus normalised according to figure 4.18. Data points 
shown as mean ±S.E.M. 
Figure 4.20. G.gallus chromosome 4 interphase common folding pattern 
Averaged positions of chromosome probes (table 4.4, 6 probes) for chicken 
chromosome 4 within the nucleus normalised according to figure 4.18. Data points 































Distance from origin, X (pixels) 




























Distance from origin, X (pixels) 











With these selections of chromosomes shown, it appears that interphase stage nuclei 
arrange/fold their chromosomes in particular ways, albeit with a large boundary of 
variation (Figure 4.19, Figure 4.20, and Figure 4.21). With a degree of a defined folding 
pattern, it is interesting to spot possible ‘shapes’ or motifs within each individual 
chromosome studied. 
Both chromosome 3 and chromosome 5 display a ‘horseshoe’ folding pattern with little 
degree of ‘overlapping’ itself.  This resolves in the final probe, the most distal of the q arm, 
on average being a close position as compared to the first probe used here as the anchor at 
0,0 (Figure 4.18, 4.20). Oppositely so, chromosome four does not show as a distinctive 
pattern to fit the ‘horseshoe’ folding motif in respect to closely plotting final probe, 
however it does fit into the narrative consistent with other chromosomes where they all 
fold ‘backwards’ towards the initial on average.  
More analysis has been made to give motions towards some degree of higher 
organisation yet unfortunately lacks the precision to make indications of the respective de-
condensed chromosome interphase structure.  
 
Figure 4.21. G.gallus chromosome 5 interphase common folding pattern 
Averaged positions of chromosome probes (table 4.5, 6 probes) for chicken 
chromosome 5 within the nucleus normalised according to figure 4.18. Data points 
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The multilayer FISH protocol has here been shown to perform concurrent high-quality 
FISH experiments for questioning of cytogenetic evolutionary theories. It is possible to use 
a selection of BAC based probes to analyse and quantify changes and properties of set 
macro-chromosomes within a metaphase stage cell and an interphase stage cell.  Use of 
G.gallus and related Galliform species as models allows robust scrutiny into the 
methodology used as they are reliable well-researched samples opposed to possibly more 
interesting branches of avian life such as previously mentioned Psittaciformes or 
Falconiformes.  
4.4.1 Comparison of measuring techniques  
The method of choice to quantify final merged image data derives from the 
standardised form of FLpter scores (Lichter et al., 1990), the data generated by the FLpter 
script is reliable in other standard FISH but is shown here to introduce a wider variation in 
scores obtained. A somewhat downside to multilayer FISH, this introduces a larger analysis 
time as compared to previous standard methodology to generate the FLpter scores used 
for BAC positioning.  
The issues identified could be attributed to the variation in the metaphase/DAPi layers 
of the images post first hybridisation arising to a small degree of altered metaphase 
morphology as discussed in the previous chapter, yielding incorrect scores.  Whilst long and 
repetitive, manual scoring of the probe positioning is shown here to be accurate with an 
increase of probe count does not cause a dramatic increase in time taken to measure, i.e. 5 
probes is 7 mouse clicks opposed to 6 probes being 8 mouse clicks.  
4.4.2 Detection of chromosomal rearrangements in Galliform 
Results here show that there are oversights, not mistakes, in Galliform 
macrochromosomes studies. Progressing on from an older paint methodology to a newer 
more precise means of BAC based probes, allowed a more in detail analysis of these 
macrochromosomes with predicted intrachromosomal rearrangements.  It is easy to see in 
context of the avian ancestral chromosome 2 (Romanov et al., 2014; Griffin et al., 2007) 
that this multilayered FISH methodology yields complimentary results when presented in 
this way, it is immediately obvious to see that turkey’s ancestral chromosome has 
undergone a ‘clean fission’ to give rise to its chromosome 3 and 6.  
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Other large possible rearrangements can be identified by simply looking at the colour 
order of probes used, such as the single example found in this study being the 
rearrangement within chromosome 2 of Chinese quail, by the reversal of probes D, CH261-
50C15 and, CH261-186J5. This clear rearrangement is not shared with any other member of 
the galliform group tested, which is interesting in context of both Japanese and Chinese 
quail showing that there are further detailed rearrangements within the old world quails, 
possibly adding evidence into the reclassification of Chinese quail into the Excalfactoria 
genus away from the general grouping of Coturnix (Crowe et al., 2006, Christidis & Boles, 
2008) 
This method also shows smaller changes across the chromosomes tested, such as 
across chromosome 4, Japanese quail expresses an increase of FLPter scoring for the first 
two probes used, a possible shift of DNA around the P-arm of this chromosome, yet returns 
to match up with the reference G.gallus. Again, Chinese quail seemingly differs from its 
closest relation in this study as this quail instead has identical first two probe positions as 
chicken, yet the later four signals score much lower FLPter values possibly indicating a shift 
of material to the Q terminus of the chromosome as the ratio between signals is consistent 
across species.  
Results demonstrated here show that there is much more going on within the macro-
chromosomes of the Galliformes and should not be neglected for study in favour of the 
‘more interesting’ microchromosomes.  
It is plausible to relate this methodology of chromosome positioning in the nucleus to 
chromosome conformation capture technologies such as Hi-C. These capturing 
technologies quantify the interactions between elements of chromatin that are nearby in 
the 3-D space of the nuclei yet may be a vast distances apart on the actual linear genome 
(Dostie and Bickmore, 2012). Hi-C can be used to detect balanced and unbalanced 
chromosome rearrangements, copy number variants and does not require the expense of 
whole genome sequencing to detect these rearrangements at the whole chromosome level 
arguably more useful than at a breakpoint level (Harewood, 2017). It would not be correct 
to suggest that either method should replace the other. Hi-C methodologies are typically 
verified and reinforced by FISH studies (Harewood, 2017). Hi-C methods require extensive 
library preparation to perform along with the computational knowledge required to 
perform and interpret. With the now reduction of cost and increased through put of FISH 
via multilayer FISH we could suggest that the 3D arrangement of a chromosome of interest 
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could be determined by both FISH and Hi-C methodologies rather than FISH used for 
verification. This would allow costs to be saved for an already established cytogenetics lab 
and allow them to get a foothold into the realm of nuclear 3D mapping and cellular 
specialisations.  
4.4.3 The Chromosome Interphase Plotter 
Here is a demonstration that is possible to adapt the multilayer FISH methodology to 
give an insight towards the structure and positioning of chromosomes in their de-
condensed interphase state. As shown, it is now possible to use this methodology and 
attached post-merging analysis to correctly path chromosomes within an interphase 
nucleus to then yield vast amounts of information about the condition of said 
chromosomes in its interphase state.  
4.4.3.1 Mechanics of the Path-Finding Tool  
The computational analysis of the path finding tool is currently in the form of vast excel 
sheets and formulas which is currently limited to 5 to 8 probes, and only two 
chromosomes. The mathematical formulas used seemingly provide an accurate means to 
calculate and therefore represent the two chromosomes within the nuclei using all probe 
signals after being given co-ordinate details via the user which has been retrieved from 
ImageJ. A lengthy task indeed, considering each nucleus has approximately 10/12 probe 
signals representing two chromosomes, and nucleus count can exceed the 100’s, a possible 
justification towards an automated means of performing this task. To apply this further for 
other questions, in the event of aneuploidy, or to be more precise polysomy, an increase in 
the ploidy of the sample would cause the underlying mathematics to change, currently not 
possible in this version of the path finding tool. As an example, a ploidy of 3n for the 
chromosome of examination would increase the number of signals from 12 to 18 using a six 
probe series, using the initial permutation equation (nr) we would have to compute 729 
individual permutations, to be separated into 243 trios. To lower this task with fewer 
probes would reduce accuracy and information given to the user so it would become 






4.4.3.2 Folding arrangements of chromosomes 
Here it is demonstrated that there is an observable pattern of chicken macro-
chromosome arrangement of which this level is not yet reported. Data aligns with the 
proposal that macro-chromosomes exhibit a peripheral territory bias (Haberman, 2001) yet 
here this method reinforces that by indicating that the whole chromosome stays in the 
external region yet some terminus located probes tend to either occupy a more central or 
more peripheral location as compared to the rest of their chromosome indicating a 
‘bending’ or a horseshoe shape back towards the initial probe point, i.e. one telomere 
‘curves’ backwards towards the telomere at the end of the opposing arm. Yet these 
findings require data to reinforce these trends, as currently there is only a poor means to 
calculate the direction of bending involved to determine if there is a tendency to bend 
inwards or outwards in respect to nuclear location. A methodology that requires more 
mathematical and possibly probability prediction means to see if there is any significant 
patterns of this observable trend.  More hypothesises have been tested using data 
obtained in this study from nuclear positioning (hypothesises tested in table 4.7). However 
due to the lack of consistent data only weak assumptions can be made but nonetheless are 
possible avenues for future work.  
4.4.3.3 The means to predict an unknown order 
Although not tested explicitly, it is possible to give an interpretation on how this 
method may be applied to a sample with unknown metaphase/karyotype and merely rely 
on FISH signals shown within an interphase preparation.  This changes the underlying 
mathematical principles where going from an ordered list of objects to an unordered list, 
the formula changes to;  
                                     
From this equation, repeating above experiments would yield, for 5 probes 3840 
permutations compared to 32 and for 6 probes 46,080 permutations as compared to 64 
and up to 8 (being the current limit) is 10,321,920 permutations as compared to 256, all far 
beyond the capacity of a spreadsheet. 
To work in reverse, it would be possible to compare signals seen to determine whether 
the chromosome in question is of same properties and therefore order to that of a 
reference, in this case chicken. This will negate the need to perform mathematical 
calculations as you would apply the known set order of chicken to the unknown sample 
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species and statistically determine if the patterns are the same, i.e. Length of chromosome 
or possibly folding pattern, if there were dramatic changes we could presume the order of 
the unknown sample’s chromosome in question is different to that of the reference. 
Regardless, this will require a substantial level of detail and further work beyond the 
scope that this thesis provides. 
4.4.3.4 Limitations of Interphase studies 
The first issue revolves around the fact that interphase nuclei are 3D structures, 
flattened down by the process of FISH. This requires many images to be taken to get a fair 
representation of the structure of the chromosome inside of the cell. Also there is the issue 
of the time of fixing of the cell, as all the DNA is in its de-condensed form, there will be 
variation between cells of transcriptional activity at the DNA level causing a possible shift of 
physical arrangement as areas are unwrapped/re-condensed as the cell requires to allow 
this mentioned transcriptional level of activity on the DNA for multiple cellular functions. 
These points direct towards variability within the nuclei, and where there is uncontrollable 
variability comes questionable conclusions that require changes to methodology to rectify. 
Understanding that this is a 2D study to represent a 3D space ultimately reduces the 
usefulness of the trends found within this study, yet acts as a good initial insight into 
further way to understand delicate highly organised chromatin structure. Again in 
reference to previous, Hi-C methods could be used along side FISH interphase studies to 
verify results. 
4.5 Conclusion 
The multilayer methodology has enabled the easy comparison of intrachromosomal 
rearrangements between multiple closely related species showing previously undiscovered 
rearrangements that previous studies have failed to find via other methodologies.  Shown 
within the Galliform study, the stark similarity between member species of this order is 
represented within their conserved macrochromosomes. However with more specific 
fluorescent methodologies (the combination of the multilayer method paired with the 
probe point plots) shows that previously overlooked and somewhat ‘presumably 
conserved’ chromosomes are worthwhile to investigate.  The selection of the Galliform 
order for this study was somewhat chosen as a ‘safe’ order for the multilayer methodology 
to be tested upon, whilst answering previously overlooked arrangements. However as the 
success of results shown here, there is plausibility that this approach be applied to other 
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species, avian or not, for other unexplored intrachromosomal rearrangements. As seen in 
the previous chapter, it is plausible that an increase of layers/probes could be applied to 
high quality prepared samples. This would allow more in-depth studies into specific 
chromosomes, or a panel of microchromosomes, for more precise re-arrangements to 
further our understanding of phylogenetic divergence as consequence of chromosomal 
changes. 
The successful adaptation of the multilayer methodology to form an interphase 
chromosome point plotter for chromosomal nuclear arrangement has been an unexpected 
outcome of mlFISH.  With creation of multiple extensive excel sheets it was possible to 
create a predictive means of assigning probes to chromosomes, then the easy analysis of 
said chromosomes within ImageJ/Excel to detect folding arrangements. Due to the nature 
of interphase mlFISH, there is an observed higher dropout of individual nuclei as compared 
to metaphases (personally found/presumed to be cytoplasmic connective remnants from 
the hypotonic isolation of genetic material linking nuclei together more so than metaphase 
chromosomes). However as there is an overabundance of interphase nuclei in samples as 
compared to metaphases this may not be too drastic of a drawback.  
Recommendations for further work in light of results generated within this chapter are 
as follows. Currently all ‘software’ elements of interphase prediction exist within excel 
sheets as formulas with input from ImageJ. With a more experienced user of ImageJ or a 
proficient user of a computer language (I would recommend Java due to cross-capabilities 
with ImageJ and SmartCapture) the generation of a succinct script/plug-in would allow the 
ease of use for further studies (such as hypothesised in table 4.7).   
With adaptation into a more computational automated system, more advanced 
algorithms can be generated that can improve current limitations, such as; increasing the 
number of signals upon a single chromosome, an increase in ploidy which would be useful 
for plant or cancer studies and the aforementioned prediction of an unknown gene order 
where many permutations will exist.  Applying these principles towards research in a 3D 
nuclei opposed to a randomly positioned flattened 2D nuclei would extraordinarily increase 
the potential use of this methodology. With an extra dimension brings extra co-ordinates, 
and more mathematical functions. However this would allow a reduced number of 
interphase to be imaged due to orientation being less of an issue which typically eliminates 
many chromosomes for study.  The multilayer methodology as outlined in the previous 
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chapter should be adaptable to a 3D system in terms of multiple layers, but this would 
require extensive testing and refinement as 3D imaging hardware is expensive.  
Hypothesis Data used Outcome 
Does length of metaphase 
chromosome correlate to 
interphase length? 
Distances from each individual 
probe point to the next – total 
length 
Very weak correlation after 
correction for not true 
terminus locations i.e. 
interphase shows true 
chromosome end where ‘First’ 
probe point does not equal 
start of chromosome 
Are the distances between 
each point in the same ratio? 
Individual probe locations, 
therefore distances 
Minimal trend, probes do tend 
to have similar distances 
between them, but requires 
more data such as angles to 
ratify   
Is there a consistent intra-
chromosomal angle seen 
between set probes? 
Generation and measurement 
of angles around ‘mid’ probes, 
angle count =probe count -2  
Angles seemingly do not follow 
a pattern unless correlated 
with their length and 
orientation, to reflect solely on 
angles will generate 
inconsistent conclusions.  
Are chromosomes in a set 
‘angle’ within the nuclei? 
Generation of angle from 
centre of mass to probe, using 
a false periphery point as 
reference to draw angle from.  
With no way to pre-orientate 
nuclei, chromosomes 
seemingly occupy a random 
territory when testing this 
hypothesis.  
Does nuclei size affect 
chromosome length? 
Total chromosome length, with 
area/perimeter derived from 
diameter measurements 
Nuclei tend to be a set range of 
sizes and chromosomes tend to 
be a set range of sizes, a very 
weak positive trend can be see 
but with very low R
2
 scores, 
0.037 for chromosome 5 
Does the chromosome occupy 
a peripheral territory? 
Distance from centre of mass to 
each point along the 
chromosome.  Diameter of 
nuclei as a scale of 0 to 1. 
A rather wide territory region, 
yet it is relatively more external 
than internal, occupies outer 
50% of the area of the nuclei, 
e.g. chromosome 4 averages 
from 60% ~75% ±20% S.E.M 
Are there any particular points 
of the chromosome that 
occupy a more peripheral or 
internal region? 
Distance from centre of mass to 
each point along the 
chromosome.  
Weak indications towards 
some points preferring a 
variation caused by a ‘bending’ 
of chromosome as previously 
discussed.  Requires means to 
quantify level of bend and 
direction of bend to further 
determine favourable regions.  
 
5. Rapid analysis of the karyotype of DT40 (Specific aim  
Table 4.7. Minor hypotheses tested within the interphase study  
Various questions that the multilayer methodology could provide data for in 
exploration of chromosome arrangement within interphase nuclei. Each hypothesis 
indicates what data is used to answer the question gained from the same sample, and 
the relevant outcome that the data sourced within this study resolves as.  
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5.1 The characteristics of DT40 
Identifying chromosome aberrations is an essential step in tackling questions regarding 
genome stability which in turn allows the ability to question other fundamental essential 
cellular steps such as correct cellular division, chromosome inheritance, cell death or 
inability to initiate cellular death. As well established, fluorescent probes are vital for the 
characterization of the chromosomally erroneous. From humans to farm stock and onto 
other species of interest, it is important to characterise chromosomes in the event of 
individuals’ fertility or alternatively in the event of an aberrant cell line.  
The use of the DT40 cell line with its ease of genetic manipulability allows it to be used 
in a large variety of cellular questions, examples of which include structural analysis of the 
BRCA2 gene (Warren et al., 2002), sister chromatid exchange mediation (Sonoda et al 
1998), infectious viral disease binding (Chi 2018) and B-cell receptor signalling (Yasuda & 
Yamamoto, 2004).  
The DT40 cell line is a chicken bursal lymphoma induced by the avian leukosis virus 
(Baba & Humphries, 1984; Baba, 1985), cells carry IgM on their surface (Baba, 1985) and 
have a disruption in the c-myc locus typical of avian leukosis viral infection. DT40 has 
integrated the viral long terminal repeat upstream of the myc-c gene (Hayward, 1981; 
Westaway et al., 1984) and is in the same orientation of c-myc thus causing an increase of 
transcription levels (Linial, 1985). The myc-c locus is found upon chicken chromosome 2.  In 
the context of human cancer, the myc-c proto-oncogene is persistently expressed in many 
cancers and imperative in the formation of Burkit lymphoma as a common chromosomal 
translocation between chromosome 8 (location of myc-c) and chromosome 14 causing an 
over expression (Finver, 1988), drawing parallels to the up regulation seen in DT40.  
 Initially, the DT40 cell line has been known to display a stable karyotype with a trisomy 
of chromosome 2 an extra unidentified microchromosme to give a karyotype of 2n=80 
(Sonoda et al., 1998) although further work has identified variation to this previous 
karyotype and a degree of cytogenetic mosaicism (Chang & Delany, 2004). Cheng and 
Delany argue that there is variation seen to chromosome number and structure based 
upon source of cells and means of growth environment. They agree with the trisomy of 
chromosome 2 they identify a monosomy for chromosome 4 and a ‘4p’ variant and insist 
that this cytogenetic instability has the probable outcome for inaccurate results and 
interpretations using this cell line for investigations. More recently (Molnár et al., 2014) 
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proposes instead that DT40 has a relatively intact genome and suited as a model cell line 
for DNA based investigations attributed to different culture conditions or a stabilisation of 
the karyotype.  
Chang and Delany use a karyotype approach opposed to Molnár who uses whole 
genome shotgun sequencing and single nucleotide polymorphism array hybridisation, 
neither using FISH as a means of verification of their findings. As previously discussed 
(1.3.4) and in light of the multiple examples of human cancers characterised by 
chromosomal aberrations and translocations, it is not sufficient to simply indicate that 
there is a loss or gain of genetic material without identifying their location and structure 
especially as the uniqueness of human cancers are revealed to us and the need for a more 
personalised approach. An example of this is the generation of resistant cell lines which 
shall be introduced in the next chapter. This chapter aims to better characterise the cell 
line DT40 with precise cytogenetic information and the verification of previous claims via 
the multilayer FISH technique. 
 
Thus, as per the aim 3 set out in section 1.5, questions aimed to be answered in this 
chapter are as follows; 
1. How well can we characterise the DT40 cell line genome, using a pre-set FISH based 
device improved with the multilayer method, to detect heterogeneity and novel 
chromosome aberrations 
2. In light of the multilayer method, how well can we compare to old genomic data 









Figure 5.1. Organisation and false colouration of the multiprobe device and glass 
slide orientation used in this study 
A representation of the glass cover slip of 24 ‘boxes’ used with corresponding pre-
dried on probe in either FITC (green/Yellow) Texas red (red/purple) or Aqua 
spectra(aqua).  The boxes containing aqua are all whole chromosome paints (Chr. 1-9 
+Z) and the rest are subtelomeric probes. The top left number in each box represents 
the first layer, coloured in the previously used way of green/red; and in the bottom 
right, is the chromosome probed in the second layer when the device has been inverted 
falsely coloured yellow and purple. Note that pairings repeat after 12 boxes to give the 
same pair yet with inverted probe fluorochrome, in this event the false colouration has 
been applied to the colours shown. 
5.2 The Multiprobe Chicken device plan 
The chromoprobe multiprobe device (Cytocell) with pre-dried probes in either FITC, 
Texas Red or Aqua spectra allows the simultaneous hybridisation of near every 
chromosome of the chicken genome, barring the not yet fully described D group. In this 
section, the multilayer methodology was implemented by first hybridising and capturing 
metaphases using the multiprobe device as outlined by the manufacturer, then adding the 
second layer by inversion of the device onto the same slide and therefore metaphase 

















5.3 DT40 FISH results 
After successful FISH, images were merged and assigned into 12 pairs, due to the 
symmetrical nature of the device (Figure 5.1), and assigned false coloration to be then 
analysed. Analysis includes the identification of chromosome abnormalities, such as 
translocations, and chromosome copy numbers.  
Chromosome Result  Chromosome Result 
1 Normal  16 Normal 
2 3 Copies  17 Normal 
3 Normal  18 Normal 
4 Normal  19 Normal 
5 Normal  20 Robertsonian translocation 
6 Normal  21 Normal 
7 Normal;ins/dup(2)(?pter)  22 Normal 
8 Normal  23 Normal 
9 Normal  24 4 Copies 
10 Normal  25 Normal 
11 Normal  26 Normal 
12 Normal  27 Normal 




14 Normal  Z Normal 
15 Normal  W Normal 
 
 
FISH results conclude that there is a trisomy of chicken chromosome 2, the same as 
reported in multiple previous studies (Figure 5.4).  Chromosome 7 appears to be normal, 
yet there is a noticeable portion of signal (red) present on another single 
macrochromosome (possibly Zq) indicating a possible translocation or duplication of a 
short region (Figure 5.5). 
Table 5.1. Summary of chromosomal aberrations identified via FISH in DT40 
Chromosome and associated result from the multilayer FISH strategy, 




Chromosome 20 expresses a single normal copy and a duplicated inverted conjoined 
chromosome, possibly representing a Robertsonian fusion on the same chromosome, 
which would effectively resemble a trisomy of 20 (Figure 5.4). Chromosome 24 was seen to 
have a tetrasomy in all metaphases viewed (Figure 5.3). Chromosome 28 has seemingly lost 
a single copy and the other has undergone a fission event to split and fuse the P-terminus 
and presumed arm to a macrochromosome and the q-terminus and presumed associated 
arm has fused to a large undistinguishable microchromosome (Figure 5.2) 
In reference to the sex chromosomes, the sample was previously reported as a female 
expressing a ZW genotype with reports of a subset of ZZW cells present in some cell lines 
(Wang and Leung 2002). Here whole chromosome paints reveal a universal ZW genotype 
with a fully intact W in every metaphase analysed.  Image results follow in respect to the 
order they were retrieved on the device post FISH analysis (Figure 5.1). 














Figure 5.2. Chicken chromosome 11 and 28 FISH results on a DT40 metaphase 
Chicken subtelomeric probes hybridised onto a DT40 metaphase; Green 11p, Red 
11Q, Yellow 28p, Purple 28q. Chromosome 11 presents normally.  There has been a 
whole chromosome deletion for 28 and the remaining chromatid has split to fuse its p 
and q terminuses onto distal ends of macrochromosomes. 
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Figure 5.3. Chicken chromosome 15 and 24 FISH results on a DT40 metaphase 
Chicken subtelomeric probes hybridised onto a DT40 metaphase; Green 15, Red 
15q, Yellow 24p, Purple 24q.  Chromosome 15 is shown to be normal whereas 
chromosome 24 shows four typical chromosome signals indicating that there are four 
copies of this chromosome.  
Figure 5.4. Chicken chromosomes 2, 5, 8 and 20 FISH results on a DT40 metaphase 
Chicken subtelomeric probes and paints hybridised onto a DT40 metaphase; Green 
2 whole chromosome paint, Red 5 whole chromosome paint, Yellow 20p, Purple 20q 
and Aqua, 8 whole chromosome paint. Chromosome 2 presents as a trisomy, and one 
copy of chromosome 20 exists as a Robertsonian translocation. 
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Figure 5.5. Chicken chromosomes 6, 7, 9 and 19 FISH results on a DT40 metaphase 
Chicken subtelomeric probes and paints hybridised onto a DT40 metaphase; Green 
6 whole chromosome paint, Red 7 whole chromosome paint, Yellow 19p, Purple 19q 
and aqua 9 whole chromosome paint. Chromosomes all appear normal except for an 
insert from chromosome 7 on a single macrochromosome.  
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5.4 DT40 karyotype results 
5.4.1 The state of metaphases 
To karyotype avian metaphases are a difficult but albeit possible task with the use of 
DAPi and Propidium iodide for complete stain and coverage of all macro and 
microchromosomes. Demonstrated here, with the aid of FISH results, multiple metaphases 
of good quality were imaged and analysed via SmartType (Digital Scientific UK).  
Full chromosome counts were established with all macrochromosomes correctly 
identified and the microchromosomes, lacking defining specific features to characterise, 
assigned as a collective count. Chromosome count thus far has been totalled to average at 
79.76 (n=30) with the modal count being 78 at 30% of the total population, as represented 














Figure 5.6. An exemplar DT40 metaphase observed 
A typical singular DT40 metaphase spread with 3 interphase nuclei in the periphery. 
The slide is stained with DAPi (white) and propidium iodide (red) to give a distinct 
banding pattern. Note presence of barely detectable microchromosomes and count of 
large macro-chromosomes in retrospect of FISH results. 
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5.4.2 The state of the karyotype  
As previously stated, the average chromosome count of the DT40 cell line was 
calculated at 2n= 79.76 with modal count at 2n=78 representing 30% of the population, 
Figure 5.7 shows this breakdown of counts in more detail. Only three metaphases were 
above previously reported count of 2n=80 (2n= 81, 124 and 131), and the rest under 80, 
there were no metaphases observed with a count of exactly 80 chromosomes. Consistently, 
in light of and complementary FISH results, observed were three chromosome 2s, four 
copies of microchromosome 24s and a monosomy of chromosome 18. In terms of 
macrochromosomes (1-8), all samples karyotyped and observed via FISH had consistent 
macrochromosome counts and features. However analysis of the post chromosome 28 
group was not possible by FISH, this group was determined by size of chromosomes within 
a karyotype (Figure 5.6, Figure 5.7 and Figure 5.8). 
From karyotype analysis, no clear sub-populations were able to be distinguished. Clear 
divisions of metaphase’s were seen with comparable total chromosome count (again 30% 
of all metaphases analysed had 2n=78, and other chromosome counts had 10%-15% of the 
population, Figure 5.6 and Figure 5.7), however due to the nature of microchromosomes 






















































Figure 5.7. Full chromosome count and frequency for karyotyped DT40 
metaphases 
DT40 metaphases karyotyped via staining with DAPi and Propidium Iodide using 
SmartType (Digital Scientific) software for analysis.  
A) Chromosome counts for individual metaphases. Normal G.gallus N=78 is 
highlighted in the black horizontal dotted line with individual metaphase chromosome 
counts from the DT40 cell line being shown 
B) Frequency of total metaphases grouped by chromosome count of 


























































































































































































































































































































































5.4.3 The State of heterogeneity and microchromosomes 
Within the population of DT40 cells investigated, there are somewhat conflicting 
results in terms of heterogeneity. In light of FISH results, there was no evidence of 
alternating chromosome state/morphology on a cell to cell basis; all signals seen were 
consistent with one another across all metaphases. The multilayer approach allowed 
singular cells to be investigated further with use of the chromoprobe being inverted to gain 
a better observational depth on a single cell level which identified no chromosomal 
deviations. However, within the analysis of metaphases via karyotyping there is an 
observable range of chromosomal counts present throughout the population, thus 
indicating some plausible degree of heterogeneity. With the macrochromosomes being 
consistent in number and features, the heterogeneity displayed must resolve in the 
microchromosomes.  
The microchromosomes vary in number from sample to sample, however during FISH 
analysis there was no observed variation of microchromosomes probed. In respect to both 
methodologies, the heterogeneity seen within the DT40 cell line must be concluded to arise 
from variation within the smallest of the microchromosomes, 29-35. To predict the 
behaviour and possible aberration features these chromosomes possess is not within 
capabilities of this study, as currently consistent BAC probes for these chromosomes are 
not available for this style of testing.  
 
5.4.4 Final cytogenetic assignment  
 
2n, ≈ 78, ZW, 









Using the multilayer methodology with a high quality chromoprobe device has allowed 
the formulation of a new karyotype and further classification of previously identified 
mutations (Sonoda et al., 1998, Chang & Delany 2004, Molnár et al., 2014). These previous 
reports have correctly identified the majority of aberrations seen within this study, such as 
the trisomy of chromosome 2. However these reports lack depth and precise description of 
these malformations seen as a result of their methodologies. 
Results here are consistent with the above-mentioned chromosome 2 trisomy and the 
tetrasomy in chromosome 24. Molnár correctly identifies the effective trisomy 20 present 
within the cell line, yet FISH results further details this by indication that this is due to one 
normal 20 and a Robertsonian translocation involving two other chromosome 20’s, 
rob(20;20)(p;p). This immediately stands out as a downfall of virtual genotyping where 
important chromosomal aberrations such as this are missed which may have been of 
importance of the characteristics of the DT40 cell line. By presuming a trisomy of 
chromosome 20, it would have also inferred an incorrect assignment of 
microchromosomes to then not be reflected in the total chromosome number seen. 
Furthermore, in reference to previous studies, multiple previously reported aberrations 
were not observed. Chromosome aberrations not seen within this study were the trisomy 
of chromosome 14, the ZZW sex chromosome variant or a mosaicism of an ‘alternative 4p’.  
With very little heterogeneity previously reported, barring the ZZW/4p variants, 
somewhat interestingly this study has eluded that there may be an underlying variation as 
highlighted by karyotype results within the microchromosomes. With this inconsistency 
observed in total chromosome count, with constant macrochromosome count/assignment, 
the smallest microchromosomes must be culprit for this phenomenon as mentioned in 
section 5.4.3.  
Results obtained may be specific to the DT40 cell line studied here, it is plausible that 
other laboratories have had various derivative clones used instead, which may possess the 
chromosomal variants. This has been well documented as seen in karyotypic heterogeneity 
(Worton 1978) and functional heterogeneity (Davies, 2013) in CHO cells to give rise to 
useful functional variants. However, variants may not give rise to useful sub clones and 
instead cause mass variation in cellular cultures used across laboratories to affect 
transcriptome, proteome and phenotypic responses of cells. This has been found within 
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HeLa cells taken from 13 international laboratories implicating proving evidence towards 
this reproducibility issue (Liu, 2019). With heterogeneity brings variation and therefore an 
inability to reliably replicate results, this causes questioning into the findings obtained from 
cultured cells. It would be expected if DT40 cell lines that have undergone many successive 
passages from other laboratories or stocks to have somewhat of a heterogenic element, 
but how this implicates upon expression of the ‘usefulness’ of the cell line needs to be 
explored via multi-omic studies. 
Karyotyping microchromosomes is an arduous process in a typical avian organism, let 
alone with an aberrated cell line; so this must be taken into consideration when 
referencing karyotypic conclusions. The complete deletion of the microchromosomes is 
somewhat hard to use as a valid conclusion for results seen due to the high gene density 
observed within these microchromosomes (Burt, 2005; Smith, 2000). It is entirely plausible 
that these microchromosomes have instead of being lost in deletion events, have 
undergone fusion/translocation events with the larger macrochromosomes which would 
not be detected within the confines of this study. One must reflect on methodology used 
and if results presented here are in fact artefacts caused by the karyotyping method and 
user error. Henceforth are alternatives to the methodology that could be used in future 
studies when other obstacles have been overcome.  
As mentioned the lack of reliable probes specific for the ‘D’ group subtelomeric regions 
prevents usage in the typical multilayer FISH way of incremental probes on chromosomes 
of interest. With access to these probes, it would be entirely possible to step-wise probe 
along the macrochromosomes, in a similar fashion to section 4.2.2, to question the 
hypothesis of microchromosomes fused to alternative larger chromosomes. The use of the 
chromoprobe device clearly aided in speed and reliability of results when testing this large 
quantity of chromosomes yet it also acts somewhat as a limiting factor. Indeed, the 
reversal of the device does cause a repetition of probe pairings across the device, however 
this is somewhat beneficial as it effectively doubles up the quantity of metaphases able to 
be analysed which relates to the study of heterogeneity. The use of custom devices would 
understandably increase the usefulness of the multilayer technique here as it could be 
designed with more layers in mind to deepen the resolution in regards to the cell by cell 
approach this method currently provides. However, this is entirely possible if the user has 
access to a large panel of probes that detail every locus within the chicken genome that the 
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device becomes redundant and even wasteful if only specific chromosomes are required 
for investigation.  
On the oncogenic properties of aberrations detailed, it is understood that the DT40 cell 
line has metastatic properties, as is able to form distal tumours in immunosupressed chicks, 
so there must be a degree of tumorigenic mutation or deregulation within ontogenetic 
promoting/suppressing factors regarding cell regulation, prevention of apoptosis and 
metastatic capabilities. The proto-oncogene myc-c is found on chromosome 2 of the 
chicken, with similar functionality as human of the regulation of approximately 15% of all 
genes (Gearheart et al., 2007), and unsurprisingly the DT40 cell line expresses chromosome 
2 in triplicate, possibly increasing the dosage of this regulator to have tumorigenic 
properties.  Commonly in ALV induced tumours, there is an association with the hybrid 
oncogenic protein gag-myc (Watson et al., 1983; Chesters et al., 2001; Law et al., 2001). To 
correctly determine genome aberration as the causative reason for gag-myc, such as 
translocation/viral insertion onto the myc-c reading frame, within the three copies of 
chromosome 2 an incremental BAC approach along the typical myc-c region could be 
performed to detect malformations.  
5.6 Conclusion 
As current reagents and equipment are limiting factors to provide a concise valid final 
cytogenetic assignment of the DT40 cell line; ultimately, the refinement and identification 
of aberrations, along with a modern interpretation of its karyotype via the multilayer 
technique has improved the current understanding of this cell line. Unfortunately the ‘D’ 
microchromosome group (29-38) still eludes us and such this study is limited in its scope of 
a complete characterisation of DT40, yet this can easily be incorporated into the multilayer 
methodology at a later time. Nevertheless, this study has shown that DT40 is a rather 
reliable stable model cell line and should be of further use to the scientific community not 
only for its capability for easy genetic manipulation of DNA integration ratio but for 
oncogenic studies as well.  
One interesting avenue would be the possible oncogenic properties of aberrations 
identified, such as the tetrasomy of chromosome 24 and the effects of that dosage level on 
cellular function, or the differences a trisomy compared to a structural trisomy as seen 
within this cell line in regards to chromosome 20 where dosages of gene products might be 
near identical. Overall, this methodology has given new insights into the cytogenetic 
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makeup of the DT40 cell line and new questions can be asked about how these specific 
aberrations attribute to its oncogenicity.   
Use of the multilayer methodology has allowed easy analysis of this cell line and the 
generation of a new updated karyotype. Furthermore, this methodology has clear 
capabilities to classify cancer cell lines which may exhibit a wider variety of intra-tumour 
heterogeneity, such as in the example of cytotoxic drug resistances which is a topic of 


















6. Cytogenetic assignment of resistant neuroblastomas 
by chromosomal aberration detection (Specific aim 4) 
6.1 Cancer cytogenetic studies thus far  
6.1.1 Cancer aberrations 
It has been well known and discussed, that tumour cells exhibit chromosomal 
aberrations (Solomon et al., 1991) Error such as aneuploidy or an increase in ploidy number 
has the consequences of an imbalanced dosage of genes, such as a gain of oncogenes or a 
decrease/loss of tumour suppressor genes (Savage, 1999). See section 1.1.4 and 1.3.2.3 for 
more information.  
Chromosomal aberrations increase the tendency to form particular types of 
malignancies, as they could cause the deregulation of genes to act as the basis of the 
progression of a normal cell into a cancerous cell. This theme has been greatly explored 
(Mitelman, 2005; Van Gent et al., 2001). As an example, chromosomal aberrations events 
could give rise to a repositioning of an oncogene within the regulatory parameters of 
another gene, such as in the case of the famous Philadelphia chromosome. The 
Philadelphia chromosome, a translocation between chromosome 9 and 22, 
t(9;22)(q34;q11), results in the fusion protein BCR-ABL to cause the uncontrolled 
replication of the cell and its genome leading onto a cancerous cell,  found in chronic 
myeloid leukaemia, (Shteper & Ben-Yehuda, 2001) and imatinib resistant leukaemia’s 
(Talpaz et al., 2006). Other examples include large scale deletions, as in a typical cancer 
25% of the genome is thought to be affected by arm-level deletion events (Beroukhim et 
al., 2010). The deletion of large segments of chromosomes will cause a loss of 
hetrozygosity; the genes contained in the lost segments are deleted hemizygously causing a 
shift in cellular product dosage (Dong, 2001; Solimini et al., 2012). This loss of hetrozygosity 
may not directly infer an oncogenesis event, yet may contribute to the malignant 
phenotype of an already cancerous cell (Cox et al., 2005; Bignell et al., 2010), an example of 
which can be described by deletion of 8p. The short arm of chromosome 8 is a common 
aberration found within cancers originating from epithelial tissue such as breast cancers 
and is linked to poor prognosis (Yarernko et al., 1995; Lebok et al., 2015). The loss of 
hetrozygosity disrupts the dosage of genes that negatively regulate cell growth (possible 
tumour suppressor genes), examples of which are MTUS1 and TUCS3, and also essential 
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genes that promote cell growth, CLU and PTK2B (Tabares-Seisdedos & Rubenstein, 2009; 
Solimini et al., 2012). With the loss of positive and negative genes associated with cell 
proliferation is presumed to balance one another out, no change in tumorigenic 
transformation. However, the loss of hetrozygosity and therefore the allelic loss of other 8p 
genes give rise to a shift in lipid metabolism to increase metastatic potential and resistant 
to hypoxic conditions, further promoting the survival of these cancerous cells (Cai et al., 
2016). 
6.1.2 Neuroblastoma 
Neuroblastoma is classified as a type of cancer that originates from immature nervous 
tissue, neuroblasts, typically in the adrenal glands but can also be found in the neck chest 
or spinal cord. Neuroblastoma is the most common cancer in newborns and the third most 
prevalent in children (Maris et al., 2007). The direct cause of neuroblastoma is viewed to be 
caused by genetic mutations inherited or present during development and birth, compared 
to causes such as environmental tumorigenic events. Key gene mutations and aberrations 
have been identified thus far as possible causes or contributing factors towards the 
development of neuroblastoma, such as in anaplastic lymphoma kinase (ALK) (Mossé et al., 
2008), KIF1B, amplification of the MYCN oncogene (Brodeur et al., 1984), duplicated 
segments of the LMO1 gene (Wang et al., 2011) and copy number variation of the NBPF10 
gene (Diskin, 2009).  
Via array-based virtual karyotyping (section 1.1.5.4), neuroblastoma tumours of 
differing lethality- governed by survival rates- could be assessed (Janoueix-Lerosey et al., 
2009). Tumours which show whole chromosome copy number variants are correlated with 
high survival rates, a segmented chromosome copy number changes decrease survival and 
the worst survival rates correlate with key aberrations such as MYCN amplification and 
specific chromosomal arm deletions (Michels et al., 2006). 
Cancerous cell lines have been experimentally used to generate resistances to currently 
used cytotoxic drugs in order to identify mechanisms of resistance, sensitivity to other 
drugs and biomarkers specific to the acquired drug resistance (Domingo-Domenech et al., 
2012; Zahreddine et al., 2014; Göllner et al., 2017).  Examples of findings specific to 
neuroblastoma include the generations of sub-lines which have gained resistance to MDM2 
inhibitors, found to be results of p53 mutations (Michaelis et al., 2011; Michaelis et al., 
2012a). More so, mechanisms behind varied drug resistances for the UKF-NB-3 cell line 
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(section 2.1.2.3) has been documented alongside key chromosome aberrations found via 
karyotyping and SKY (Kotchetkov., 2005; Michaelis et al., 2012b) with more information to 
resistance mechanisms and aberrations as compared to the closely related UKF-NB-2 and 
UKF-NB-4 cell lines (Kotchetkov, 2005; Bedrnicek et al., 2005). 
6.1.3 Cancer cytogenetics of past and present 
The use of G or R banding techniques was soon sequestered by the rise of 
fluorescence-based hybridisation techniques such as FISH, m-FISH (Jentsch et al., 2001), 
spectral karyotyping (SKY) (Liyanage et al., 1996), comparative genomic hybridisation (CGH) 
(Kallioniemi et al., 1992) and array-CGH (see section 1.1.5 for details on these methods). 
The arrival of high throughput methods, commonly known as next generation sequencing, 
allowed whole genomes to be sequenced in a quick, inexpensive and automated process in 
vast parallel quantities (Grada & Weinbrecht, 2013). However, over the past 20 years that 
these techniques have been available, they have not gained popularity due to their 
extensive labour requirements, high running costs and somewhat vague results produced.  
Focuses turned to the ‘functional’ aspects of the genome, typically the exome, as interests 
were in finding answers to medical problems due to the mutations within genes, such as 
inherited disease conditions (Lai-Cheong & McGrath, 2011).  Initially, exome studies could 
only be carried out on few samples due constraints of the quantity of data that could be 
obtained (T. Sjöblo, et al., 2006) yet from this specific gene candidates were proposed to 
focus on based upon identified cancer mechanisms and possible targets for therapy 
(Greenman et al., 2007). Improvements accumulated over time via increased knowledge, 
computational power increases and falling costs, to allow high numbers of cancer genomes 
to be sequenced to genome level, expression of genes -transcriptome level- (Maher et al., 
2009) and exome level (Ley et al., 2008).  As of current it is possible via ultra-high-
throughput sequencing that hundreds of thousands of samples can be run in parallel 
(Tucker et al., 2009) and has allowed the sequencing of an entire human genome within a 
day (Straiton et al., 2019). 
However, even with technological advances, it has become more apparent that the 
data obtained from the analysis of the tumour as a unanimous population, can only draw 
limited conclusions due to the intra-tumour genetic heterogeneity (Navin et al. 2011) .An 
example of which, in order to define copy number variants of a cancer line, it is made 
difficult by the unknown level of ploidy caused by probable multiple numerical and 
structural chromosome abnormalities present (Storchova. & Pellman, 2004; Storchova  & 
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Kuffer, 2008).  Alongside this difficulty, the heterogeneous population could cause a shift 
towards an ongoing subclonal ‘speciation’ event, the generation of sub-populations that 
could become phenotypically distinct from the original tumour (Navin et al., 2010; Navin et 
al. 2011) (see section 1.3.4). The current methods used to combat this problem are array 
CGH (Lyng et al., 2008) or via single cell sequencing (Navin et al. 2011), are not as useful of 
a strategy as once thought to be in order to fully characterise the cancer genome 
(International Cancer Genome Consortium, 2010). With NGS, the analysis is needed to be 
at a great depth in order to correctly identify translocations or alternatively by using other 
techniques to pre-identify translocations (Allen et al., 2014), currently FISH remains the 
best candidate in terms of cost and ease to identify the overall chromosomal 
divergence/structure and to correctly assess the level of heterogeneity within the sample. 
FISH will always be limited in its resolution and inability to detect single point mutations or 
polymorphisms between samples where NGS will always outperform in this regard. The use 
of either method must be trialed against the primary research target, for a now quick 
relatively inexpensive cytogenetic analysis on the state of the chromosomes multilayer FISH 
shall exceed. Opposed to a potentially highly sensitive methodology that allows 
identification of base level abberations.  
With the increase of data obtained via NGS coupled with falling costs, it is an attractive 
model for researchers as it could be argued that the technical expertise and cost of FISH 
based genomics is off-putting. However by increasing throughput of FISH and lowering the 
overall cost it could be seen as a useful tool to counter the shortcomings of NGS methods 
mentioned previously.  The use of specific BAC’s via FISH can enable the identification of 
chromosome number, rearrangements, and complex aberrations such as multiple or 
balanced translocations or centromere abnormalities. The current downside to a FISH 
based approach is the limited analysis few fluorophores can provide in one single 
experiment (Hasty & Montagna, 2014). Modern FISH methodologies have been tried 
successfully, such as the use of alternative fluorophore ratios tied to specific BACs to 
increase the number of alternative colours seen, a strategy borrowed from M-FISH, to 
detect aneuploidy in large quantities. These experiments called for a strategy to detect the 
full 24 chromosomes via FISH in order to aid clinical diagnosis in a cost effective and 
reliable manner (Ioannou et al., 2011). As described in this thesis these issues of cost, 
labour intensively and accuracy of results can be overcome by the multilayer methodology 




We are presented with two main problems that multilayer FISH may be a useful 
methodology to explore, the possibility of detecting the level of heterogeneity in cancer 
cell lines, and detecting unknown chromosomal aberrations that may be hidden by 
traditional sequencing techniques which may bring about new oncogenic properties or 
resistances to specific therapeutic agents. The neuroblastoma cell line is an ideal model to 
use; as already established derivative resistant populations exist (Table 2.1) with 
chromosome aberration identification performed using classical hybridisation based 
techniques. 
The objectives aimed to be answered in this chapter are as follows and to achieve 
thesis aim 4: 
Via use of the multilayer FISH strategy  
o Assess the heterogeneity and inheritance of neuroblastoma cell line (the 
UKF-NB-3)  and derivative resistant lines 
o Highlight key chromosomal aberrations that could possibly infer a means to 
detect or cause resistance in subpopulations 
o Assign the neuroblastoma cell lines a cytogenetic notation in reference of 
all results seen 
6.1.4 Method of Multilayer probe groups 
To cover all human chromosomes with at least one probe and to have as little ‘panels’ 
or ‘groups’ as possible to increase the chance of detecting suspected subpopulation genetic 
variants, an proficient   methodology was required.  The resources used in this chapter 
were composed of a varied selection of commercially available probes, in an assortment of 
fluorophores and classifications (9. Appendix) (Cytocell) arranged in a way to not overlap in 
fluorophore signal to be consistent within the multilayer process 
To summarise the overall methodology requirements, in order of importance; 
1. To follow the standard 2 colour FISH with sequential layers, the protocol 
established in section 3.4 of this thesis 
2. To have minimal panels/groups  




With being limited to six unique layers for a single round of mlFISH, the requirement 
would be at least 4 differing panels to encompass at least a single probe on each unique 
chromosome.  This was reduced by the use of commercial probes that consist of multiple 
targets that could be analysed during the merging process to identify chromosomes. An 
example of this is the 1/5/19 alpha satellite probe (Table 6.1) which consists of three FITC 
probes at differing concentrations, thus allowing the identification based upon probe 
intensity post-FISH. Likewise it is possible to combine colours in layers such as in the 
example of chromosome 3, 6 and 14 in panel 2 (Table 6.2). Chromosome 3 can be 
identified using the chromosome paint in FITC, alongside the IGH / CCND3 Translocation 
Dual fusion probe set which identifies 14q32.33 in Texas Red and 6p21 in FITC. One would 
predict a normal result to be easily to differentiate between a paint signal and a specific 
location signal in the same colour therefore able to differentiate the chromosomes. An 
inability to do this would signify there is a degree of chromosomal abnormality, a 




Label + Loci 
1 
1/5/19 α. Satellite 
00FF00 FITC 1p11.1-q11.1 
5 FFFF00 FITC 5p11.1-q11.1 
19 00EEFF FITC 19p11.1-q11.1 
2 ALK Breakapart 
CC00CC FITC 2p23.2-p23.1 
FF00FF TX 2p23.2-p23.1 
8 α. Satellite CC6600 TX  8p11.1-q11.1 
10 α. Satellite FFAA00 FITC 10p11.1-q11.1 
12 α. Satellite. FFFFFF FITC 12p11.1-q11.1 






Table 6.1. Probes selected for group 1 panel analysis for the UKF-NB-3 lines 
H.sapiens probes are shown here with chromosome assignment and specific 
associated loci. Cytocell product identifier is shown to give an indication towards the 
intended purpose of these products; each probe has been assigned a false colour used 
in the multilayer process. 
The order of FISH was as follows; 1) 1/5/9 α-Satellite + 18 α-Satellite 2) ALK 








Label + Loci 
3 Paint 00FF00 FITC Paint 
4 α. Satellite FFFF00 TX p11.1-q11.1 
6 
IGH / CCND3 Translocation Dual fusion 
FF0000 FITC 14q32.33 
14 00EEFF TX 6p21 
11 α. Satellite. FFFFFF FITC 11p11.1-q11.1 
16 CBFβ (CBFB)/MYH11 
CC66CC FITC 16p13.1 
FFAA00 Tx 16q22 
22 IGL Breakapart 
CC00CC FITC 22q11.23 








Label + Loci 
9 α. Satellite 00FF00 FITC 9p11.1 9q11.1 
13 D13S25 Deletion 
CC00CC FITC 13q34 
FF00FF Tx 13q14.3 
15 α. Satellite FFFF00 FITC 15p11.1-q11.1 




CC6600 FITC 21Q22.2-22.3 
FFAA00 TX 21Q22.2-22.3 
FFFFFF AQUA 21Q22.13-q22.2 






Table 6.2. Probes selected for group 2 panel analysis for the UKF-NB-3 lines 
H.sapiens probes are shown here with chromosome assignment and specific 
associated loci. Cytocell product identifier is shown to give an indication towards the 
intended purpose of these products; each probe has been assigned a false colour used 
in the multilayer process. 
 The order of FISH was as follows; 1) 3 Paint + IGH/CCND3 translocation dual 
fusion 2) 4 α-Satellite + IGL Breakapart 3)CBFB/MYH11 + 11 α Satellite. 
 
Table 6.3. Probes selected for group 3 panel analysis for the UKF-NB-3 lines 
H.sapiens probes are shown here with chromosome assignment and specific 
associated loci. Cytocell product identifier is shown to give an indication towards the 
intended purpose of these products; each probe has been assigned a false colour used 
in the multilayer process. 
 The order of FISH is as follows; 1) 9 α-Satellite + 17 Classical Sat 2) 15 α.Satellite 
+ D13S25 Deletion, 3) TMPRSS2/ERG Deletion/Breakpoint + X α.Satellite. 
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6.2 Metaphase analysis 
Attempts to consistently fully karyotype the UKF-NB-3 cell line were unsuccessful 
(n≥60), partial karyotypes were possible and it was clear that there was an abundance of 
chromosomal aberrations and a degree of instability between individual nuclei of the same 
sample/cell line.  The UKF-NB-3 Parental cell line (Parental) and the UKF-NB-3 rVincristine 
(rVincristine) line both had near normal chromosome counts in respect to total 
chromosome count, parental average range 48±4 (n=22), rVincristine average range 48±4 
(n=24), whereas UKF-NB-3 rCisplatin (rCisplatin) did not show any commonality or 

















Figure 6.1. Metaphase spreads for all the UKF-NB-3 Cell lines used 
A) Normal H.sapiens male 46<2n>XY used as a control in this study. B) Parental UKF-
NB-3 cell line. C) UKF-NB-3 rCisplatin metaphase.D) UKF-NB-3 rVincristine metaphase. 
All metaphases were stained with DAPi (white), and immediately imaged; the scale bar 







6.3 Multilayer FISH results 
Multilayered FISH was performed on the three neuroblastoma cell lines alongside a 
control healthy human metaphase preparation by the standard multilayer methodology, 
using the probes detailed previously in tables 6.1, 6.2 and 6.3. After imaging, layers were 
merged and probe signals given false colouration to allow identification of abnormalities on 
individual metaphases across the four populations. Results of these are detailed in the 
following sections as tables of frequency of aberrations, metaphase representatives of cells 
from each cell line along side normal human metaphases and a hypothesised phylogenetic 
tree.  As the control sample displayed no abnormalities, it has been excluded from some 
result figures. 








+1 - 16.67 - 
+1,+1 - 11.11 - 
-1 89.29 16.67 - 
+der 1, 1/2/18 100.00 - - 
+der 1, 1/2 - - 100.00 
+der 1, 1/18 - 94.44 - 
+2 - 38.89 - 
+2,+2 - 27.78 - 
+2,+2,+2,+2,+2,+2 - 5.56 - 
-2 3.57 5.56 15.38 
+5 - - 7.69 
-5 14.29 44.44 7.69 
+8 3.57 45.45 - 
+8,+8 - 18.18 - 
-8 32.14 - - 
+10 - 41.18 - 
-10 10.71 11.76 - 
+12 53.57 36.36 - 
-12 7.14 18.18 - 
-18 100.00 94.44 100.00 
-18,-18 - 5.56 - 
+19 - 16.67 - 
-19 28.57 33.33 23.08 





Table 6.4. Probe panel 1 aberration frequency across all cell lines.  
Displayed is the level of individuals of the given cell line population that expresses a 
particular aberration as compared to the total number of nuclei examined for that cell 
line in this probe panel. Aberrations are identified and classified as if ranked against a 
normal 46<2n>XY genotype in light of FISH results.  A ‘-‘notates that this particular 




It is possible to identify similar and dissimilar ‘individuals’ with classification of 
expressed abnormalities, and therefore generate a list of subpopulations that exist within 
the sample population as a whole. Results thus far indicate that there is a clear mixture of 
subpopulations within each sample indicating a heterogeneous nature of each cell line. 
From this, modal (or most frequent) genotypes of these subpopulations were chosen to 
represent the state of the individual cell lines and are as follows. 
6.3.1.1 Modal Parental 
Within the parental cell line in context of results from panel 1, the most abundant 
genotype (and will be identified as Par.1A) was as follows (32% of sample population); 
Par.1A = -1, +der(1)dup(1;2)(pter;p23.1-23.2)t(1;18)(p?;p11.1), +12,-18 
6.3.1.2 Modal rVincristine 
The rVincristine cell line, the most abundant genotype (rVin.1A) was as follows (62% of 
sample population); 
rVin.1A = +der(1) dup(1;2)(pter;p23.1-23.2),-18 
6.3.1.3 Average rCisplatin 
rCisplatin did not show any evidence for a modal genotype, as all metaphases analysed 
had a unique aberration profile, i.e. no two metaphases were the same. In light of this, the 
most abundant aberration (modal aberration) for individual chromosomes is selected to 
represent the ‘modal’ (rCis.1   as follows; 
rCis.1  = +der(1)t(1;18)(p?;p11.1),+2,+8 -18 
6.3.1.4 Derivative chromosome 1 
A noticeable conserved chromosome aberration is a presumed chromosome 1 with a 
double p-arm translocation with 18p11.1 (red) and chromosome 2p23.1-23.2 (purple/pink) 
in the parental cell line (Figure 6.3, top right/ 100% of sample metaphases). Surprisingly, 
both resistant lines seemingly express a similar derivative chromosome 1 yet with only one 
of the translocations seen as in the parental line (Figure 6.3 bottom left, bottom right. 
FLpter analysis was performed to investigate the similarities or differences between these 
chromosomes to assess a possible means of inheritance or spontaneous mutation in each 
















































Figure 6.2. Probe point plot showing derivative chromosome 1 for NB3 
parental/rCisplatin/rVincristine FLpter scores and corresponding chromosome 
schematic 
A) Probe position measured as FLpter values and averaged across all metaphases 
obtained using probes from panel 1 (table 6.1).  
B) Generated schematic chromosomes for each cell line by using metaphase FLpter 
data generated. Position of coloured band corresponds directly to FLpter scores 
generated and colour corresponding to assigned probe. Not a true representative of 










Figure 6.2 indicates that the parental and rVincristine have identical FLpter scores for 
their similar probe locations, whereas rCisplatin has a reduction in both centromere 
location and its paired probe location in reference to the parental. Alternatively, assessing 
the relative chromosomal distance between the centromere location and the 18p signal, an 
identical distance is noted between the parental and rCisplatin (Table 6.5), this is also 
shown by equal gradients on the probe point plot (Figure 6.2) generated from FISH results 
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Table 6.5. FLpter scores for derivative chromosome 1 within; NB3 parental/ 
rCisplatin / rVincristine, with relative distances between signals.  
Rows 2-4, the associated FLpter scores for the position of the indicated probes 
found on the derivative chromosome 1 conserved in each cell line. Error is given as 
S.E.M. 
Rows5-6, the distance between the probes as a fraction of total chromosome 
length recorded. Error is given as S.E.M.  ‘-‘annotates that this was not observed for the 
signified cell line at that specific probe location.  
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6.3.1.5 Proposed Phylogenetic Principles of classification.  
It is possible to use the results of the FISH panels to deduce a feasible hypothesis of 
phylogeny within the cell line populations between sub-populations, and if sufficient, 
detect possible divergence positions for the resistant cell lines. In order to speculate a ‘best 
fit model’ of phylogeny, principles must be rationalised in order to fit this differing model of 
evolution. The rules that will be obeyed to generate the phylogenetic trees (Figure 6.4, 
Figure 6.6 and Figure 6.8) in this study are as follows; 
I. Assume there is no change in selection pressure since initial cell line divergence 
i. Therefore, subpopulation abundance is in proportion to its ‘age’ 
i. New subpopulations with lower abundance are products of more 
recent mutative events. 
ii. New genotypes should not out-compete old genotypes as there is 
no new ecological niche to fill. 
II. All deviations from the ‘progenitor’ should exist within the population, yet in 
smaller abundance. 
III. The most appropriate phylogenetic pathway should have the least sum of ‘missing 
genotypes’ to fill. 
i. Assume single chromosome malformation events would cause these to be 
filled and not be removed from the population as per initial assumption. 
IV. Those cells which generate non-viable chromosomal aberrations shall not survive 
to metaphase stage, and therefore will not be able to generate any further 
diverged subpopulations. These shall not be incorporated into the best fit model. 
 
These principles can allow a mixed population of varying genotypes to comprise 
subpopulations that can be linked by single chromosomal mutation events, with reference 






























Figure 6.3. Merged multilayer FISH images of Human and three NB3 cell lines from 
panel 1 
A) Normal H.sapiens male 46<2n>XY B) Parental NB3 (Par.1A).C) NB3 rCisplatin 
(Cis.1 ). D) NB3 rVincristine (rVin.1A). All metaphases were stained with DAPi (Blue); 
the scale bar in each image is representative of 10μm.  Arrows with numbers annotate 
the determined chromosome seen as represented by the false colour signal (Table 6.1) 



















































































































































































































































































































































































































































+3 7.69 4.76 - 
+3,+3 - 4.76 - 
-3 - 19.05 9.09 
3t(3;?) - 90.48 - 
3t(3;?),3t(3;?) - 4.76 - 
Del (3q) - - 9.09 
+4 - 45.00 9.09 
+4,+4 7.69 15.00 - 
-4 15.38 15.00 18.18 
Der(4)Del(4q?) 
t(4;11or16)(p;p11.1orp13.1) 
- 25.00 - 
Del 4(qTer) - - 9.09 
Del 4(qTer),Del 4(qTer) - - 9.09 
+6 - 4.76 - 
-6 - 19.05 - 
-11 7.69 20.00 - 
-11,-11 - 13.33 - 
Der(11)t(11;6)(p;p22) - 85.71 - 
Dup(11Q) - 66.67 - 
Dup(11Q), Dup(11Q), Dup(11Q) - 13.33 - 
+14 - 61.90 - 
-14 7.69 14.29 - 
+16 - 13.33 - 
-16 - 20.00 18.18 
-16,-16 - 6.67 9.09 
t(16;macro?)(q22;p) 76.92 60.00 - 
t(16;macro?)(q22;p), t(16;macro?)(q22;p) 7.69 33.33 - 
Del(16p) - 13.33 - 
Del(16q) - 13.33 - 
-22 - 57.14 9.09 
-22,-22 - 14.29 - 
Der(22)t(22;16)(q;q22) - 55.56 - 
Dup(22)(22;macro?)(q11.23;p?), 
Dup(22)(22;macro?)(q11.23;p?) 










Table 6.6. Probe panel 2 aberration frequency across all cell lines.  
Displayed is the level of individuals of the given cell line population that expresses a 
particular aberration as compared to the total number of nuclei examined for that cell 
line in probe panel 2  Aberrations are identified and classified as if ranked against a 
normal 46<2n>XY genotype as a result of FISH results.  A ‘-‘notates that this particular 




FISH results from panel two (Table 6.6, Figure 6.5) , likewise to the first panel, indicated 
towards a presence of subpopulations defined by chromosome features with varying levels 
of abundances. Genotypes of these subpopulations were chosen to represent the state of 
the individual cell lines and are as follows. 
6.3.2.1 Modal Parental 
Within the parental cell line in context of results from panel 2, the most abundant 
genotype (and will be identified as Par.2A) was as follows (53% of sample population); 
Par.2A = t(16;macro?)(q22;p?), -11 
6.3.2.2 Modal rVincristine 
The rVincristine cell line, the most abundant genotype (rVin.2A) was as follows (27% of 
sample population); 
rVin.2A = +3 
6.3.2.3 Average rCisplatin 
Similar to before, the rCisplatin sample did not show any non-unique metaphases to 
derive a modal genotype. Likewise to the previous panel, the modal aberration for 
individual chromosomes was selected to represent the ‘modal’ (rCis.2   as follows; 
rCis.2  = +3, t(3;?)(3qArm;?), +4, +11, dup(11q), 































Figure 6.5. Merged multilayer FISH images of Human and three NB3 cell lines from 
panel 2 
A) Normal H.sapiens male 46<2n>XY. B). Parental NB3 (Par.2A). C) NB3 rCisplatin 
(Cis.2 ). D) NB3 rVincristine (rVin.2A). All metaphases were stained with DAPi (Blue); 
the scale bar in each image is representative of 10μm.  Arrows with numbers annotate 
the determined chromosome seen as represented by the false colour signal (Table 6.2) 











































































































































































































































































































































































































































































































+9 - 84.21 - 
+9,+9 - 5.26 - 
-9 11.11 5.26 7.69 
+13 - - 69.23 
-13 11.11 20.00 - 
-13,-13 - - 30.77 
Dup(13)(13;macro?)(q14.3;?) - 60.00 - 
Dup(13)(13;macro?)(q32.33;?) - 20.00 - 
Dup(13)(13;macro?)(q32.33;?), 
Dup(13)(13;macro?)(q32.33;?) 
- 20.00 - 
Del(13qter), Del(13qter) - - 15.38 
Del(13qter), Del(13qter), Del(13qter) - - 15.38 
+15 - 80.00 - 
-15 33.33 - - 
-17 100.00 73.68 - 
Dic(17) 77.78 84.21 - 
Dic(17), Dic(17) 11.11 - - 
iso (17q) 11.11 52.63 - 
Der(17)Dup(17q)t(17;13or15)(p;q34orp11.1) - 80.00 - 
Dup(17Q), Dup(17Q), Dup(17Q) - 20.00 - 
+21 - 80.00 84.62 
+21,+21 11.11 - - 
-21 11.11 - - 





The final panel contained less variation of chromosomes due to the fluorophore 
required for individual probes, for example chromosome 21 required three coloured 
fluorophore severely limiting what it could be paired with.  Regardless, even with a reduced 
number of targeted chromosomes, the panel and FISH results provided enough data to 
comment on the hetrozygosity of the three samples (Table 6.7, Figure 6.7), keeping with 
the consistency of previous panels. Populations were analysed and subpopulations 
identified with differing genotypes, again characterised by identifiable chromosome 
aberrations (Figure 6.8).  
 
Table 6.7. Probe panel 3 aberration frequency across all cell lines.  
The quantity of individuals of the three differing cell line populations that shows the 
given aberration as compared to the total number of nuclei examined for that cell line 
in this probe panel. Aberrations are identified and classified as if ranked against a 
normal 46<2n>XY genotype in light of FISH results.  A ‘-‘notates that this particular 





6.3.3.1 Modal Parental 
The parental line was found to have a most abundant genotype (Par.3A, 33% of 
sample) and is as follows; 
Par.3A = -17, dic(17) 
6.3.3.2 Modal rVincristine 
rVincristine, with  the most abundant genotype (rVin.3A) was as follows (44% of sample 
population); 
rVin.3A = +13, +21 
6.3.3.3 Average rCisplatin 
With no homologous metaphases identified, the modal aberrations are selected to 
represent the ‘modal’ (rCis.3   as follows; 
rCis.3  = +9, t(13;macro?)(q14.3;?), +15 ,t(16;macro?)(q22;p?),-17, 
iso17(q), dic(17), +der(17)dup(17q)t(17;15-or-13)(p;p11.1-or-q34), +21 
6.3.3.4 Variants of Chromosome 17 
Chromosome 17 within this panel has highlighted very different abnormalities, from a 
suspected isochromosome, a di-centric chromosome and a possibly highly duplicated q 
arm.  As seen in table 6.7, these variants are somewhat found in the parental and rCisplatin 
yet absent in rVincristine. As the probe for chromosome 17 used is a centromeric probe, it 
is possible to predict the lengths of the p and q arms via FLpter scores to further quantify 
and classify these seen variants. 
As both cell lines possessed a normal 17, individual metaphases were measured 
(section 2.2.2.1) for all chromosome 17 variants to be directly compared to its own 
chromosome 17 to account for the differing levels of chromatin condensation seen across 
metaphases within the same sample. Each ‘normal’ 17’s length is represented by ‘p+q=1’ 
where p and q can be derived from the FLpter scores to give a ratio of length of arms with 
associated physical length. These lengths can be directly compared to the variants within 
the same metaphase measured for their own respective FLpter scores in order to identify 


































































Each segment of the di-centric chromosomes were split up into; Start to first signal (ST-
>FS),  First signal to second signal (FS->SS) and lastly second signal to end (SS->EN) and 
compared to their metaphase counterpart to identify possible p and q segments. Analysis 
signified that the length of individual segments from the di-centric chromosome did not 
match either p or q value of the normal 17 previously obtained.  
Distances between segments could be represented as a ratio between parts and 
therefore compared across cell lines to see if they were homologous. The data obtained 
(table 6.8) indicated that these are in fact differing di-centric chromosomes. Total size 
relative to the normal 17 was also obtained and is also displayed in table 6.8. With low 
abundance, the parental isochromosome could not be adequately measured, yet this was 
not the case of rCisplatin. A ‘p’vs’q’ length was obtained and presented in table 6.8. The 
presumed duplicated q arm 17 found in the rCisplatin line was measured in a similar 
fashion as previous examples, measurement of FLpter scores and the proportional 
representative as length in respect to its ‘normal 17’ metaphase pair. Data is presented in 
table 6.8 to determine the makeup of this chromosome. 
Table 6.8. Results from chromosome 17 variant analysis 
FLpter analysis of chromosome 17 and its derivatives presumed to be 
malformations of chromosome 17 in all cell lines. Use of ‘normal’ 17 FLpter scores 
within singular metaphases as compared to the malformed 17 present in said 
metaphase. 
ST=Start of chromosome. FS= first probe signal. SS=second probe signal. En=end of 
chromosome. 
 
P y ical dis ances were measured and compared WITHIN the metaphase o obtain 
a relative ratio. This was then averaged across its own population. THEN the averages 






















Figure 6.7. Merged multilayer FISH images of Human and three NB3 cell lines from 
panel 3 
A) Normal H.sapiens male 46<2n>XY. B) Parental NB3 (Par.3A). C) NB3 rCisplatin 
(Cis.3 ). D) NB3 rVincristine (rVin.3A). All metaphases were stained with DAPi (Blue); 
the scale bar in each image is representative of 10μm.  Arrows with numbers annotate 
the determined chromosome seen as represented by the false colour signal (Table 6.3) 







































































































































































































































































































































































































































6.3.4 Predicted modal cell genotypes 
Whilst somewhat incorrect to assume a subpopulation from one probe panel is 
identical to the same subpopulation shown in another probe panel without a complete 
probe panel, a more probable expected genotype can be hypothesised of the most 
abundant genotypes seen. Below, in context of the FISH probe panels, predicts would be 
the most common subpopulation genotype seen in each individual cell line at this stage of 
‘tumour’ progression.  (Lines are presumed of male origin due to only one X being seen 
consistently, if not then X0 for all cell lines).  
 Parental = <2n> XY?,-1, +der(1) dup(1;2)(pter;23.1-23.2);t(1;18)(p?;p11.1), -11, 
+12, t(16;macro?)(q22;p?), -17, dic17,-18 
 
rVincristine = <2n> XY?, +der(1) dup(1;2)(pter;23.1-23.2), +13,-18, +21 
 
rCisplatin = <2?n> XY?,-1,+der(1)t(1;18)(p?;p11.1), +3, t(3;?)(3qarm?;?), +4, +8, 
+9, +11, dup(11q), t(13;macro?)(q14.3;?), +14, +15 ,t(16;macro?)(q22;p?),-17, 
iso17(q), dic17, +der(17)dup(17q)t(17;15or13)(p;p11.1orq34), -18 +21, -22, 









































Cell Line  (Set1/Set2/Set3) 
p1 p2 p3 p1 p2 p3 p1 p2 p3 













Aberrations away from the modal (Parental and rVincristine) or average (rCisplatin) 
were calculated to assist the prediction of phylogenetic trees. Each lines population’s 
average aberrations away from the modal subpopulation can be calculated across probe 
panels to highlight the deviation across these populations, a means to highlight the level of 
homo or hetrozygosity. As seen in figure 6.9, parental and rVincristine lines exhibit on 
average between 1 to 3 aberrations from the mean with minimal deviation, opposed to 
rCisplatin which has a much higher level of average aberrations and variation across all 
panels.  Examples displaying the most abnormal cell lines discovered within the sample 




Figure 6.9. Average aberrations away from the modal cell subpopulation in each 
panel tested. 
A count of differing chromosome aberrations individual cells are away from the 
‘modal cell’ of that population. Each value is given as an average of the altered nuclei 
chromosome aberration count (not including modal cell populations) with Standard 
error of the mean shown as error bars. Each group of three represents the three 
different cell lines used in this study, with each grouping from left to right, panel 1 (p1), 
























Figure 6.10. Examples of the most mutated subpopulation metaphases in respect 
to the ‘modal’ subpopulation 
Subpopulation merged metaphase examples from each cell line (rows) from each 
probe panel (columns, left to right, 1, 2, 3). Colours refer to the specific false colour 
attributed to each probe as seen in the tables in section 6.1.4. Each metaphase has the 
highest aberration count seen as compared to the modal or average mutation as 




6.5 Discussion  
The use of multilayer FISH has allowed the identification of novel chromosomal 
aberrations alongside identification of sub-populations indicating a level of heterogeneity 
in all cell lines studied. The presence of unique aberrations and the level of heterogeneity 
within both resistant neuroblastoma cell lines could be indicative of a mechanism for said 
resistance or a means to identify as a ‘marker molecule’. Thus in light of these results, we 
can say it has been worthwhile to apply the multilayer methodology to improve current 
understanding in retrospect to just using NGS techniques.  
Detected throughout all three panels were clear divisions of genotype across sub-
populations, from which presumed phylogenetic assignment can be hypothesised as seen 
in figures 6.4, 6.6 and 6.8. Whilst hypothetical lineages have been presumed, in no way 
should results seen in this section be treated as indicative of the true phylogenetic 
assignment of these cell lines as evident by results presented. Results from this study 
should instead be used as an introductory insight into the level of heterogeneity and level 
of chromosomal variety within these cell lines to highlight the need for more in-depth 
multilayer FISH testing. Nevertheless there is somewhat evidence that shows the derivative 
nature of both resistant cell lines from the parental, indicated by shared chromosomal 
aberrations.  
6.5.1 Oncogenic properties of aberrations  
Shown throughout all FISH results panels are the conservation of specific chromosomal 
aberrations across the cell lines. An interesting aberration is that of chromosome 1, seen in 
figure 6.2 and figure 6.3 where seemingly the distal p arm has been lost, most likely 
through deletion events as common in advanced neuroblastomas (Maris et al., 2001), and 
insertions of chromosome 18 and 2p.23.1-23.2 (the loci of ALK, which is frequently involved 
in translocations that lead to malignant gene fusions (Van Slooten et al., 1998). 
Fascinatingly the parental derivate 1 has both of the 18 and 2 insertion yet each resistant 
line has lost one of these aberrations rCisplatin the ALK from chromosome 2 and 
rVincristine has lost the 18 insertion. Loss of either insertion is clearly not lethal however 
the presumed importance would be from the presumed loss of 1p36.3 location of a tumour 
suppressor gene (Munirajan et al., 2008). The loss of a whole chromosome 18 is near 
universal across all cell lines, bar the possible insertion into chromosome 1, is the loss of 
BCL-2 a regulator of apoptosis implicated in aggressive tumours with proliferative activity 
(Van Slooten et al., 1998; Van Goethem er al., 2017). 
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The abundant copy number amplification of chromosome 2 in rCisplatin could resolve 
in the increased dosage of MYCN, associated with many tumours but in particular 
neuroblastomas (Durbin et al., 2018; Hald et al., 2019). The translocation of chromosome 
6p21 onto a chromosome 11 in 85% of rCisplatin cells examined indicates the translocation 
of the CCND3 gene. CCND3 is within the conserved cyclin family to regulate progression 
through the cell cycle (section 1.1.3) and seen in many cancer cases either as a 
translocation (Wlodarska et al., 2008; Beltran et al., 2013) or observed to undergo 
mutations (Cancer Genome Atlas Network, 2012; Arneja & Gujar, 2015; Rohde et al., 2017). 
Chromosome 11 loss and gain across subpopulations of rCisplatin, absence of NCAM at 
11q23.2 is seen as an unfavourable prognostic phenotype for advanced stage 
neuroblastoma as seen in 33% of cells identified in this study (Valentiner et al., 2011). 
Alternatively the apparent duplication of chromosome 11q in 79% of rCisplatin cells could 
induce over expression of cyclin D3, another cell regulatory gene that has association in 
some cancers (Lopez-Beltran et al, 2010). 
There is an apparent duplication and insertion of 16q22 in the parental line and 
rCisplatin, this probe is specific for CBFβ which is of significance in cancer development 
such as leukaemia (The Cancer Genome Atlas Network, 2012). Translocation events cause 
impaired functionality of CBFβ, and form oncogenic fusion proteins further contributing to 
the oncogenesis factors of these cell lines (Park et al., 2010; Noort et al., 2018). Within 
rCisplatin observed with near exclusively, bar a small sub-clonal population within 
rVincristine, there are multiple aberrations regarding chromosome 22. With either whole 
chromosome loss or apparent translocations with many other chromosomes (16 and other 
unidentified) indicates a possible generation of oncogenic fusion proteins. The BCR gene 
located on 22q (section 1.3.2.3.1) has been implicated in many fusion proteins and could 
relate to the progressive tumour features of this resistant cell line.  
6.5.2 State of heterogeneity and comparison to previous studies 
The level of heterogeneity within all three cell lines was larger than was originally 
anticipated. Previous work involving the generation of these neuroblastoma cell lines relied 
on SKY to assign their respective karyotypes (Kotchetkov, 2005). Detailed here are 
abnormalities observed within this study, such as the derivative chromosome 1 with 
translocations, the whole chromosome loss of 18, an extra 21 and 13 in rVincristine, only 
one chromosome X, and more. However, rVincristine was found to have the derivative 1 
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t(1;18) which was not observed in a single instance within this study, and instead 
exclusively found within rCisplatin. In comparison of results, whilst the ‘average’ 
cytogenetic assignment is comparable in both studies, lower frequency aberrations are 
seen within sub-populations which are not detailed in the report. Especially within the 
parental line, the loss of chromosome 11 is not seen alongside the large aberrations 
regarding chromosome 17 (detailed below).  
These findings could be summarized by two different events, either as individual or 
most probable to be a combination of both. Firstly, the SKY methodology used incurred 
erroneous assignments due to the previously described fluorochrome ‘sandwich effect’ 
(section 1.1.5.3) hiding translocations or causing false positives. With the use of SKY comes 
the question of number of singular cells examined with the post-analysis of deciding which 
aberrations are non-representative of given karyotype. Secondly, there could be an 
element of continuous evolution of said cell lines over time; a new sub-clonal population 
arises to out-compete the previous dominant with new chromosomal aberrations. This 
factor is relevant more so to the specific tumour microenvironment (section 1.3.4.1) within 
a person, yet the possible progression seen could comment on the microenvironment of 
‘cell culturing’ and the effect that has on the genome of cancer cells. Far beyond reach and 
aims of this thesis, but it is plausible to be of focus in further studies. 
With regards to the heterogeneity seen in the parental and rVincristine somewhat 
displays what to be expected with a ‘progenitor’ being the initial population that has been 
selected for to give rise to a genetically diverse population. Here observed is a ‘core’ high 
frequency common genotype population with smaller populations branching off in regards 
to further low number chromosomal mutations (figure 6.9). This process would generate 
populations that would slowly drift from the ‘progenitor’ but fail to establish large 
subpopulations due to a lack of selective pressure. Quite the opposite story is that of 
rCisplatin, in none of the panels tested here was there a single cell that existed as a ‘clone’ 
of another. In other words, every singular cell examined was unique at the chromosomal 
level; true there were commonalities with chromosomal aberrations shared amongst 
individuals, but a high level of genomic instability must exist to have caused this large 
variation (also represented by large unstable chromosomal count (section 6.2).  
The suggestion is that the level of heterogeneity itself can be used as a bio-marker for 
treatment/progression as a more heterogeneous tumour may be more likely to contain a 
resistant sub-population (Marusyk et al., 2012).  This could be represented with the 
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parental/rVincristine direct overlap observed in panel 2, exact aberrations detected in cells 
of parental and rVincristine samples are the same. rVin.2D is found within both samples 
and more interestingly Par.2E (in low frequency) exhibits the same chromosomal features 
as rVin.2A the most abundant population within rVincristine. This somewhat gives some 
evidence that there may be resistant populations residing as low frequency populations 
within the ‘parental tumour’ that could be selected again with introduction to more 
selective pressures.   
6.5.3. On the chromothripsis of chromosome 17 
Chromosome 17 has mass aberrations within the parental and rCisplatin cell line (and 
surprisingly not observed in rVincristine), location of p53. Within neuroblastoma, p53 
mutations are rare at first diagnosis/testing yet seen after a selective pressure, such as 
chemotherapy, to be seen as a potential role in acquiring of drug resistance (Xue et al., 
2007). Obviously there may be genetic manipulations within the gene that the study 
presented here cannot detect, but the vast aberration of chromosome 17 within the 
parental and rCisplatin is something of great interest.  The suspected isochromosome 
17(q), as determined from (table 6.8), would cause a lower dosage of P53 (as is located on 
the p arm) regardless of its ‘coding-gene-mutation-state’ to infer a higher oncogenic state 
of the cell. Isochromosome 17(q) specifically within neuroblastoma is seen as one of the 
more frequent isochromosome aberration seen within neoplasia and also used as a marker 
for poor patient survival (Gilbert et al., 1984; Barbouti et al., 2004; Mendrzyk et al., 2006).  
The presence of a di-centric chromosome seen consistently in both lines indicates an 
inheritance from the parental to rCisplatin at time of ‘branching’, not to presume it has 
been the selective initial cytotoxic drug resistant causing aberration. However, there is 
variation within this di-centric chromosome across the two lines; the rCisplatin’s being 
almost twice the length of that in the parental (table 6.8). The ratio between ‘segments’, 
described within the table are seemingly near equal between the cell lines, indicating a 
post-branching duplicative event across the whole di-centric chromosome within rCisplatin. 
The derivative chromosome 17 only seen within the rCisplatin can be somewhat explained 
via this study. The ‘p’ arm has the same relative ‘length’ as a normal 17q, although some 
with translocations from chromosome 13 or 15 yet this is presumed to be balanced. The 
new ’q’ arm for this longer 17 is presumed to be three duplications of the original 17q or an 
amalgamation from something else entirely.  
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Regardless of specific state/location of p53, both parental and rCisplatin have in-depth 
malformations of their chromosome 17 and derivatives. A plausible explanation is the 
event of a single catastrophic process within the parental that catalyzed the ability for large 
swathes of genomic instability seen explicitly within rCisplatin.  A ‘possible’ singular 
chromothriptic event regarding chromosome 17 within a sub-population of the parental 
cell line allowed the onset of a possible rCisplatin precursor with higher levels of genomic 
instability due to a lower dosage of p53. This event must have happened after the 
branching of rVincristine due to two apparently normal copies of chromosome 17 observed 
in all cells and vastly less noted genomic instability indicated by lower aberration counts 
and lower levels of heterogeneity. Somewhat interesting as previous reports a loss of WT 
p53 in these cells (Kotchetkov, 2005). Vincristine is thought to induce cellular death by p53-
independent-pathways as is a microtubule binding drug to prevent the expansion of mitotic 
spindles thus cellular division. By vincristine resistant cells circumventing this requirement 
the resistant cells must have alternative mechanisms to prevent the cytotoxic action of 
vincristine (Hientz, 2017). The resistant cells therefore can maintain a relatively stable (as 
compared to rCisplatin) genome as their mechanism(s) of resistance has little interaction 
with direct DNA mutative events to cause instability and instead allows the correct 
formation of spindle fibers for cellular replication. Cisplatin resistance can arise through 
increase in DNA repair mechanisms (Lin & Howell, 2006; Heintz, 2017), this somewhat 
explains the large heterogeneity and large chromosome count/vairability (Rao, 1998) 
observed in the resistant cell line. With increased DNA repair, any breakages or replicative 
errors (caused through the direct DNA damaging action cisplatin or alternative means) can 
be successfully repaired and not drive apoptopic factors to cause cellular death. With a 
population of resistant cisplatin cells via the action of upregulated repair mechanisms 
(TP53 linked or not) would be subjected to mutations on the DNA at different locations 
across the genome to be repaired independently of one another and not become 
‘unselected’ and therefore push this high level of growth and heterogeneity observed.  The 
incidence of chromothripsis is seen to be correlated with the lack of p53 ((Rausch et al., 
2012; Cai et al., 2014; Fernandez-Banet et al., 2014; Bochtler et al., 2017) where the lack of 
activity to induce cell cycle arrest can explain the faster growth of rCisplatin observed from 
previous personal observations of culture maintenance. Furthermore these 
chromoanagenesis events are seen consistently in neuroblastoma and other childhood 
cancers paired with poor prognosis most likely caused by the cytotoxic drug resistance 
(Molenaar et al., 2012; Luijten & Ting, 2018). 
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One can presume that the addition of the cytotoxic drug cisplatin during selective 
growth for rCisplatin cells had indeed induced a ‘chaotic’ survival event with more 
chromoanagenesis like aberrations throughout its genome spawning many derivatives, as 
represented by its heterogenic state, which are resistant to the drug. The lack of 
heterogeneity seen in the parental line, as compared to rCisplatin, can be explained by the 
lack of a selective pressure to cause a resistant sub-population to become dominant. 
Furthermore this pairs with the fact that rVincristine has much lower levels of genome 
reorganization and chromoanagenesis like events by the lower aberration and 
heterogeneity level seen. 
 
6.6 Conclusion 
Analysis of results provided by the use of the multilayer method within this study it is 
notable that there has been a new perspective of already established cancer cell lines and 
their cytotoxic drug resistant derivatives. This suggests that opposed to a ‘bottom-up’ 
approach, whereby prospective oncogenic genes are analysed via specific base pair 
sequences for mutations and copy number, a ‘top-down’ view may be considered alongside 
to look for aberrations first then investigate what it may specifically cause. It is plausible to 
say that both methodologies are worthwhile into the investigation of cancer lines for 
causative effects, treatment options, detection of heterogeneity, identification of bio-
markers and possible evolutionary pathways taken. One must also be aware that genomic 
aberrations may not be indicative of phylogenetic attributes seen.  In the example of the 
rCisplatin cell line, a vast diversity in the genome across the population may not have a 
reflection upon the characteristics of the cancer.  
With reference to patient diagnostics and treatment options, the current means is 
dependent on specific tumour drivers presented, such as ALK, MYCN and TrkB. The current 
focus is placed more so on therapeutic developments such as immunotherapy and targeted 
delivery of drugs opposed to specific treatments for specific ‘genomes’ (Pastor & Mousa, 
2019). Whilst it is true that initial biopsies of tumours yield invaluable genomic information 
to refine treatments and prognosis, it is clearly evident that genomic evolutionary models 




What this study has indicated is that there is an overabundance of future work that can 
be proposed. One such would be the idea of a probe specific to each human locus along a 
chromosome or being tailored to specific genes/aberrations of interest (e.g. MYCN). Here 
within this study, it was only possible to use a ‘one probe to many chromosome’ approach 
rather than a ‘many probes to single chromosome’ demonstrated within previous chapters 
due to reagent constraints (hence why not every chromosome was assessed due to lack of 
specific probe). However even with a limited pool of specific FISH probes it has 
demonstrated the usefulness of the multilayer approach by efficiently and cheaply 


















7. General Discussion 
7.1 Summary of accomplishments 
In regards to the aims and themes set out within the opening chapter, I believe that 
this thesis has been successful in demonstrating how each of these aims was accomplished.  
1. The analysis of the ‘state of play’ for current in situ hybridisation, with the 
testing of new reagents and current commercially available buffers, has 
allowed an apt view in regards to the use of FISH to solve comparative genomic 
questions. The supposed high throughput ‘fast’ hybridisation buffer performed 
marginally better than the current ‘standard’ formamide based buffer and 
would reliably reduce hybridisation times for experiments. However, with 
regard to a comparative genomics lab (opposed to a time sensitive diagnostics 
lab) the gain of output is vastly insignificant to the costs attained for this 
alternative faster acting buffer. In light of this, a new means of increasing 
effective output vs. cost was required and the refined multilayer methodology 
was devised. Further refinements and augmentation of this methodology can 




a.  Detection of intrachromosomal rearrangements within the Galliform order 
has been presented within this thesis; hypothesised to exist yet overlooked 
due to the nature of this order and methodologies needed. The identification 
of novel rearrangements within the ‘conserved’ macro-chromosomes of these 
species has brought light onto the fact that more may yet exist within this 
order and are worthy of attention to further influence phylogenetic 
assignments. One rearrangement within this order is to be of note and 
relevant to recent re-assignment of E.chinensis from Coturnix to Excalafactoria 
indicating a clear chromosomal event which may exist within other members 
of both species to refine their assignments between these two genera.  
b. Although only three of the five chromosomes studied were suitable enough to 
analyse within an intra-nuclei arrangement, the multilayer method was 
sufficient at generating data to allow a preliminary insight into folding 
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arrangements as a de-condensed state.  The generation of a ‘skeleton’ system 
to computationally organise and path/fold has been of great benefit as it has 
shown that there is somewhat of a distinctive conserved folding pattern of the 
macrochromosomes studied indicated by a ‘horseshoe’ shape. Further studies 
are obviously required to validate these findings and see if the same principle 
occurs for other chromosomes in other species or an alternate arrangement is 
found. This work also highlights that spatial modelling in a 2D environment is 
fundamentally flawed in design, yet with some conclusions being drawn from 
this study it shows that it may be worthwhile to adapt the multilayer method 
into a 3D methodology. Furthermore, adapatation into 3D nuclei arrangement 
would pair well with Hi-C methodologies of current as a two angle approach to 
determining arrangement of chromosomes, especially in species not 
commonly researched upon. Multilayer FISH could be performed rapidly and 
fairly inexpensively on any species of choice, even those hard to source and 
grow as only interphase stage cells are required whereas bespoke libraries for 
Hi-C will have to be created. 
 
3. Adapting an existing multiprobe device it was possible to use within context of 
the multilayer method to refine and put forth an updated karyotypic 
representation of the DT40 cell line. With comparison to previous research 
using next generation sequencing techniques, it has been highlighted that 
previously identified chromosomal aberrations exist in a different 
conformation that previously thought or do not exist at all. Use of the two 
combined methods allowed the quick classification of this cell line to inform 
researchers of genomic changers underpinning the features which make DT40 
a useful research tool. Understandably, it is clear that this could be adapted 
further for other aberrated cell lines to assess the genomic state and level of 
heterogeneity.  
 
4. Applying a ‘one probe to many chromosomes’ approach via multiple layers has 
allowed an easier system in order to classify vastly rearranged cancer lines and 
their derivative cytotoxic daughter lines.  As shown within chapter 6, there are 
observable chromosomal differences between each cell line which may be 
indicative of a means of cytotoxic resistance or a biomarker used for other 
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neuroblastomas. Interestingly it is also seen that the level of heterogeneity 
within these cell lines vary considerably, with the parental and rVincristine 
having a key ‘modal’ sub-population with lesser frequent alternative sub-
populations with minor genomic structural changes, rCisplatin expresses the 
opposite where there is no modal sub-population seen with every cell 
possessing an unique cytogenetic assignment.  Further work is required to 
assess the nature of other chromosomes within these cell lines, and the 
possibility of sequential probes across chromosomes of interest (such as the 
possible chromothripsis of 17) to understand the mechanisms of this cancer 
better.  
To summarise, this thesis has shown that the technique of FISH is suitable for modern 
genomic studies across different fields via use of the multilayer methodology enabling 
extensive data to be produced at a much low cost compared to previous FISH 
methodologies (section 3.6.3). Rightly so, the technique of FISH has been effectively 
‘refreshed’ for use in a modern day laboratory. Also shown, new methods that can apply to 
cytogenetic studies are; a means of testing new commercial or homemade buffers and the 
creation of algorithms to determine chromosome probe order and assignment in 
interphase nuclei. These techniques alongside the multilayer method have demonstrated 
usefulness in a wide range of cytogenetic areas, such as the identification of 
rearrangements that exist within previously studied species, an updated assignment of a 
useful research cell line, and the exploration into human neuroblastoma cell lines which 
have gained resistance to modern day cytotoxic drugs.  These summarise a small area 
within cytogenetics where the multilayer method could be a valuable tool for and many 
more questions can be aided furthermore in respect to the work outlined in this thesis.  
7.2 Impact of the Multilayer Fluorescent in Situ Hybridisation 
method  
As previously stated the use of the multilayer method has enabled a variety of areas to 
be investigated relating to multiple areas of genetics.  The number of studies that exist 
whereby the use of whole exome sequencing as compared to a single cell approach is 
vastly increasing (Figure 1.16, Shi, 2018), it has been reported and seen in many 
studies/cases that this wider approach can miss small yet significant events relating to a 
multitude of issues, the key one being the development of resistant cancers (Baca, 2013; 
Navin et al., 2011; Storchova  & Pellman, 2004; Storchova & Kuffer, 2008; International 
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Cancer Genome Consortium, 2010; Allen et al., 2014). The use of multilayer FISH can 
increase the usefulness of the cytogenetic s led research opposed to sole reliance on NGS 
techniques to somewhat balance the scales between the two overarching approaches. The 
reduction of cost as demonstrated in chapter 2 (approximately four times the difference 
when performing large studies, using the example from 3.6.3, applied to 23 chromosomes 
of a human we would expect a cost of £210 for the multilayer method as compared to 
£1,189 for traditional FISH) should be an important factor in use of this methodology as 
costs of multiple fluorophores and a limitation of number of fluorophores used at any one 
time is a major off-putting reason to abstain from use of FISH techniques (Eastmond et al., 
1995; Hasty & Montagna, 2014). Now having established a technique that has been shown 
to display useful results across multiple areas of study, one should hope that its application 
has a positive effect across multiple genomic fields and allow the appreciation of FISH as a 
suitable 21st century technique. 
7.3 Future studies in light of this thesis 
Presented throughout this thesis are many examples of areas of research that could be 
further explored in light of results presented here, however here I wish to highlight some 
key areas that are worthy of being singled out.  
1. Re-investigating intrachromosomal rearrangements within species of similar 
order to reinforce phylogenetic assignment. As seen in chapter 4, there are 
hidden intrachromosomal modifications which have been overlooked by 
traditional painting methods to be detected using multilayer FISH. These may 
be of significant use in the classification of debatable existing assignment for 
any organism with established sequences along their chromosomes to 
generate probes. This would be a substantial aid, to be paired alongside NGS 
techniques, for evolutionary cytogenetic areas of questionable assignment. 
 
2.  The generation of a standalone script or plug-in to adapt methods represented 
in chapter 4 to correctly assign and interpret signals within an interphase 
nuclei.  Far beyond the reach of this thesis, the means to correctly identify 
folding patterns of chromosomes within nuclei would be a tremendous factor 
to better understand gene expression and control in any cell. In particular, 
finding differences between a ‘normal’ and aberrated chromosome, such as in 
the event of a cancer within an interphase state can only be of benefit to make 
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links towards how a mutative event in the genome can induce observable 
phenotypic changes across a cell. Furthermore, future work to follow on from 
the expansion of the current chromosome folding software would be to adapt 
its usage for a 3D environment, such as with a confocal microscope, which 
would only benefit users further.  
 
3. More work should be conducted on the NB3 cell line and its resistant 
derivatives to close links between the phylogenetic trees proposed within 
chapter 6. As limited by probe material in this study, the generation of varied 
panels of probes for every chromosome can fully assess the genome at a single 
cell level and reflect upon the heterogeneity across the cell line population. It 
would be of great reward to synthesise a system of ‘a BAC at every loci’ to be 
applied to future cell lines of interest (possibly in a similar fashion to the 
chromoprobe device used in chapter 5) to assess the genome of a cancerous 
cell line from a ‘top down’ perspective. 
 
4. The excessive heterogeneity identified within chapter 6 can be used to 
comment on the genomic instability cancers embrace, especially those with 
poor prognosis and limited clinical choices. It is also reflective of the state of 
research cell lines used over many years, as they may have mutated to become 
non-comparable as compared to when they were first isolated; is this a 
disadvantage of laboratory-based research? I would propose that (with aid of 
expert clinicians) when a primary tumour is identified within a patient the 
genomic arrangement be tracked at this stage and at further biopsies during 
the course of treatment. Here possible clinical events such as remission, 
reoccurrence and resistance could be identified throughout treatment rather 
than a singular ‘snapshot’ from a single biopsy (which could be at any stage of 
cancer progression) that may not be representative of the cancer at these key 








7.5 Concluding remarks  
The journey that this PhD and culmination into a thesis is one that will leave a lasting 
effect upon me, which I shall look fondly upon in the future. The opportunity to be involved 
in a field of vast progression and groundbreaking research where I have somewhat 
contributed towards is an achievement I can be proud of. With the synthesis of the 
multilayer method, I like to entertain the possibility that this is a means of giving back to 
the scientific community; to further aid research in a multitude of genetic fields for the 
selflessness means to benefit society as a whole.  I will treasure the fact that I have been 
able to isolate myself in such a precise niche of scientific research by solving the problem of 
modernising FISH to apply to many different yet interesting areas of biology where in 
truthfulness each deserve a whole PhD project of their own to fully appreciate.  
With such a deeper understanding of genomics at this time we shall soon expect vast 
improvements within many aspects of everyday life. Even now there are many products 
that allow a level of personalised genomic information to be revealed such as ancestry and 
a drive within the National Health Service to fully sequence multiple thousands of healthy 
patients for medical focused research. The ‘genomic age’ is soon to be upon us with 
extensive personalised medicine and tailored products we cannot even start to guess may 
look like. To comment on the state of society and it’s capability for these upcoming changes 
is far too in-depth for me to comment on, however though understanding of biology and 
genetics shall enable a prepared generation to exceed and flourish in this new age. This is 
but a single reason of many to direct my own future endeavours; by pursuing a career in 
education, to divulge the wonders of life (governed by genetics) to future generations we 
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Identifier Colour Position Loci 




2 ALK Breakapart FITC + TX 2P 
FITC 2p23.2p23.1 
TX 2p23.2-p23.1 
3 Paint FITC Paint 
 
4 Alp.Sat. TX Centromere TX p11.1-q11.1 
6/14 
IGH / CCND3 
Translocation, Dual 
fusion 
FITC + TX 6P + 14Q 
FITC 14q32.33 
TX 6p21 
8 Alp.Sat. TX Centromere TX  8p11.1-q11.1 
9 Apl.sat FITC Centromere FITC 9q12 
10 Alp.Sat. FITC Centromere FITC 10p11.1-q11.1 
11 Alp.Sat. FITC Centromere FITC 11p11.1-q11.1 
12 Alp.Sat. FITC Centromere FITC 12p11.1-q11.1 
13 D13S25 Deletion FITC+TX 13Q 
FITC 13q34 / Tx 
13q14.3 
 








17 Classical Sat. Blue Centromere Blue 17p11.1-q11.1 










22 IGL Breakapart TX+FITC 22Q 
FITC 22q11.23 
Tx 22q11.21 







Measuring FLpter script VS Manual measurement, Paired T-test 
results 4.2.1 
Probe A  Script score Manual score 
Mean 0.04702 0.071992 
Variance 0.001561 0.000505 
Observations 20 20 
Pearson Correlation 0.58294 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -3.47802 
 P(T<=t) one-tail 0.001259 
 t Critical one-tail 1.729133 
 P(T<=t) two-tail 0.002518 
 t Critical two-tail 2.093024  
 Probe B 
  Mean 0.193485 0.224616 
Variance 0.00168 0.000762 
Observations 20 20 
Pearson Correlation 0.250599 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -3.21545 
 P(T<=t) one-tail 0.002277 
 t Critical one-tail 1.729133 
 P(T<=t) two-tail 0.004554 
 t Critical two-tail 2.093024  
Probe C 
  Mean 0.282626 0.306693 
Variance 0.002182 0.001979 
Observations 19 19 
Pearson Correlation 0.532197 
 Hypothesized Mean Difference 0 
 df 18 
 t Stat -2.37605 
 P(T<=t) one-tail 0.014403 
 t Critical one-tail 1.734064 
 P(T<=t) two-tail 0.028807 
 t Critical two-tail 2.100922  
Probe D 
  Mean 0.768715 0.707258 
Variance 0.007119 0.001612 
Observations 20 20 
Pearson Correlation 0.32406 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat 3.399726 
 P(T<=t) one-tail 0.001503 
 t Critical one-tail 1.729133 
 P(T<=t) two-tail 0.003006 
 t Critical two-tail 2.093024  
Probe E 
  Mean 0.82814 0.839619 
Variance 0.001868 0.000427 
Observations 20 20 
Pearson Correlation 0.294843 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -1.22068 
 P(T<=t) one-tail 0.11857 
 t Critical one-tail 1.729133 




t Critical two-tail 2.093024 
 Probe F 
  Mean 0.91841 0.935292 
Variance 0.001354 0.000879 
Observations 20 20 
Pearson Correlation 0.538261 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -2.32048 
 P(T<=t) one-tail 0.015798 
 t Critical one-tail 1.729133 
 P(T<=t) two-tail 0.031596 
 t Critical two-tail 2.093024  
Total Length of chromosome 
  Mean 104.9502 112.7868 
Variance 747.042 988.828 
Observations 20 20 
Pearson Correlation 0.973931 
 Hypothesized Mean Difference 0 
 df 19 
 t Stat -4.46056 
 P(T<=t) one-tail 0.000134 
 t Critical one-tail 1.729133 
 P(T<=t) two-tail 0.000268 
 t Critical two-tail 2.093024  
 
 
